
<html lang="en"     class="pb-page"  data-request-id="d276d85f-a5c4-4029-a98b-1470cb1cd463"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01279;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases" /></meta><meta name="dc.Creator" content="Wooseok  Han" /></meta><meta name="dc.Creator" content="Yu  Ding" /></meta><meta name="dc.Creator" content="Zheng  Chen" /></meta><meta name="dc.Creator" content="John L.  Langowski" /></meta><meta name="dc.Creator" content="Cornelia  Bellamacina" /></meta><meta name="dc.Creator" content="Alice  Rico" /></meta><meta name="dc.Creator" content="Gisele A.  Nishiguchi" /></meta><meta name="dc.Creator" content="Jiong  Lan" /></meta><meta name="dc.Creator" content="Gordana  Atallah" /></meta><meta name="dc.Creator" content="Mika  Lindvall" /></meta><meta name="dc.Creator" content="Song  Lin" /></meta><meta name="dc.Creator" content="Richard  Zang" /></meta><meta name="dc.Creator" content="Paul  Feucht" /></meta><meta name="dc.Creator" content="Tatiana  Zavorotinskaya" /></meta><meta name="dc.Creator" content="Yumin  Dai" /></meta><meta name="dc.Creator" content="Pablo  Garcia" /></meta><meta name="dc.Creator" content="Matthew T.  Burger" /></meta><meta name="dc.Description" content="Overexpression of PIM 1, 2, and 3 kinases is frequently observed in many malignancies. Previously, we discovered a potent and selective pan-PIM kinase inhibitor, compound 2, currently in phase I cl..." /></meta><meta name="Description" content="Overexpression of PIM 1, 2, and 3 kinases is frequently observed in many malignancies. Previously, we discovered a potent and selective pan-PIM kinase inhibitor, compound 2, currently in phase I cl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 1, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01279" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01279" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01279" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01279" /></link>
        
    
    

<title>Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01279" /></meta><meta property="og:title" content="Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0013.jpeg" /></meta><meta property="og:description" content="Overexpression of PIM 1, 2, and 3 kinases is frequently observed in many malignancies. Previously, we discovered a potent and selective pan-PIM kinase inhibitor, compound 2, currently in phase I clinical trials. In this work, we were interested in replacing the amino group on the cyclohexane ring in compound 2 with a hydroxyl group. Structure-based drug design led to cellularly potent but metabolically unstable tetra-substituted cyclohexyl diols. Efforts on the reduction of Log D by introducing polar heterocycles improved metabolic stability. Incorporating fluorine to the tetra-substituted cyclohexyl diol moiety further reduced Log D, resulting in compound 14, a cellularly potent tetra-substituted cyclohexyl diol inhibitor with moderate metabolic stability and good permeability. We also describe the development of efficient and scalable synthetic routes toward synthetically challenging tetra-substituted cyclohexyl diol compounds. In particular, intermediate 36 was identified as a versatile intermediate, enabling a large-scale synthesis of highly substituted cyclohexane derivatives." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01279"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01279">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01279&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01279&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01279&amp;href=/doi/10.1021/acs.jmedchem.0c01279" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 14885-14904</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01303" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01451" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Wooseok Han</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wooseok Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#0a7d6565796f656124626b644a6d676b636624696567"><span class="__cf_email__" data-cfemail="05726a6a76606a6e2b6d646b456268646c692b666a68">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wooseok++Han">Wooseok Han</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7567-1883" title="Orcid link">http://orcid.org/0000-0002-7567-1883</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu Ding</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Ding</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">BeiGene, Ltd., San Mateo, California 94403, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Ding">Yu Ding</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zheng Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zheng Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Boston Analytical, Salem, New Hampshire 03079, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Chen">Zheng Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John L. Langowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John L. Langowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Kite, a Gilead Company, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+L.++Langowski">John L. Langowski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cornelia Bellamacina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cornelia Bellamacina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Crystallographic Consulting, Berkeley, California 94704, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cornelia++Bellamacina">Cornelia Bellamacina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alice Rico</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alice Rico</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Exelixis, Alameda, California 94502, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alice++Rico">Alice Rico</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gisele A. Nishiguchi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gisele A. Nishiguchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gisele+A.++Nishiguchi">Gisele A. Nishiguchi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiong Lan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiong Lan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Genfleet Therapeutics, Inc., Pudong District, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiong++Lan">Jiong Lan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gordana Atallah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gordana Atallah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Pharmacyclics, an AbbVie Company, Sunnyvale, California 94085, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gordana++Atallah">Gordana Atallah</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mika Lindvall</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mika Lindvall</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Recursion Pharmaceuticals, Salt Lake City, Utah 84101, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mika++Lindvall">Mika Lindvall</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Song Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Song Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Astex Pharmaceuticals Inc., Pleasanton, California 94588, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Song++Lin">Song Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Zang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Zang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Global Blood Therapeutics, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Zang">Richard Zang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Feucht</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Feucht</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Feucht">Paul Feucht</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tatiana Zavorotinskaya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tatiana Zavorotinskaya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">ORIC Pharmaceuticals, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tatiana++Zavorotinskaya">Tatiana Zavorotinskaya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yumin Dai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yumin Dai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Bristol Myers Squibb, Redwood City, California 94158, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yumin++Dai">Yumin Dai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pablo Garcia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pablo Garcia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Circle Pharma, Inc., South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pablo++Garcia">Pablo Garcia</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Matthew T. Burger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew T. Burger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+T.++Burger">Matthew T. Burger</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01279&amp;href=/doi/10.1021%2Facs.jmedchem.0c01279" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 14885–14904</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 1, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 August 2020</li><li><span class="item_label"><b>Published</b> online</span>1 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01279</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D14885%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWooseok%2BHan%252C%2BYu%2BDing%252C%2BZheng%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D23%26contentID%3Dacs.jmedchem.0c01279%26title%3DSynthesis%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2BTetra-Substituted%2BCyclohexyl%2BDiol%2BInhibitors%2Bof%2BProviral%2BInsertion%2Bof%2BMoloney%2BVirus%2B%2528PIM%2529%2BKinases%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D14904%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01279"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1140</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01279" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wooseok&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;L. Langowski&quot;},{&quot;first_name&quot;:&quot;Cornelia&quot;,&quot;last_name&quot;:&quot;Bellamacina&quot;},{&quot;first_name&quot;:&quot;Alice&quot;,&quot;last_name&quot;:&quot;Rico&quot;},{&quot;first_name&quot;:&quot;Gisele&quot;,&quot;last_name&quot;:&quot;A. Nishiguchi&quot;},{&quot;first_name&quot;:&quot;Jiong&quot;,&quot;last_name&quot;:&quot;Lan&quot;},{&quot;first_name&quot;:&quot;Gordana&quot;,&quot;last_name&quot;:&quot;Atallah&quot;},{&quot;first_name&quot;:&quot;Mika&quot;,&quot;last_name&quot;:&quot;Lindvall&quot;},{&quot;first_name&quot;:&quot;Song&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Zang&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Feucht&quot;},{&quot;first_name&quot;:&quot;Tatiana&quot;,&quot;last_name&quot;:&quot;Zavorotinskaya&quot;},{&quot;first_name&quot;:&quot;Yumin&quot;,&quot;last_name&quot;:&quot;Dai&quot;},{&quot;first_name&quot;:&quot;Pablo&quot;,&quot;last_name&quot;:&quot;Garcia&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;T. Burger&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;14885-14904&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01279&quot;},&quot;abstract&quot;:&quot;Overexpression of PIM 1, 2, and 3 kinases is frequently observed in many malignancies. Previously, we discovered a potent and selective pan-PIM kinase inhibitor, compound 2, currently in phase I clinical trials. In this work, we were interested in replacing the amino group on the cyclohexane ring in compound 2 with a hydroxyl group. Structure-based drug design led to cellularly potent but metabolically unstable tetra-substituted cyclohexyl diols. Efforts on the reduction of Log D by introducing polar heterocycles improved metabolic stability. Incorporating fluorine to the tetra-substituted cyclohexyl diol moiety further reduced Log D, resulting in compound 14, a cellularly potent tetra-substituted cyclohexyl diol inhibitor with moderate metabolic stability and good permeability. We also describe the development of efficient and scalable synthetic routes toward synthetically challenging tetra-substituted cyclohexyl diol compounds. In particular, intermediate 36 was identified as a versatile intermediate, enabl&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01279" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01279&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01279" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01279&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01279" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01279&amp;href=/doi/10.1021/acs.jmedchem.0c01279" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01279" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01279" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01279%26sid%3Dliteratum%253Aachs%26pmid%3D33258605%26genre%3Darticle%26aulast%3DHan%26date%3D2020%26atitle%3DSynthesis%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2BTetra-Substituted%2BCyclohexyl%2BDiol%2BInhibitors%2Bof%2BProviral%2BInsertion%2Bof%2BMoloney%2BVirus%2B%2528PIM%2529%2BKinases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D23%26spage%3D14885%26epage%3D14904%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292020" title="Diols">Diols</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/jmcmar.2020.63.issue-23/20201210/jmcmar.2020.63.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Overexpression of PIM 1, 2, and 3 kinases is frequently observed in many malignancies. Previously, we discovered a potent and selective pan-PIM kinase inhibitor, compound <b>2</b>, currently in phase I clinical trials. In this work, we were interested in replacing the amino group on the cyclohexane ring in compound <b>2</b> with a hydroxyl group. Structure-based drug design led to cellularly potent but metabolically unstable tetra-substituted cyclohexyl diols. Efforts on the reduction of Log D by introducing polar heterocycles improved metabolic stability. Incorporating fluorine to the tetra-substituted cyclohexyl diol moiety further reduced Log D, resulting in compound <b>14</b>, a cellularly potent tetra-substituted cyclohexyl diol inhibitor with moderate metabolic stability and good permeability. We also describe the development of efficient and scalable synthetic routes toward synthetically challenging tetra-substituted cyclohexyl diol compounds. In particular, intermediate <b>36</b> was identified as a versatile intermediate, enabling a large-scale synthesis of highly substituted cyclohexane derivatives.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proviral insertion of Moloney virus (PIM) kinases is a family of three serine/threonine kinases (PIM1, PIM2, and PIM3) initially identified as frequent sites of integration in viral-induced murine lymphomas.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In a normal setting, PIM expression is induced in response to growth factors and cytokines to promote the survival and proliferation of hematopoietic cells, and their activity is primarily regulated by the balance between synthesis and degradation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, the overexpression of PIMs <i>in vitro</i> or in transgenic mouse models has confirmed a role for this family in tumorigenesis of hematological tissues, either alone or in synergy with other oncogenes.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> In humans, increased expression of PIM1 is reported in acute lymphoblastic leukemia, acute myeloid leukemia, and diffuse B-cell lymphoma, while high PIM2 expression is noted in multiple myeloma.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In addition, increased expression or dysfunction of all three PIMs has been reported in solid tumors including those of prostate, hepatocellular, colon, and gastric origin.<a onclick="showRef(event, 'ref2 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8 ref9 ref10">(2,7−10)</a></div><div class="NLM_p">Given the apparent functional redundancy of PIMs in oncogenesis and a differential expression across a wide array of cancers, a pan-PIM kinase inhibitor would be predicted to offer the greatest potential clinical utility.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In addition, elevated expression of PIM2 specifically has been described in multiple myeloma relative to other hematologic cancers, and this expression has been shown to be required for proliferation, presenting an effective pharmacological target for inhibition.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, identification of pan-PIM inhibitors retaining potent PIM2 inhibitory capacity in myeloma cells is challenging given the 10–100 times lower <i>K</i><sub>m</sub> for ATP possessed by PIM2 relative to PIM1 and PIM3.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21">(13−21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Novartis pan-PIM Inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the course of our lead optimization efforts on the pyridylcarboxamide scaffold, we reported the discovery of compound <b>1</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> a potent pan-PIM inhibitor and <i>in vivo</i> tool compound, through the structure-guided optimization of a singleton HTS hit (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Compound <b>1</b> demonstrated <i>in vivo</i> efficacy in multiple myeloma (KMS-11.luc) and acute myeloid leukemia (EOL-1) xenograft mouse models. However, it showed high clearance in human liver microsomes, and the piperidine A-ring was identified as the major metabolic moiety by metabolic identification studies. Replacements of the piperidine A-ring with other rings such as heteroaryl<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and cyclohexyl were explored, and cyclohexane rings improved metabolic stability in liver microsomes, resulting in the identification of an orally available, potent, and selective pan-PIM kinase inhibitor (PIM447), compound <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We recently disclosed the phase I clinical trial data for PIM447 that displayed good tolerability and single agent efficacy in several patients with relapsed/refractory multiple myeloma.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p last">A key structural motif of compound <b>2</b> is the cyclohexyl amine moiety. The X-ray co-crystal structure in PIM1 showed that the amino group participated in polar H-bond interactions with the Asp128 side chain carboxylate and the Glu171 backbone carbonyl in the ribose patch, which are crucial for PIM potency.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In the early stage of the discovery of compound <b>2</b>, we were interested in replacing the amino group with non-basic isosteres such as a hydroxyl group as an alternative H-bond acceptor and donor. Without an ionizable group, such molecules could differentiate and display distinct overall drug properties.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Herein, we present the medicinal chemistry efforts on optimizing cyclohexyl diol inhibitors of pan-PIM kinases focusing on improving metabolic stability and cellular potency and describe the development of a diverse set of efficient synthetic routes to access synthetically challenging highly substituted cyclohexyl diol intermediates.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Medicinal Chemistry</h3><div class="NLM_p">Our medicinal chemistry efforts of the cyclohexyl diol series began with replacement of the amino group of compound <b>2</b> with a hydroxyl group. We initially performed molecular docking studies of compound <b>3</b> with PIM1 kinase, which displayed a single H-bond interaction between the hydroxyl group and the Glu171 residue, unlike the amino group of compound <b>2</b> that makes two H-bond interactions with Glu171 and Asp128 residues, as shown in the X-ray co-crystal structure (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure of compound <b>2</b> in PIM1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR">5DWR</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As predicted from the docking result, the potency of compound <b>3</b> decreased in both biochemical and cellular assays (EC<sub>50</sub> = 3.41 μM, >20-fold decrease in potency in the KMS-11.luc assay, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Because the biochemical potency reached the lowest limit of detection in the series, the cellular potency was used as to guide SAR. The permeability profile of compound <b>3</b> was encouraging [Caco-2 assay: <i>P</i><sub>app</sub> (A–B) = 26.5 × 10<sup>–6</sup> cm/s, ER = 0.9]; however, the increased lipophilicity (Log D = 4.6) resulted in high intrinsic clearance in liver microsomes across species (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In the previous piperidinyl amine series, a hydroxyl group adjacent to the amino group was successfully implemented to improve drug-like properties by lowering Log D.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Based on this knowledge, we synthesized the <i>trans</i>-diol analogue, compound <b>4</b>, with a reduced Log D value (Log D = 3.0). The introduction of the additional hydroxyl group favorably influenced microsomal intrinsic clearance while having no negative impact on Caco-2 permeability and efflux, and a slight gain in cellular potency (EC<sub>50</sub> = 1.88 μM) was achieved relative to compound <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Next, we employed a structure-based drug design approach to further improve on the potency of compound <b>4</b>. As previously reported for compounds <b>1</b> and <b>2</b>,<a onclick="showRef(event, 'ref13 ref23'); return false;" href="javascript:void(0);" class="ref ref13 ref23">(13,23)</a> the methyl group at the 5-position fills a hydrophobic dimple in the glycine rich loop, resulting in the potency increase with minimal increase in lipophilicity. Therefore, we pursued the same strategy by examining the glycine rich loop region in the docking pose of compound <b>4</b>. It was anticipated that the axial methyl group at the 4-position would make a hydrophobic contact with the Phe49 residue of the glycine rich loop (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). We synthesized compound <b>5</b> and observed an increase in the cellular potency by 6-fold (EC<sub>50</sub> = 0.32 μM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with minimal increase in lipophilicity (Log D = 3.2). Since compounds <b>4</b> and <b>5</b> have similar Caco-2 values, it was thought that the increased cellular potency mainly resulted from the increase in the binding affinity of compound <b>5</b> to the PIM kinases by incorporating the 4-methyl group. We obtained the X-ray co-crystal structure of compound <b>5</b> in PIM1 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b), which demonstrated that the methyl group at the 4-carbinol position of the cyclohexane ring clearly made a hydrophobic interaction with Phe49 residue of the P-loop, as predicted by the docking model (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). The X-ray structure also revealed that the 4-hydroxyl group participates in a hydrogen bond network with the Asp128 residue, an interaction that was not present in the X-ray structure of compound <b>1</b> illustrating the flexibility of the side chain of Asp128.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking model of compound <b>4</b> and the X-ray structure of compound <b>5</b> in PIM1. (a) Docking model of 4-methyl analogue of compound <b>4</b> in PIM1. (b) X-ray co-crystal structure of compound <b>5</b> in PIM1. The hydroxyl groups at the 3- and 4-positions on the cyclohexyl A-ring form H-bond interactions with the backbone residues Glu171 and Asp128, respectively. While the methyl group at the carbinol carbon made a hydrophobic interaction with Phe49, the methyl group at the 5-position occupies the hydrophobic dimple under the P-loop. The pyridine nitrogen at the B-ring interacts with the catalytic Lys67 residue (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1oblv">1oblv</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potency, Clearance, Permeability, and Physicochemical Property for PIM Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0012.gif" alt="" id="GRAPHIC-d7e849-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">Ki (mM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">CL<sub>int</sub> (mL/min/kg)</th><th class="rowsep1 colsep0" colspan="2" align="center">ER_H<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Caco-2</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd no.</th><th class="colsep0 rowsep0" align="center">PIM1</th><th class="colsep0 rowsep0" align="center">PIM2</th><th class="colsep0 rowsep0" align="center">PIM3</th><th class="colsep0 rowsep0" align="center">cell prolif KMS-11 luc EC<sub>50</sub> (mM)</th><th class="colsep0 rowsep0" align="center" char=".">log D<sub>7.4</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">tPSA (Å)</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub>A–B (10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">ER (<i>P</i><sub>app</sub>B–A/<i>P</i><sub>app</sub>A–B)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">0.017</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="left">198</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">0.88</td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.51</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left">0.004</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left">3.41</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="left">375</td><td class="colsep0 rowsep0" align="left">352</td><td class="colsep0 rowsep0" align="left">0.93</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="char" char=".">26.5</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">1.88</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" align="char" char=".">28.8</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="left">183</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="char" char=".">27.6</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" colspan="4" align="center">N/D</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="left">0.004</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">108</td><td class="colsep0 rowsep0" colspan="4" align="center">N/D</td><td class="colsep0 rowsep0" align="char" char=".">13.4</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">1.06</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">0.71</td><td class="colsep0 rowsep0" align="char" char=".">28.1</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">0.93</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="left">149</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="char" char=".">10.1</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="char" char=".">23.5</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left">0.004</td><td class="colsep0 rowsep0" align="left">3.24</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.011</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">1.71</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="left">133</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="char" char=".">30.3</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">1.74</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Measured Log D at pH 7.4.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">ER_H (hepatic extraction ratio) = CL<sub>h</sub>/Q<sub>h</sub> (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">ER: Efflux ratio (<i>P</i><sub>app</sub>B–A/<i>P</i><sub>app</sub>A–B).</p></div></div></div><div class="NLM_p">However, while compound <b>5</b> exhibited increased potency relative to compound <b>4</b>, it showed high <i>in vitro</i> and <i>in vivo</i> clearance<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> in rats (CL<sub>int</sub> = 187 μL/min/mg and CL = 56 mL/min/kg, respectively), which correlated with the increased Log D (Log D for compound <b>5</b> = 3.2, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Having identified the 4-axial methyl group in the cyclohexyl diol A ring as a driver of potency, we next focused on improving metabolic stability of compound <b>5</b> by focusing on physicochemical properties, especially lowering Log D by introducing polar C and/or D rings. C ring heterocycle analogues of compound <b>5</b> were first explored. Compounds <b>6</b> and <b>7</b>, thiazole, and pyrimidine C ring analogues were not potent in KMS-11.luc cellular assay, but the corresponding analogues having a hinge amino group on the C-ring, compounds <b>8</b> and <b>9</b>, showed around 1 μM in the cellular proliferation assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Interestingly, while the hinge amino group in thiazole and pyrimidine C rings provided a positive effect on cellular potency, pyridine C ring analogues showed the opposite trend; des-hinge amino compound <b>5</b> was slightly more potent than compound <b>10</b>. Our previous observation in other series was that the hinge amino group negatively affected permeability and/or efflux, but the cyclohexyl diol series did not show much difference on the Caco-2 values irrespective of the presence of hinge amino group. In addition, the introduction of a hinge amino group to the C ring did not affect liver microsomal clearance profiles, except for clearance in human liver microsomes for compound <b>9</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We then investigated heterocyclic D rings such as thiazole, pyrazole, and pyridine in the presence of hinge amino C rings. Among them, compound <b>11</b>, a fluoropyridine D ring analogue, displayed moderate extraction ratio in rat and human liver microsomes in alignment with a lower Log D value (Log D for compound <b>11</b> = 2.3, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). It was the first compound that showed a modest clearance in rat liver microsomes among cell active compounds in the series. A subsequent rat PK study of compound <b>11</b> showed good oral bioavailability (% <i>F</i> = 49) and moderate clearance (CL = 18 mL/min/kg). However, the cellular proliferation EC<sub>50</sub> of compound <b>11</b> was not satisfactory (3.24 μM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), probably due to the reduced permeability and increased efflux [Caco-2 assay: <i>P</i><sub>app</sub> (A–B) = 6.61 × 10<sup>–6</sup> cm/s, ER = 6.9] relative to compound <b>5</b> [Caco-2 assay: <i>P</i><sub>app</sub> (A–B) = 27.6 × 10<sup>–6</sup> cm/s, ER = 1.1]. Since compound <b>11</b> has a hinge amino group that might deteriorate selectivity against other kinases, we assessed its kinase selectivity using an internal panel of 36 kinases (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_001.pdf" class="ext-link">Supporting Information</a>). Gratifyingly, compound <b>11</b> was highly selective against 35 kinases (IC<sub>50</sub>s > 10 μM), while maintaining >100-fold selectivity against GSK3β (IC<sub>50</sub> = 0.54 μM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Having demonstrated that oral bioavailablity in the cyclohexyl diol series could be achieved, we turned our attention back to the diol functionality on the A-ring to further enhance the cellular potency. We hypothesized that incorporation of additional lipophilicity to the quaternary methyl group would increase membrane permeability by shielding the polar group<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> or <i>via</i> an intramolecular hydrogen bond.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Docking studies demonstrated that a methyl or fluorine would accommodate into the ligand pocket surface of the glycine rich residues.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">Therefore, we synthesized ethyl and fluoromethyl analogues of <b>11</b>, compounds <b>12</b> and <b>13</b>. Compared to compound <b>11</b> [EC<sub>50</sub> = 3.24 μM, <i>P</i><sub>app</sub>(A–B) = 6.61, ER = 6.9, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>], both compounds improved the permeability and reduced the efflux ratio in Caco-2 permeability assay as hypothesized, but surprisingly, it did not significantly translate into the cellular potency (EC<sub>50</sub> = 1.71 and 1.74 μM for <b>12</b> and <b>13</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). While the increased Log D value of compound <b>12</b> (Log D = 3.2) had a positive effect on the permeability in Caco-2 assay, it resulted in high microsomal clearances in rat and human liver microsomes. Compound <b>13</b> maintained the moderate intrinsic clearances that were explicable because it has a lower Log D value (1.8 <i>vs</i> 2.3) than compound <b>11</b>.</div><div class="NLM_p">We obtained the X-ray co-crystal structure of compound <b>13</b> in PIM1 protein (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The binding pose was almost identical to that of compound <b>5</b> with a newly formed hydrogen bond between Glu121 residue with the hinge amino group of compound <b>13</b>. As shown in compound <b>5</b>, the 4-hydroxyl group makes a hydrogen bond interaction with Asp128. The fluoro group in the fluoromethyl faces toward Phe49 residue, being in the gouche and anti-conformations with 3- and 4-hydroxyl groups, respectively. In the fluoropyridine D-ring, the pyridine nitrogen is located in the opposite side of the C ring pyridine nitrogen.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray co-crystal structure of compound <b>13</b> in PIM1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ozrb">1ozrb</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We continued to evaluate combinations of other C and/or D ring analogues of compound <b>13</b>. Among them, compound <b>14</b> with the aminopyrimidine C ring displayed a low Log D value (1.4, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and maintained good permeability and low efflux potential in Caco-2 assay that translated to improved cell proliferation activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Gratifyingly, compound <b>14</b> showed an EC<sub>50</sub> of 0.25 μM in KMS-11.luc assay that was comparable to 0.18 μM for the clinical candidate, compound <b>2</b>. In comparison with its des-fluoro analogue, compound <b>9</b>, the fluorine effect<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> on compound <b>14</b> was more pronounced with respect to permeability and Log D. The permeability and efflux profiles were improved even with a lower Log D value by 1.4 unit (Log D for compound <b>14</b>: 1.4), which apparently resulted in the 3.7 fold increase in cellular potency, while still maintaining moderate intrinsic clearances. However, this fluoro addition reduced solubility (HT-Eq Sol. at pH 7.4: 6 μM for compound <b>14</b>; 19 μM for compound <b>9</b>) but improved the CYP inhibition profile of compound <b>14</b> (IC<sub>50</sub>s of CYP450 3A4, 2C9, 2D6, and 1A2 isozymes: >30 μM for compound <b>14</b>; 26, 9.8, 9.9, and >30 μM, respectively, for compound <b>9</b>). Also, compound <b>14</b> demonstrated a superior permeability and efflux profile to the basic amine analogues, compounds <b>1</b> and <b>2</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Due to the advancement of compound <b>2</b> (PIM447) to clinical stage, we made no further effort to pursue the cyclohexyl diol series. Overall, we demonstrated the improvement of permeability and microsomal stability by reducing Log D values through the structural modification of diol functionality and the introduction of polar C and/or D ring, resulting in the achievement of a cellularly potent pan-PIM inhibitor in the cyclohexyl diol series. In general, these cyclohexyl diol analogues did not show strong inhibitory activities against CYP450 enzymes and hERG potassium channel.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our strategy for the synthesis of hydroxy- or di-hydroxy-substituted cyclohexyl analogues was to utilize (±)-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-en-1-one <b>15</b>, a key intermediate for cyclohexyl amine A–B ring of compound <b>2</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> to develop efficient and scalable syntheses to various tetra-substituted cyclohexyl diol intermediates. The final compounds were synthesized through amide coupling reaction between A–B rings and the corresponding C–D ring acids. When C–D ring acid intermediates were not accessible, C ring acids were used for amide coupling reaction with A–B rings followed by Suzuki coupling reaction to introduce the D ring. A racemic mixture of final compounds or intermediates was resolved by chiral HPLC. On the basis of X-ray co-crystal structural information and/or biochemical results, we assigned absolute stereochemistry for the final compounds.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chiral separation; (b) TBDMSCl, imidazole, >99%; (c) H<sub>2</sub>, Pd on carbon, EtOAc, MeOH, 2 h, 85%; (d) EDC, HOAt, DMF; (e) HCl, THF, MeOH, 37% (over 2 steps); (f) <sup><i>t</i></sup>BuOK, THF, 90%; (g) AcOH (cat.), MeCN, water, 33%; (h) TBDMSCl, imidazole, 50%; (i) H<sub>2</sub>, Pd on carbon, EtOAc, EtOH, 50%; (j) chiral separation, 43%; (k) <b>18</b>, EDC, HOAt, DMF, >99%; (l) HCl, THF, MeOH, 57% (over 2 steps).</p></p></figure><div class="NLM_p">The synthesis of compound <b>3</b> started from intermediate <b>16</b>. The desired enantiomer of <b>16</b>, benzyl (4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-hydroxy-5-methylcyclohexyl)pyridin-3-yl)carbamate, was protected with a TBDMS group followed by Cbz group deprotection. The resulting amino intermediate <b>17</b> underwent amide coupling with <b>18</b> and subsequent deprotection of the TBDMS group under acidic conditions to yield compound <b>3</b>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">To synthesize the A-B ring diol intermediate <b>22</b>, the bromohydrin intermediate <b>19</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was subjected to basic conditions to produce an epoxide intermediate <b>20</b>. An acid-catalyzed epoxide ring opening reaction afforded a mixture of trans/cis cyclohexene diols in ∼3:2 ratio. After protecting the alcohols with TBDMS, a mixture of trans and cis isomers was separated by a series of purification methods: silica column chromatography and preparative reverse phase HPLC. The desired trans diastereomer <b>21</b> underwent palladium-catalyzed hydrogenation followed by chiral resolution to yield enantiomerically pure intermediate <b>22</b>. After amide coupling between <b>22</b> and <b>18</b> followed by desilylation compound <b>4</b> was obtained. However, the current method to intermediate <b>22</b> gave a very poor yield (3% yield over 8 steps from <b>15</b>) that was not amenable for analogue and large scale. To improve the overall yield, we considered an orthogonal protection on the diol functionality strategy that would facilitate selective functionalization of A-ring diol. To execute this, we examined several different α-hydroxylation reactions of intermediate <b>15</b>. Among them, Rubottom oxidation of <b>23</b> successfully provided the desired α-hydroxy enone <b>24</b>. Whereas the reaction with mCPBA gave poor yield, <i>in situ</i>-generated DMDO<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> afforded good yield of a mixture of trans and cis hydroxy cyclohexenones (1.3:1 ratio) The facial selectivity was slightly favored toward the desired trans isomer <b>24</b>, which was readily separable by silica gel chromatography.</div><div class="NLM_p">The trans isomer <b>24</b> was protected with an acetyl group, and the resulting acetate intermediate underwent NaBH<sub>4</sub> reduction in the presence of CeCl<sub>3</sub> which selectively yielded trans acetoxy cyclohexenol <b>25</b>. Subsequent TBDMS protection and palladium-catalyzed hydrogenation gave a racemic mixture of aniline intermediates that underwent chiral separation to give the desired aniline (<b>26</b>). Compound <b>26</b> was then coupled with intermediate <b>18</b> to yield compound <b>4</b> after the deprotection of TBDMS and acetyl groups. When compared to the previous route to <b>22</b>, this new synthetic route largely improved the yield of intermediate <b>26</b> with one less step (11% yield over 7 steps from <b>15</b>), enabling the scale-up of compound <b>4</b> for <i>in vivo</i> pharmacokinetic studies.</div><div class="NLM_p">For the synthesis of compound <b>5</b> with a quaternary stereogenic center at the 4-position on the cyclohexane ring, we used intermediate <b>27</b> (<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) to modify the 4-position hydroxyl group selectively. Intermediate <b>27</b> was synthesized from the cis isomer of the Rubottom oxidation of <b>23</b> (<b>24-cis</b>), (51% yield over 4 steps, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The amino group of <b>27</b> was then protected with a Boc group to yield a mixture of mono- and bis-Boc protected products. Under basic conditions, the acetyl group underwent hydrolysis to give a 4-hydroxyl intermediate, which concomitantly removed one Boc group from the bis-Boc protected intermediate. The resulting 4-hydroxyl intermediate underwent 1,4 O → O silyl migration<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> leading to a mixture of 3- and 4-hydroxyl intermediates. The mixture was subsequently subjected to Dess–Martin oxidation reaction to afford a mixture of 3- and 4-cyclohexanone intermediates. The desired 4-cyclohexanone <b>28</b> was separated by silica column chromatography (20% yield over 4 steps from <b>27</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). To establish a tertiary alcohol at the 4-position, we tested the addition of MeMgBr to cyclohexanone <b>28</b> to examine axial/equatorial selectivity, which led to the predominant formation of undesired <i>cis</i>-cyclohexane diol resulting from the equatorial attack of the methyl group. On the basis of this outcome, we thought that an exo-methylene group at the 4-position would provide a handle to install hydroxyl group. The exo-methylene intermediate <b>29</b> was successfully synthesized through Peterson olefination reaction of intermediate <b>28</b>. While the epoxidation of <b>29</b> with mCPBA or DMDO mostly formed the N-oxide of <b>29</b> as a byproduct, osmium-catalyzed dihydroxylation provided the triol intermediate <b>30</b> in a highly stereoseletive manner.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The mesylation of the triol <b>30</b> selectively occurred at the primary hydroxy group, followed by LiAlH<sub>4</sub> reduction to yield the diol intermediate <b>31</b>. Sequential selective TBDMS protection and Boc de-protection provided intermediate <b>32</b>, which underwent amide coupling with <b>18</b>. After TBDMS deprotection, the coupling product was resolved by chiral column chromatography to yield compound <b>5</b>. The exo-methylene strategy successfully led to the desired <i>trans</i>-diol intermediate <b>32</b> having a quaternary carbon center, but the overall yield to <b>32</b> was only 4% over 18 steps from <b>15</b>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiHMDS, TMSCl, THF, 0 °C, 96%; (b) Oxone, NaHCO<sub>3</sub>, acetone, water, EtOAc, 2 h, 61% (<b>24</b>/<b>24-cis</b> = 1.3:1); (c) acetic anhydride, pyridine, >99%; (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, THF, MeOH, 97%; (e) TBDMSCl, imidazole, DCM, 84%; (f) H<sub>2</sub>, Pd on carbon, EtOAc, EtOH, 88%; (g) chiral separation, 45%; (h) EDC, HOAt, DMF; (i) HCl, THF, MeOH; (j) LiOH, THF, water, 17% (over 3 steps).</p></p></figure><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ac<sub>2</sub>O, pyridine, 83%; (b) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, THF, MeOH, 82%; (c) TBDMSCl, imidazole, DCM, 75%; (d) H<sub>2</sub>, Pd on carbon, EtOAc, EtOH, >99%; (e) Boc<sub>2</sub>O, DMAP, DCM, 65%; (f) LiOH, THF, 60 °C, 99%; (g) TBDMSCl, imidazole, DCM, 55%; (h) Dess-Martin reagent, DCM, 90%; (i) TMSCH<sub>2</sub>MgCl, THF, 35 °C, 92%; (j) HCl (cat.), acetone, 97%; (k) OsO<sub>4</sub> (cat.), NMO, 77%; (l) MsCl, pyridine, DCM; (m) LiAlH<sub>4</sub>, THF, 98% (over 2 steps); (n) TBDMSCl, imidazole, DCM, 70%; (o) TFA, DCM, >99%; (p) EDC, HOAt, DMF; (q) HCl, THF, MeOH, 45% (over 2 steps); (r) chiral separation, 39%.</p></p></figure><div class="NLM_p">To further improve the current synthetic route, we sought the possibility of early establishment of the exo-methylene moiety on intermediate <b>15</b>. We explored several different carbon-carbon bond formation reactions of <b>15</b>; however, reactions requiring a strong base, such as LiHMDS turned rapidly to a dark purple solution, which was supposedly due to the electron-withdrawing nitropyridine ring, leading to decomposition of the starting material. We found a suitable example for the introduction of an exo-methylene group to the α-position of cyclohexenone using Eschenmoser’s salt.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In order to implement this strategy in our route, we prepared the silyl enol ether <b>23</b> from the common cyclohexenone intermediate <b>15</b>, which reacted with Eschenmoser’s salt to give dimethylaminomethylation intermediate <b>33</b>. Subsequent methylation gave a quaternary ammonium salt <b>34</b>, which underwent elimination under basic conditions to yield α-<i>exo</i>-methylene cyclohexenone <b>35</b>. For further functionalization of <b>35</b>, we performed selective reduction of the carbonyl group under Luche conditions, which successfully yielded <i>cis</i>-cyclohexenol intermediate <b>36</b> as the major isomer.</div><div class="NLM_p">Our initial idea for creating a quarternary carbinol stereogenic center from the exo-methylene group of <b>36</b> was to employ an epoxidation/ring-opening strategy. To do this, after TBDMS group protection of <b>36</b>, the epoxidation of <b>37</b> was performed with mCPBA to afford epoxide intermediate <b>37</b> in good yield without forming a pyridin N-oxide byproduct that was observed in the epoxidation of NHBoc-pyridine compound <b>29</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). However, it turned out that the exo-methylene intermediate <b>37</b> underwent axial epoxidation, providing the epoxide <b>38</b> with unwanted regioselectivity that was confirmed by a <sup>1</sup>H NMR NOE study of <b>38</b>. This result was well supported by literature precedents<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> for similar exo-methylene cyclohexanes, which also described the equatorial epoxide formation through a halohydrin/ring closing reaction from exo-methylene cyclohexanes. Then, we carried out the bromohydrin formation by reacting intermediate <b>36</b> with N-bromosuccinimide in the presence of water, which resulted in the selective formation of a bromohydrin product <b>39</b> at the exo-methylene group with a decent facial selectivity toward the desired trans diol (∼2.5:1). The stereochemistry of <b>39</b> was confirmed with the structure of the epoxide <b>41</b> that was synthesized from a ring closing reaction of TBDMS-protected bromohydrin <b>40</b> under basic conditions. The <sup>1</sup>H NMR spectra of <b>41</b> was clearly different from that of the epoxide <b>38</b> from mCPBA reaction.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Having established a trans relationship between the vicinal diol group of <b>39</b>, we next tried to find a global reduction condition for de-halogenation and hydrogenation of nitro and alkene groups. Under high pressure palladium-catalyzed hydrogenation conditions, we were able to obtain intermediate <b>32</b> in a decent yield with a good facial selectivity (∼4:1). The amide coupling of <b>32</b> with <b>18</b> followed by deprotection of TBDMS group on under acidic conditions gave compound <b>5</b> after chiral resolution. When compared to the previous synthesis in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> (4% yield over 17 steps from <b>15</b>), this new synthetic method to intermediate <b>32</b> made significant improvements in the overall yield as well as the number of reaction steps (15% yield over 7 steps from <b>15</b>). However, the hydrogenation reaction of <b>40</b> was very slow even under high pressure of hydrogen gas (200 psi). We reasoned that hydrogen bromide generated <i>in situ</i> may slow down the reactions. We continued to examine milder conditions using intermediate <b>39</b> and discovered that in the presence of pyridine, palladium-catalyzed hydrogenation went to completion even at room temperature and under atmospheric hydrogen pressure. Pearlman’s catalyst was also replaced by Pd on carbon. The diol intermediate <b>42</b> was obtained in good yield with similar levels of selectivity (trans/cis = ∼4:1). We also found that chiral SFC could resolve the diol <b>42</b> in the absence of the TBDMS group, saving one additional step. The desired enantiomer was used for the synthesis of compound <b>5</b>. This newly developed synthetic route facilitated the scale-up of compound <b>5</b> for <i>in vivo</i> animal studies. Compounds <b>6</b> to <b>11</b> were synthesized using the desired diols of <b>32</b> or <b>42</b> and the corresponding carboxylic acids.</div><div class="NLM_p">For the synthesis of compound <b>12</b>, intermediate <b>37</b> underwent Upjohn dihydroxylation to give a triol intermediate <b>43</b> with high levels of selectivity. Subsequent oxidation reaction yielded the aldehyde <b>44</b>, which was then reacted with Bestmann–Ohira’s reagent for one carbon homologation.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> The resulting alkyne <b>45</b> was subjected to a palladium-catalyzed hydrogenation followed by chiral resolution to afford the desired aniline intermediate <b>46</b>. The amide coupling of <b>46</b> with 3-amino-6-bromopicolinic acid <b>47</b> followed by boronic ester formation yielded intermediate <b>48</b>, which underwent Suzuki coupling reaction with 2-bromo-3-fluoropyridine to afford compound <b>12</b>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">To synthesize fluoromethyl aniline <b>49</b>, the ring-opening reaction of epoxide intermediate <b>41</b> was performed in the presence of triethylamine trihydrofluoride (<named-content content-type="anchor" rid="sch4" type="simple"></named-content><named-content content-type="anchor" rid="sch5" type="simple"></named-content><a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).<a onclick="showRef(event, 'ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50">(47−50)</a> Subsequent Pd-catalyzed hydrogenation yielded intermediate <b>49</b>. Compound <b>14</b> was synthesized through amide coupling of <b>49</b> with pyrimidine acid intermediate <b>51</b> followed by chiral resolution. Compound <b>13</b> was prepared from <b>49</b> and 3-amino-6-bromopicolinic acid <b>47</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>) using the same synthetic procedures used for the synthesis of compound <b>12</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). For the synthesis of intermediate <b>51</b>, intermediate <b>50</b> underwent a cyclization reaction with mucobromic acid to give 5-bromo-2-(2,6-difluorophenyl)pyrimidine-4-carboxylic acid, which turned to intermediate <b>51</b> through copper-catalyzed amination.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Exo-methylene Intermediate <b>36</b> and Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Eschenmoser’s salt, DCM, 18 h, 99%; (b) Iodomethane, THF, 18 h; (c) NaHCO<sub>3</sub>, 5 h, 63%; (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, MeOH, 72%; (e) TBDMSCl, imidazole, DCM, 86%; (f) mCPBA, NaHCO<sub>3</sub>, DCM, 14 h, 90%; (g) NBS, THF, water, 3 h, 56%; (h) TBDMSCl, imidazole, DMF, 75%; (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, water, 1 h, 97%; (j) H<sub>2</sub> (200 psi), Pd(OH)<sub>2</sub> on carbon, MeOH, 4 d; 88%; (k) H<sub>2</sub>, Pd on carbon, pyridine, MeOH, 24 h; 70%; (l) <b>18</b>, EDC, HOAt, DMF, >99%; (m) HCl, THF, MeOH, 86% (over 2 steps); (n) chiral resolution, 31%; (o) TBAF, THF.</p></p></figure><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) OsO<sub>4</sub>, NMO, acetone, water, 1 h, 95%; (b) Dess–Martin periodinane, DCM, 72 h, 77%; (c) Bestmann–Ohira’s reagent, MeOH, K<sub>2</sub>CO<sub>3</sub>, 1.5 h, 96%; (d) H<sub>2</sub>, Pd on carbon, MeOH, 12 h, 33%; (e) chiral separation, 33%; (f) EDC, HOAt, DMF, 16 h; (g) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane), Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, KOAc, dioxane, K<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min; (h) 2-bromo-3-fluoropyridine, PdCl<sub>2</sub>(dppf), DME, Na<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min; (i) HCl, THF, MeOH, 1 h, 30% (over 3 steps).</p></p></figure><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>13</b> and <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Et<sub>3</sub>N·3HF, 100 °C, 8 h, 46%; (b) H<sub>2</sub>, Pd on carbon, MeOH, 12 h, 49%; (c) 3-amino-6-bromopicolinic acid <b>47</b>, EDC, HOAt, DMF, 16 h, 85%; (d) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane), Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, KOAc, dioxane, K<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min; (e) 2-bromo-3-fluoropyridine, PdCl<sub>2</sub>(dppf), DME, Na<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min, 10% (over 3 steps); (f) chiral resolution, 24%; (g) mucobromic acid, NaOEt, EtOH, 40 °C, 2 h; (h) NH<sub>4</sub>OH, CuSO<sub>4</sub>, 110 °C, 1 h, 25% (over 2 steps); (i) <b>51</b>, EDC, HOAt, DMF, 12 h, 25%; (j) chiral resolution, 34%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Our goal to identify a pan-PIM inhibitor bearing a cyclohexyl diol A-ring moiety was successfully achieved, leading to a cellularly potent compound <b>14</b> with moderate metabolic clearance profile. Structure-based design guided us to find compound <b>5</b> with the axial methyl group at the 4-position of the cyclohexyl A-ring that improved cellular potency but suffered from poor oral bioavailability and high <i>in vivo</i> clearance in rats. We focused on the modulation of physicochemical properities, especially, the reduction of Log D value by introducing more polar C and/or D ring to improve metabolic stability. In parallel, the introduction of a fluorine atom near the diol functionality to improve permeability resulted in a cellularly potent cyclohexyl diol compound <b>14</b> with moderate metabolic stability. For our structure–activity relationship (SAR) exploration, we established efficient and scalable synthetic routes to complex cyclohexyl diol ring systems that contain contiguous stereogenic centers including a tertiary alcohol. In particular, we identified (±)-cis-5-methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-en-1-ol <b>36</b> as a versatile intermediate for the synthesis of all the cyclohexyl analogues, which could be employed to synthesize a diverse set of cyclohexane ring systems.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General</h3><div class="NLM_p">The compounds and/or intermediates were characterized by high performance liquid chromatography (HPLC) using a Waters Millenium chromatography system with a 2695 Separation Module (Milford, MA). The analytical columns were Alltima C18 reverse phase, 4.6 × 50 mm, flow 2.5 mL/min, from Alltech (Deerfield, IL). A gradient elution was used, typically starting with 5% acetonitrile/95% water and progressing to 100% acetonitrile over a period of 10 min. All solvents contained 0.1% TFA. Compounds were detected by ultraviolet light (UV) absorption at either 220 or 254 nm. HPLC solvents were from Burdick and Jackson (Muskegan, MI) or Fisher Scientific (Pittsburgh, PA). In some instances, purity was assessed by thin layer chromatography (TLC) using glass or plastic backed silica gel plates, such as, for example, Baker-Flex Silica Gel 1B2-F flexible sheets. TLC results were readily detected visually under ultraviolet light or by employing well known iodine vapor and other various staining techniques.</div><div class="NLM_p">Mass spectrometric analysis was performed on one of two LCMS instruments: a Waters System (Alliance HT HPLC and a Micromass ZQ mass spectrometer; Column: Eclipse XDB-C18, 2.1 × 50 mm; solvent system: 5–95% (or 35–95%, or 65–95% or 95–95%) acetonitrile in water with 0.05% TFA; flow rate 0.8 mL/min; molecular weight range 200–1500; cone Voltage 20 V; column temperature 40 °C) or a Hewlett Packard System (Series 1100 HPLC; Column: Eclipse XDB-C18, 2.1 × 50 mm; solvent system: 1–95% acetonitrile in water with 0.05% TFA; flow rate 0.8 mL/min; molecular weight range 150–850; cone Voltage 50 V; column temperature 30 °C). All masses were reported as those of the protonated parent ions.</div><div class="NLM_p">HRMS ESI-MS data were recorded using a Synapt G2 HDMS (TOF mass spectrometer, Waters) with electrospray ionization source. The resolution of the MS system was approximately 15,000. Leucine Enkephalin was used as lock mass (internal standards) infused from lockspray probe. The compound was infused into the mass spectrometer by UPLC (Acquity, Waters) from sample probe. The separation was performed on Acquity UPLC BEH-C18 1 × 50 mm column at 0.2 mL/min flow rate with the gradient from 5 to 95% in 3 min. Solvent A was water with 0.1% formic acid, and solvent B was acetonitrile with 0.1% formic acid. The mass accuracy of the system has been found to be <5 ppm with lock mass.</div><div class="NLM_p"><sup>1</sup>H Nuclear magnetic resonance (NMR) analysis was performed on some of the compounds with a Varian 300 or 400 MHz NMR and a Bruker 500 MHz NMR. The spectral reference was either TMS or the known chemical shift of the solvent.</div><div class="NLM_p last">Preparative separations were carried out using a Teledyne ISCO chromatography system, by flash column chromatography using silica gel (230–400 mesh) packing material, or by HPLC using a Waters 2767 Sample Manager, C18 reversed phase column, 30 × 50 mm, flow 75 mL/min. Typical solvents employed for the Teledyne ISCO chromatography system and flash column chromatography were dichloromethane, methanol, ethyl acetate, hexane, acetone, aqueous ammonia (or ammonium hydroxide), and triethylamine. Typical solvents employed for the reverse phase HPLC were varying concentrations of acetonitrile and water with 0.1% TFA. The purity of all compounds screened in the biological assays was examined by LC–MS analysis and was found to be ≥ 95%.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of Compound <b>3</b></h3><div class="NLM_p last">4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine (<b>17</b>). (±)-benzyl 4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate <b>16</b> was resolved by chiral HPLC (4.5 mg/1 mL ethanol, heptane/isopropanol = 85:15, 1 mL/min, IA column). Benzyl 4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate was eluted at 8.526 min. To a solution of benzyl 4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate (423 mg, 1.243 mmol) in DMF (1.5 mL) was added TBDMSCl (243 mg, 1.615 mmol) and imidazole (186 mg, 2.73 mmol). The reaction mixture was stirred at room temperature overnight. After diluted with water, the reaction mixture was extracted with EtOAc (15 mL) three times. The combined organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield crude benzyl 4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-ylcarbamate (571 mg, >99% yield). LCMS (<i>m</i>/<i>z</i>): 455.4 [M + H]<sup>+</sup>. To a solution of crude benzyl 4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-ylcarbamate (571 mg, 1.256 mmol) in EtOAc (3 mL) was added Pd on carbon (134 mg, 0.126 mmol) and MeOH (6 mL). The mixture was degassed with nitrogen stream for 10 min, purged with hydrogen gas, and equipped with hydrogen balloon. The reaction mixture was stirred for 3 h. The mixture was filtered through 1μm PTFE Acrodisc filter, eluting with EtOAc (30 mL). The filtrate was concentrated in vacuo to yield crude 4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine <b>17</b> (403.4 mg, 98% yield). 6-(2,6-difluorophenyl)-5-fluoro-<i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-hydroxy-5-methylcyclohexyl)pyridin-3-yl)picolinamide (<b>3</b>). To a solution of 4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine <b>17</b> (50 mg, 0.156 mmol) in DMF (1.5 mL) was added 6-(2,6-difluorophenyl)-5-fluoropicolinic acid <b>18</b> (47.4 mg, 0.187 mmol), HOAt (25.5 mg, 0.187 mmol), and EDC (35.9 mg, 0.187 mmol). The reaction mixture was stirred at room temperature overnight. LCMS showed the coupling reaction was completed. LCMS (<i>m</i>/<i>z</i>): 556.4 [M + H]<sup>+</sup>. After partitioned between EtOAc (10 mL) and water (10 mL), the crude product was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated in vacuo to yield crude <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide. The crude product (87 mg, 0.157 mmol) was dissolved in THF (1 mL) and methanol (0.5 mL) followed by addition of 6 N HCl aqueous solution (0.048 mL, 1.57 mmol). The reaction mixture was stirred at room temperature for 2 h. After neutralized with saturated Na<sub>2</sub>CO<sub>3</sub> aqueous solution, the mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated in vacuo. The crude product was purified by reverse phase HPLC. After pure fractions were combined and free-based with saturated Na<sub>2</sub>CO<sub>3</sub> aqueous solution, the crude product was extracted with EtOAc. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated in vacuo. After dissolving in water and acetonitrile (1:1, 2 mL) and adding 1 equivalent of 1 N HCl soltuion, the solution was lyophilized to yield 6-(2,6-difluorophenyl)-5-fluoro-<i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-hydroxy-5-methylcyclohexyl)pyridin-3-yl)picolinamide <b>3</b> as its HCl salt (60.9 mg, 0.137 mmol, 87% yield over 2 steps). LCMS (<i>m</i>/<i>z</i>): 442.2 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>F<sub>3</sub> [M + H]<sup>+</sup>, 442.1742; found, 442.1745. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 10.6 (s, 1H), 9.09 (s, 1H), 8.71 (d, <i>J</i> = 5.85 Hz, 1H), 8.38 (dd, <i>J</i> = 8.6, 3.92 Hz, 1H), 8.24 (t, <i>J</i> = 8.81 Hz, 1H), 7.78 (d, <i>J</i> = 6.24 Hz, 1H), 7.65–7.76 (m, 2H), 7.36 (t, <i>J</i> = 8.21 Hz, 2H), 3.41 (m, 1H), 2.95 (m, 1H), 1.75 (m, 2H), 1.61 (m, 1H), 1.4 (m, 1H), 1.31 (m, 1H), 0.99 (m, 1H), 0.89 (m, 1H), 0.86 (d, <i>J</i> = 6.63 Hz, 3H).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of Compound <b>4</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h3><div class="NLM_p last">(±)-4-((1<i>S</i>,5<i>S</i>)-5-Methyl-7-oxabicyclo[4.1.0]hept-2-en-3-yl)-3-nitropyridine (<b>20</b>). To a solution of (±)-(1<i>S</i>,5<i>S</i>,6<i>S</i>)-6-bromo-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol <b>19</b> (1.05 g, 3.35 mmol) in THF (33.5 mL) was added potassium <i>tert</i>-butoxide (0.564 g, 5.03 mmol) at room temperature. The reaction mixture was stirred for 10 min. The reaction mixture was quenched with NH<sub>4</sub>Cl solution and extracted with EtOAc by washing with water and brine. The organic layers were dried over anhydrous sodium sulfate, filtered off, and dried in vacuo. The crude product <b>20</b> (700 mg, 3.01 mmol, 90%) was used in the next step without further purification. <i>R</i><sub><i>f</i></sub> = 0.5 (50% EtOAc/hexanes). LCMS (<i>m</i>/<i>z</i>): 251.2 [M + H]<sup>+</sup> (detected as a diol). To a solution of crude (±)-4-((1<i>S</i>,5<i>S</i>)-5-methyl-7-oxabicyclo[4.1.0]hept-2-en-3-yl)-3-nitropyridine <b>20</b> (700 mg, 3.01 mmol) in CH<sub>3</sub>CN (20.1 mL) and H<sub>2</sub>O (10.1 mL) was added a catalytic amount of acetic acid (0.052 mL, 0.904 mmol) at room temperature. The reaction mixture was stirred for 16 h at room temperature. After quenched with NaHCO<sub>3</sub> solution, the reaction mixture was concentrated to remove the majority of CH<sub>3</sub>CN and the residue was partitioned between EtOAc and water. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. A mixture of <i>trans</i>- and <i>cis</i>-(±)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diols was obtained as a white solid in 33.1% yield (250 mg, 0.99 mmol) by flash column chromatography. <i>R</i><sub><i>f</i></sub> = 0.3 (100% EtOAc; diols were not separable on TLC). LCMS (<i>m</i>/<i>z</i>): 251.1 [M + H]<sup>+</sup>. To a solution of a mixture of <i>trans</i>- and <i>cis</i>-(±)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diols (250 mg, 0.99 mmol) in DMF (3.33 mL, 0.3 M) was added TBDMSCl (1.05 g, 7.0 mmol), imidazole (612 mg, 9 mmol) at room temperature. The reaction mixture was stirred at room temperature overnight. After quenched with saturated NaHCO<sub>3</sub>, the reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The trans and cis isomers were separated by ISCO (gradient eluting with EtOAc and hexanes) and subsequent preparative reverse phase HPLC (55–95% acetonitrile in water, then run 5–95% acetonitrile in water) to yield 130 mg of <i>cis</i>-(±)-4-((3<i>S</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohex-1-enyl)-3-nitropyridine (27.2% yield) and 240 mg of <i>trans</i>-(±)-4-((3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohex-1-enyl)-3-nitropyridine <b>21</b> (50.2% yield). LCMS (<i>m</i>/<i>z</i>): 479.0 [M + H]<sup>+</sup>, respectively. 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-Bis((<i>tert</i>-butyldimethylsilyl)oxy)-5-methylcyclohexyl)pyridin-3-amine (<b>22</b>). To a solution of <i>trans</i>-(±)-4-((3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohex-1-enyl)-3-nitropyridine <b>21</b> (550 mg, 1.149 mmol) in ethanol (5.7 mL) and EtOAc (5.7 mL) was added Pd on carbon (122 mg). After degassed for 15 min, the reaction mixture was charged with hydrogen at room temperature and stirred at room temperature overnight. The reaction mixture was filtered through Celite pad and washed with EtOAc. The filtrate was concentrated in vacuo. The crude product was purified by ISCO (heptane/EtOAc) to yield <i>trans</i>-(±)-4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine (260 mg, 58% yield). LCMS (<i>m</i>/<i>z</i>): 451.2 [M + H]<sup>+</sup>. 260 mg of the pure racemate was resolved by chiral HPLC (IC column, 1 mL/min, 5% IPA in heptane). Peak 1: 4-((1<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine <b>22-ent</b> (114 mg, 99% ee, <i>R</i><sub><i>t</i></sub> = 6.1 min). LCMS (<i>m</i>/<i>z</i>): 451.2 [M + H]<sup>+</sup>. Peak 2: 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine <b>22</b> (112 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 7.83 min). LCMS (<i>m</i>/<i>z</i>): 451.2 [M + H]<sup>+</sup>. 6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide (<b>4</b>). To a reaction vial with a stir bar was added 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine <b>22</b> (17 mg, 0.038 mmol), 6-(2,6-difluorophenyl)-5-fluoropicolinic acid <b>18</b> (10.50 mg, 0.041 mmol), and HOAt (6.15 mg, 0.045 mmol) followed by DMF (0.4 mL). After the reaction mixture was homogeneously mixed, EDC (8.67 mg, 0.045 mmol) was added to the reaction mixture in a single portion. The reaction mixture was stirred at room temperature overnight. After quenched with water, the reaction mixture was extracted with EtOAc. The organic layers were washed with water, 1 M NaOH aqueous solution, and brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Crude <i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide was obtained in >99% yield (26 mg, 0.038 mmol). LCMS (<i>m</i>/<i>z</i>): 686.4 [M + H]<sup>+</sup>. To a solution of crude <i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (26 mg, 0.038 mmol) in MeOH (126 μL) and THF (253 μL) was added HCl (120 μL, 0.360 mmol) at room temperature. The reaction mixture was stirred at room temperature for 1 h. After quenched with saturated NaHCO<sub>3</sub> solution, the reaction mixture was extracted with EtOAc. The organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. After preparative HPLC purification and lyophilzation, 6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>4</b> was obtained as its TFA salt (12.4 mg, 0.021 mmol, 57% over 2 steps). LCMS (<i>m</i>/<i>z</i>): 458.3 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub> [M + H]<sup>+</sup>, 458.1692; found, 458.1691. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 10.5 (s, 1H), 8.88 (s, 1H), 8.51 (d, <i>J</i> = 5.83 Hz, 1H), 8.31 (dd, <i>J</i> = 8.61, 3.91 Hz, 1H), 8.16 (t, <i>J</i> = 9.0 Hz, 1H), 7.65 (m, 2H), 7.29 (t, <i>J</i> = 8.22 Hz, 2H), 3.15 (ddd, <i>J</i> = 10.96, 8.61, 4.3 Hz, 1H), 2.94 (d, <i>J</i> = 12.3 Hz, 1H), 2.75 (t, <i>J</i> = 9.0 Hz, 1H), 1.81 (m, 1H), 1.58 (d, <i>J</i> = 12.3, 2.54 Hz, 1H), 1.46 (m, 1H), 1.23 (m, 2H), 0.84 (d, <i>J</i> = 6.26 Hz, 3H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of Compound <b>4</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h3><div class="NLM_p last">Trans-(±)-(5<i>S</i>,6<i>R</i>)-6-hydroxy-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone (<b>23</b>). A solution of (±)-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>15</b> (3 g, 12.9 mmol) and TMSCl (1.65 mL, 12.9 mmol) in THF was added LiHMDS (1.0 M solution in THF, 13.56 mL, 13.56 mmoL) at 0 °C slowly over 1 h. The reaction mixture was warmed up to room temperature and stirred for 2 h. The reaction mixture was quenched with NaHCO<sub>3</sub> aqueous solution and removed THF <i>in vacuo</i>. The residue was extracted with EtOAc 3 times. The organic layers were washed with water and brine, dried over anhydrous K<sub>2</sub>CO<sub>3</sub>, filtered, and concentrated <i>in vacuo</i> to yield crude (±)-4-(5-methyl-3-(trimethylsilyloxy) cyclohexa-1,3-dienyl)-3-nitropyridine <b>23</b> (3.6 g, 11.83 mmol, 96% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.14–9.00 (m, 1H), 8.80–8.64 (m, 1H), 7.42–7.25 (m, 1H), 6.00–5.88 (m, 1H), 4.98 (br s, 1H), 2.86–2.53 (m, 1H), 2.51–2.29 (m, 1H), 2.27–2.03 (m, 1H), 1.21–1.03 (m, 3H), 0.36–0.15 (m, 9H). A solution of (±)-4-(5-methyl-3-(trimethylsilyloxy) cyclohexa-1,3-dienyl)-3-nitropyridine (3.6 g, 10.39 mmol), sodium bicarbonate (4.36 g, 51.9 mmol), acetone (7.63 mL, 104 mmol), water (51.9 mL), and ethyl acetate (51.9 mL) was vigorously stirred at 0 °C. To this, a solution of Oxone (6.39 g, 10.39 mmol) in water (45 mL was slowly added <i>via</i> dropping funnel for 1 h 30 min. After addition, the reaction mixture was allowed to stir at room temperature for 2 h. The pH of the mixture was adjusted to around 4 by adding 1 N HCl aqueous solution. After stirring for 30 min, the reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered, and concentrated <i>in vacuo</i>. A mixture of crude trans and cis products was purified by ISCO (50% EtOAc in heptane). For <i>trans</i>-(±)-(5<i>S</i>,6<i>R</i>)-6-hydroxy-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>24</b> (890 mg, 34.5% yield), LCMS (<i>m</i>/<i>z</i>): 249 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.34 (s, 1H), 8.9 (d, <i>J</i> = 5.2 Hz, 1H), 7.28 (s, 1H), 6.09 (d, <i>J</i> = 2.4 Hz, 1H), 3.99 (d, <i>J</i> = 12.4 Hz, 1H), 3.68 (d, <i>J</i> = 2.0 Hz, 1H), 2.61–2.52 (m, 2H), 2.39 (m, 1H), 1.27 (d, <i>J</i> = 8.0 Hz, 3H). For <i>cis</i>-(±)-(5<i>S</i>,6<i>R</i>)-6-hydroxy-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>24-cis</b> (680 mg, 26.4% yield), LCMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.32 (s, 1H), 8.9 (d, <i>J</i> = 4.0 Hz, 1H), 7.28 (s, 1H), 6.06 (d, <i>J</i> = 2.8 Hz, 1H), 4.53 (d, <i>J</i> = 12.0 Hz, 1H), 3.60 (m, 1H), 3.11 (m, 1H), 2.8 (m, 1H), 2.47 (d, <i>J</i> = 2.0 Hz, 1H), 1.09 (d, <i>J</i> = 8 Hz, 3H). (1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-Hydroxy-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate (<b>25</b>). To a solution of (±)-(5<i>S</i>,6<i>R</i>)-6-hydroxy-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>24</b> (4.2 g, 16.9 mmol) in pyridine (56.4 mL) was slowly added acetic anhydride (3.19 mL, 33.8 mmol). The reaction mixture was stirred at room temperature overnight. After all volatile materials were removed in vacuo, the residue was diluted with EtOAc. The organic layers were washed with 1 N aqueous HCl solution and water, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo. The crude product was purified by ISCO (gradient EtOAc in heptane) to yield (±)-(1<i>R</i>,6<i>S</i>)-6-methyl-4-(3-nitropyridin-4-yl)-2-oxocyclohex-3-enyl acetate (4.9 g, 16.9 mmol, >99% yield). LCMS (<i>m</i>/<i>z</i>): 291.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.35 (s, 1H), 8.9 (d, <i>J</i> = 4.0 Hz, 1H), 7.27 (s, 1H), 6.04 (s, 1H), 5.56 (d, <i>J</i> = 12.0 Hz, 1H), 2.65–2.55 (m, 3H), 2.25 (s, 3H), 1.16 (d, <i>J</i> = 4.0 Hz, 3H). To a suspension of (±)-(1<i>R</i>,6<i>S</i>)-6-methyl-4-(3-nitropyridin-4-yl)-2-oxocyclohex-3-enyl acetate (580 mg, 2 mmol) in THF (4 mL) and MeOH (6 mL) was added cerium(III) chloride heptahydrate (744 mg, 2 mmol). The reaction mixture was stirred for 2 h at room temperature. At 0 °C, NaBH<sub>4</sub> (76 mg, 2 mmol) was slowly added to the reaction mixture, which was then stirred at room temperature overnight. The reaction mixture was extracted with EtOAc (20 mL) twice. The combined organic layers were washed with water and NaHCO<sub>3</sub> solution and brine. The crude product was purified by ISCO (0–40% EtOAc in heptane) to yield (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-hydroxy-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate <b>25</b> (567 mg, 1.94 mol, 97% yield). LCMS (<i>m</i>/<i>z</i>): 293.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.16 (s, 1H), 8.76 (d, <i>J</i> = 4.8 Hz, 1H), 7.27 (s, 1H), 6.04 (s, 1H), 5.3 (m, 1H on alkene), 4.75 (dd, <i>J</i> = 10.8, 7.2 Hz, 1H on acetoxy attached carbon), 4.38 (m, 1H on hydroxyl attached carbon), 2.35 (s, 1H), 2.21 (m, 2H), 2.19 (s, 3H), 1.16 (d, <i>J</i> = 6.0 Hz, 3H). To a solution of (1.34 g, 4.58 mmol) in DCM (9.17 mL) was added imidazole (0.468 g, 6.88 mmol) and TBDMSCl (0.829 g, 5.50 mmol). The reaction mixture was stirred at room temperature overnight. After diluted with water, the mixture was extracted with EtOAc (50 mL). The combined organic layers were washed with water and NaHCO<sub>3</sub> solution and brine. The crude product was purified by ISCO (0–40% EtOAc in heptane) to yield (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate (1.56 g, 3.84 mmol, 84% yield). LCMS (<i>m</i>/<i>z</i>): 407.1 [M + H]<sup>+</sup>. To a solution of (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate (411 mg, 1.011 mmol) in ethanol (1.7 mL) and EtOAc (1.7 mL) was added Pd on carbon (108 mg). The reaction mixture was equipped with hydrogen gas balloon. The reaction mixture was stirred at room temperature overnight, filtered through Celite pad, and washed with EtOAc, and then, the filtrate was concentrated in vacuo. The crude product was purified by ISCO (gradient EtOAc in heptane) to yield (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-6-methylcyclohexyl acetate <b>26-rac</b> (335 mg, 0.885 mmol, 88% yield). LCMS (<i>m</i>/<i>z</i>): 379.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.06 (s, 1H), 8.04 (d, <i>J</i> = 4.0 Hz, 1H), 6.99 (d, <i>J</i> = 8.0 Hz, 1H), 4.69 (t, <i>J</i> = 8.0 Hz, 1H), 3.7 (m, 1H), 3.61 (s, 1H), 2.65 (m, 1H), 2.11 (s, 3H), 2.05 (m, 3H), 1.82 (m, 1H), 0.95 (d, <i>J</i> = 8.0 Hz, 3H), 0.86 (s, 9H), 0.06 (s, 6H). 335 mg of <b>26-rac</b> was resolved by chiral HPLC (AS-H column, 1 mL/min, heptane/EtOH = 98:2). Peak 1: (1<i>S</i>,2<i>S</i>,4<i>S</i>,6<i>R</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methylcyclohexyl acetate <b>26-ent</b> (115.7 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 6.72 min). LCMS (<i>m</i>/<i>z</i>): 379.0 [M + H]<sup>+</sup>. Peak 2: (1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate <b>26</b> (154.7 mg, 99% ee, <i>R</i><sub><i>t</i></sub> = 11.31 min). LCMS (<i>m</i>/<i>z</i>): 379.0 [M + H]<sup>+</sup>. 6-(2,6-Difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide (<b>4</b>). To a reaction vial with a stir bar was added (1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate <b>26</b> (40 mg, 0.106 mmol), 6-(2,6-difluorophenyl)-5-fluoropicolinic acid <b>18</b> (29.4 mg, 0.116 mmol), and HOAt (18.7 mg, 0.137 mmol) followed by DMF (0.2 mL). After the reaction mixture was homogeneously mixed, EDC (30.4 mg, 0.158 mmol) was added to the reaction mixture in a single portion. The reaction mixture was stirred at room temperature for 18 h. After quenched with water, the reaction mixture was extracted with EtOAc. The organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to afford crude (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-4-(3-(6-(2,6-difluorophenyl)-5-fluoropicolinamido)pyridin-4-yl)-6-methylcyclohexyl acetate. LCMS (<i>m</i>/<i>z</i>): 614.3 [M + H]<sup>+</sup>. The crude product was dissolved in THP (1 mL) and MeOH (0.5 mL) followed by 1 N HCl aqueous solution (0.5 mL). After stirring for 3 h, the mixture was neutralized with saturated NaHCO<sub>3</sub> solution and extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by reverse phase HPLC. The pure fractions were combined and lyophilized to yield (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-(6-(2,6-difluorophenyl)-5-fluoropicolinamido)pyridin-4-yl)-2-hydroxy-6-methylcyclohexyl acetate (19.4 mg, 0.039 mmol). LCMS (<i>m</i>/<i>z</i>): 500.2 [M + H]<sup>+</sup>. The acetate product was dissolved in MeOH (0.5 mL), and THF (0.5 mL) was added 1 N LiOH solution (0.5 mL) at room temperature. The reaction mixture was stirred at room temperature overnight. After neutralized with 1 N HCl aqueous solution, the reaction mixture was extracted with EtOAc. The organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. After preparative HPLC purification and lyophilzation, 6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>4</b> was obtained as its TFA salt (10 mg, 0.018 mmol, 17% over 3 steps). LCMS (<i>m</i>/<i>z</i>): 458.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis of Compound <b>5</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>)</h3><div class="NLM_p last"><i>cis</i>-(±)-(1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-Aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methylcyclohexyl acetate (<b>27</b>). For step a, <i>cis</i>-(±)-(1<i>S</i>,6<i>S</i>)-6-methyl-4-(3-nitropyridin-4-yl)-2-oxocyclohex-3-enyl acetate was synthesized from <i>cis</i>-(±)-(5<i>S</i>,6<i>R</i>)-6-hydroxy-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone (<b>24-cis</b>) according to step c in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (83% yield), LCMS (<i>m</i>/<i>z</i>): 291.1 [M + H]<sup>+</sup>. For step b, <i>cis</i>-(±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-hydroxy-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate was synthesized according to step d in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (82% yield), LCMS (<i>m</i>/<i>z</i>): 293.0 [M + H]<sup>+</sup>. For step c, <i>cis</i>-(±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate was synthesized according to step e in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (75% yield), LCMS (<i>m</i>/<i>z</i>): 407.2 [M + H]<sup>+</sup>. For step d, <i>cis</i>-(±)-(1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methylcyclohexyl acetate <b>27</b> was synthesized according to step f in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (>99% yield), LCMS (<i>m</i>/<i>z</i>): 379.4 [M + H]<sup>+</sup>. (±)-<i>tert</i>-Butyl (4-((1<i>R</i>,3<i>R</i>,5<i>S</i>)-3-((<i>tert</i>-butyldimethylsilyl)oxy)-5-methyl-4-oxocyclohexyl)pyridin-3-yl)carbamate (<b>28</b>). To a solution of (±)-(1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methylcyclohexyl acetate (2.8 g, 7.40 mmol) in DCM (37.0 mL) was added DMAP (0.181 g, 1.48 mmol) and Boc<sub>2</sub>O (4.29 mL, 18.49 mmol). The reaction mixture was stirred at room temperature over-the-weekend. After diluted with water, the mixture was extracted with DCM (10 mL). The combined organic layers were washed with water and NaHCO<sub>3</sub> solution and brine. The crude product was purified by ISCO (0–50% EtOAc in heptane) to yield (±)-(1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-(bis(<i>tert</i>-butoxycarbonyl)amino)pyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methylcyclohexyl acetate (2.8 g, 4.84 mmol, 65% yield). LCMS (<i>m</i>/<i>z</i>): 579.3 [M + H]<sup>+</sup>. To a solution of (±)-(1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-(bis(<i>tert</i>-butoxycarbonyl)amino)pyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methylcyclohexyl acetate (2.8 g, 4.84 mmol) in THF (16.12 mL) was added LiOH (9.67 mL, 9.67 mmol). The reaction mixture was heated at 60 °C overnight. LCMS still showed the starting material remained. Next day, after adding 4 mL of LiOH more, the reaction was heated at 60 °C again overnight. LCMS showed the reaction went to completion, but two product peaks indicated that a half of TBDMS was migrated to de-acetylated alcohol (∼1:1). After neutralized with 1 N HCl aqueous solution, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by ISCO (gradient EtOAc in heptane) to afford a mixture of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate and (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-4-(<i>tert</i>-butyldimethylsilyloxy)-3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate (2.1 g, 4.81 mmol, 99%). LCMS (<i>m</i>/<i>z</i>): 437.2 [M + H]<sup>+</sup>, 0.98 min and 1.0 min. To a solution of a mixture of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate and (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-4-(<i>tert</i>-butyldimethylsilyloxy)-3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate (2.1 g, 4.81 mmol) in DCM (16 mL) was added Dess–Martin periodinane (2.55 g, 6.01 mmol) at room temperature. The reaction mixture was stirred at room temperature overnight. LCMS showed the reaction went to completion. After quenched with NaHCO<sub>3</sub> solution/Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (8:1), the mixture was vigorously stirred for 2 h and extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The desired cyclohexanone product was separated by ISCO (0–80% EtOAc in DCM) to yield (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methyl-4-oxocyclohexyl)pyridin-3-ylcarbamate (577 mg, 1.328 mmol, 55% yield). LCMS (<i>m</i>/<i>z</i>): 435.2 [M + H]<sup>+</sup>, 0.96 min. The undesired cyclohexanone, (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-4-(<i>tert</i>-butyldimethylsilyloxy)-3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate, was obtained in 34% yield (405 mg, 0.932 mmol). LCMS (<i>m</i>/<i>z</i>): 435.2 [M + H]<sup>+</sup>, 1.01 min. (±)-<i>tert</i>-Butyl 4-((1<i>R</i>,3<i>R</i>,5<i>S</i>)-3-hydroxy-5-methyl-4-methylenecyclohexyl)pyridin-3-ylcarbamate (<b>29</b>). To a solution of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methyl-4-oxocyclohexyl)pyridin-3-ylcarbamate (1.09 g, 2.508 mmol) in THF (12.5 mL) was added trimethylsilylmethylmagnesium chloride (25.1 mL, 25.1 mmol) at room temperature. The reaction mixture was heated to 35 °C overnight. After quenched with saturated NH<sub>4</sub>Cl aqueous solution, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by ISCO (gradient EtOAc in heptane) to yield (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-5-methyl-4-((trimethylsilyl)methyl)cyclohexyl)pyridin-3-ylcarbamate (1.2 g, 2.3 mmol, 92%). LCMS (<i>m</i>/<i>z</i>): 523.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.6 (s, 1H), 8.38 (d, <i>J</i> = 4.0 Hz, 1H), 7.21 (d, <i>J</i> = 4.0 Hz, 1H), 6.11 (s, 1H), 4.69 (t, <i>J</i> = 8.0 Hz, 1H), 2.41 (m, 1H), 2.31 (s, 1H), 1.79 (m, 2H), 1.61 (m, 1H), 1.52 (s, 9H), 1.37 (m, 1H), 1.28 (m, 1H), 1.06 (d, <i>J</i> = 8.0 Hz, 3H), 0.9 (s, 9H), 0.88 (m, 2H), 0.13 (s, 4H), 0.09 (s, 9H). To a solution of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-5-methyl-4-((trimethylsilyl)methyl)cyclohexyl)pyridin-3-ylcarbamate (1.2 g, 2.295 mmol) in acetone (7.65 mL) was added 0.191 mL of 1 N HCl aqueous solution. The mixture was stirred at room temperature for 20 min. After neutralized with saturated NaHCO<sub>3</sub> aqueous solution, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to yield crude (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,5<i>S</i>)-3-hydroxy-5-methyl-4-methylenecyclohexyl)pyridin-3-ylcarbamate (710 mg, 2.23 mmol, 97%). LCMS (<i>m</i>/<i>z</i>): 319.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.69 (s, 1H), 8.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.12 (d, <i>J</i> = 4.0 Hz, 1H), 6.2 (s, 1H), 5.15 (s, 1H), 4.88 (s, 1H), 4.23 (m, 1H), 3.08 (m, 1H), 2.27 (m, 2H), 1.91 (m, 2H), 1.79 (m, 2H), 1.65 (m, 1H), 1.52 (s, 9H), 1.18 (d, <i>J</i> = 8.0 Hz, 3H). (±)-<i>tert</i>-Butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3,4-dihydroxy-4-(hydroxymethyl)-5-methylcyclohexyl)pyridin-3-ylcarbamate (<b>30</b>). To a solution of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,5<i>S</i>)-3-hydroxy-5-methyl-4-methylenecyclohexyl)pyridin-3-ylcarbamate (490 mg, 1.539 mmol) in acetone (24.6 mL) and water (6.15 mL) was added 4-methylmorpholine 4-oxide (NMO) (541 mg, 4.62 mmol) followed by osmium tetroxide (4% in water) (0.097 mL, 0.308 mmol) at room temperature. The reaction was stirred overnight but did not attain completion. After adding the same amounts of the reagents, the reaction was stirred overnight once more. The reaction was quenched with saturated Na<sub>2</sub>SO<sub>3</sub> aqueous solution (30 mL) and stirred for additional 1 h. After evaporation of acetone in vacuo, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by ISCO (gradient EtOAc in heptane) to yield (±±)-4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3,4-dihydroxy-4-(hydroxymethyl)-5-methylcyclohexyl)pyridin-3-ylcarbamate <b>30</b> (416 mg, 1.18 mmol, 77% yield). LCMS (<i>m</i>/<i>z</i>): 353.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.62 (s, 1H), 8.34 (d, <i>J</i> = 4.8 Hz, 1H), 7.15 (d, <i>J</i> = 5.2 Hz, 1H), 6.86 (s, 1H), 4.20 (d, <i>J</i> = 11.6 Hz, 1H), 3.82–3. 72 (m, 2H), 2.97 (m, 1H), 2.08 (m, 1H), 2.04 (m, 1H), 1.75 (m, 2H), 1.68 (m, 1H), 1.65 (m, 1H), 1.51 (s, 9H), 1.0 (d, <i>J</i> = 7.2 Hz, 3H). (±)-<i>tert</i>-Butyl 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-ylcarbamate (<b>31</b>). To a solution of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3,4-dihydroxy-4-(hydroxymethyl)-5-methylcyclohexyl)pyridin-3-ylcarbamate (84 mg, 0.238 mmol) in DCM (794 μL) was added pyridine (96 μL, 1.192 mmol). After cooling down to 0 °C, methanesulfornyl chloride (18.57 μL, 0.238 mmol) was added to the reaction mixture, which was stirred overnight. However, LCMS showed that a small amount of the product formed. One equivalent of methanesulfornyl chloride was added to the mixture, which was stirred for 2 h. LCMS showed no starting material remained. After quenched with water, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to yield (±)-((1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-(<i>tert</i>-butoxycarbonylamino)pyridin-4-yl)-1,2-dihydroxy-6-methylcyclohexyl)methyl methanesulfonate. The crude product was used in the next step without further purification. LCMS (<i>m</i>/<i>z</i>): 337.1 [M + H]<sup>+</sup>. To a solution of (±)-((1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-(<i>tert</i>-butoxycarbonylamino)pyridin-4-yl)-1,2-dihydroxy-6-methylcyclohexyl)methyl methanesulfonate (85 mg, 0.197 mmol) in THF (1.974 mL) was slowly added LiAlH<sub>4</sub> (14.99 mg, 0.395 mmol) at room temperature. The reaction mixture was stirred at room temperature overnight. After quenched with water slowly, the reaction was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to yield (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-ylcarbamate <b>31</b> (65 mg, 0.193 mmol, 98%). The crude product was used in the next step without further purification. (±)-(1<i>S</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1,6-dimethylcyclohexanol (<b>32</b>). To solution of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-ylcarbamate (77 mg, 0.229 mmol) in DCM (0.458 mL) was added imidazole (23.37 mg, 0.34 mmol) and TBDMSCl (37.9 mg, 0.252 mmol). The reaction mixture was stirred at room temperature overnight. After quenched with water, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by ISCO (gradient EtOAc in heptane) to yield (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-4,5-dimethylcyclohexyl)pyridin-3-ylcarbamate (72 mg, 70% yield). LCMS (<i>m</i>/<i>z</i>): 451.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.67 (s, 1H), 8.37 (d, <i>J</i> = 5.2 Hz, 1H), 7.15 (d, <i>J</i> = 5.2 Hz, 1H), 6.12 (s, 1H), 3.61 (dd, <i>J</i> = 11.2 Hz, 4 Hz, 1H), 2.88 (m, 1H), 2.1 (s, 1H), 1.89 (m, 1H), 1.76 (m, 1H), 1.68 (m, 1H), 1.52 (s, 9H), 1.23 (m, 2H), 1.14 (s, 3H), 1.01 (d, <i>J</i> = 7.2 Hz, 3H), 0.91 (s, 9H), 0.11 (s, 3H), 0.79 (s, 3H). To a solution of (±)-<i>tert</i>-butyl 4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-4,5-dimethylcyclohexyl)pyridin-3-ylcarbamate (72 mg, 0.16 mmol) in DCM (1.2 mL) was added TFA (0.4 mL). The reaction mixture was stirred for 1 h 30 min. After diluted with toluene, the volatile materials were removed in vacuo, neutralized with saturated NaHCO<sub>3</sub> aqueous solution, and extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to yield crude (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1,6-dimethylcyclohexanol <b>32</b> (56 mg, 0.16 mmol, >99%). The crude product was used in the next step without further purification. LCMS (<i>m</i>/<i>z</i>): 351.3 [M + H]<sup>+</sup>. 6-(2,6-Difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide (<b>5</b>). To solution of (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1,6-dimethylcyclohexanol <b>32</b> (32 mg, 0.091 mmol) in DMF (114 μL) was added 6-(2,6-difluorophenyl)-5-fluoropicolinic acid <b>18</b> (25.4 mg, 0.1 mmol), HOAt (16.2 mg, 0.119 mmol) and EDC (26.2 mg, 0.137 mmol). The reaction mixture was stirred at room temperature for 18 h. After quenched with water, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. LCMS (<i>m</i>/<i>z</i>): 586.3 [M + H]<sup>+</sup>. The crude product was dissolved in THF (1 mL) and MeOH (0.5 mL) followed by 3 N HCl aqueous solution (0.5 mL). The reaction mixture was stirred for 3 h. After neutralized with saturated NaHCO<sub>3</sub> aqueous solution, the mixture was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by ISCO (0–10% MeOH in EtOAc) to yield 24 mg of (±)-6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>5-rac</b> (45% yield over 2 steps). LCMS (<i>m</i>/<i>z</i>): 472.2 (MH<sup>+</sup>). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 9.96 (br s, 1H), 9.34 (s, 1H), 8.44 (d, <i>J</i> = 4.0 Hz, 1H), 8.42 (m, 1H), 7.78 (t, <i>J</i> = 8.0 Hz, 1H), 7.52 (m, 1H), 7.19 (d, <i>J</i> = 4 Hz, 1H), 7.11 (t, <i>J</i> = 8.0 Hz, 1H), 3.57 (dd, <i>J</i> = 12 Hz, 4 Hz, 1H), 2.99 (m, 1H), 2.02 (m, 1H), 1.78–1.52 (m, 4H), 1.36–1.26 (m, 1H), 1.12 (s, 3H), 0.9 (d, <i>J</i> = 4 Hz, 3H). 24 mg of <b>5-rac</b> was resolved by chiral HPLC (AD-H column, heptane/EtOH = 75:25, 1 mL/min). Peak 1: 6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>5-ent</b> (9.7 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 4.45 min). LCMS (<i>m</i>/<i>z</i>): 472.2 [M + H]<sup>+</sup>. Peak 2 6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>5</b> (9.3 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 6.056 min). LCMS (<i>m</i>/<i>z</i>): 472.2 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub> [M + H]<sup>+</sup>, 472.1848; found, 472.1850.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of Compound <b>5</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>)</h3><div class="NLM_p">(±)-5-Methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-enone (<b>35</b>). To a solution of Eschenmoser’s salt (19.33 g, 105 mmol) in DCM (140 mL) was added (±)-4-(5-methyl-3-(trimethylsilyloxy)cyclohexa-1, 3-dienyl)-3-nitropyridine <b>23</b> in DCM (100 mL) at 0 °C slowly over 60 min. The reaction mixture was allowed to warm up to room temperature and stirred for 18 h. After the reaction mixture was transferred to a larger vessel and diluted with DCM (100 mL), 1 M HCl aqueous solution (160 mL) was added to the reaction mixture, which was stirred for 20 min at 0 °C. After 2 N NaOH aqueous solution (80 mL) was slowly added at 0 °C, the reaction mixture was stirred for 1 h and pH of the mixture was adjusted to 12 by adding 3 N NaOH aqueous solution. After organic layers were separated, aqueous phase was extracted with DCM 3 times. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated <i>in vacuo</i> to yield crude (±)-6-((dimethylamino)methyl)-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>33</b> (27.5 g, 95 mmol, 99% yield). LCMS (<i>m</i>/<i>z</i>): 290.0 [M + H]<sup>+</sup>. To a solution of (±)-6-((dimethylamino) methyl)-5-methyl-3-(3-nitropyridin-4-yl) cyclohex-2-enone <b>33</b> (27.5 g, 95 mmol) in THF (190 mL) was added iodomethane (7.13 mL, 114 mmol) slowly at 0 °C. The reaction mixture was allowed to warm up to room temperature and stirred for 18 h to yield the trimethyl ammonium salt intermediate <b>34</b>. After saturated NaHCO<sub>3</sub> aqueous solution (35.9 g in water) was added, the reaction mixture was stirred at room temperature for 5 h, diluted with EtOAc, and stirred at room temperature for another 6 h. After the organic layers were separated, aqueous phase was extracted with EtOAc 3 times, the combined organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified by ISCO (gradient EtOAc in heptane) to afford (±)-5-methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>35</b> (14.7 g, 60.2 mmol, 63%). LCMS (<i>m</i>/<i>z</i>): 245 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 M Hz, CDCl<sub>3</sub>): δ ppm 9.33 (s, 1H), 8.88 (d, <i>J</i> = 5.1 Hz, 1H), 6.19 (m, 1H), 6.16 (s, 1H), 5.42 (s, 1H), 3.15 (m, 1H), 2.59 (dd, <i>J</i> = 17.4, 5.3 Hz, 1H), 2.43 (ddd, <i>J</i> = 7.3, 9.5, 2.2 Hz, 1H), 1.31 (d, <i>J</i> = 6.7 Hz, 3H). (±)-<i>cis</i>-5-Methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-enol (<b>36</b>). To a solution of (±)-5-methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>35</b> (13.7 g, 56.1 mmol) in methanol (260 mL) was added cerium (III) chloride heptahydrate (23 g, 61.7 mmol). The reaction mixture was stirred at room temperature for 1 h. After cooled down to at 0 °C, NaBH<sub>4</sub> (2.1 g, 56.1 mmol) was added slowly and stirred for 30 min. After quenched with water, the volatile materials were removed <i>in vacuo</i>, and saturated NaHCO<sub>3</sub> aqueous solution was added into mixture with vigorous stirring. The reaction mixture was extracted with EtOAc, and the organic layers were washed with brine and dried over anhydrous sodium sulfate, filtered off, and concentrated <i>in vacuo</i>. The crude product was purified by ISCO (heptane/EtOAc, 80:20 to 20:80) to give (±)-<i>cis</i>-5-methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-enol <b>36</b> as a yellow solid (10 g, 40.76 mmol, 72% yield). LCMS (<i>m</i>/<i>z</i>): 247 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.13 (s, 1H), 8.75 (d, <i>J</i> = 4.7 Hz, 1H), 7.26 (s, 1H), 5.72 (m, 1H), 5.25 (s, 1H), 5.03 (m, 1H), 4.86 (br s, 1H), 2.67 (m, 1H), 2.39 (dd, <i>J</i> = 16.6, 4.9 Hz, 1H), 2.11 (br s, 1H), 1.91 (m, 1H), 1.23 (d, <i>J</i> = 6.7 Hz, 3H). 1D NOE: selective irradiation of δ 4.86 ppm (H at 3-position) revealed the strongest NOE to δ 2.67 ppm (H at 5-position) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><div class="NLM_p">(±)-4-((3<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-5-methyl-4-methylenecyclohex-1-enyl)-3-nitropyridine (<b>37</b>). To solution of (±)-(1<i>R</i>,5<i>S</i>)-5-methyl-6-methylene-3-(3-nitropyridin-4-yl) cyclohex-2-enol <b>36</b> (5.0 g, 20.3 mol) in DCM (77 mL) was added imidazole (2.07 g, 30.5 mmol) and TBDMSCl (3.37 g, 22.33 mol). The reaction mixture was stirred for 18 h at room temperature. The volatile materials were removed <i>in vacuo</i>, and the residue was partitioned between EtOAc and water. The combined organic layers were washed with water and brine and dried over anhydrous sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The crude material was purified by flash column chromatography (gradient EtOAc in heptane) to yield (±)-4-((3<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methyl-4-methylenecyclohex-1-enyl)-3-nitropyridine <b>37</b> (6.3 g, 17.47 mmol, 86% yield). LCMS (<i>m</i>/<i>z</i>): 361.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.12 (s, 1H), 8.73 (d, <i>J</i> = 5.1 Hz, 1H), 7.27 (d, <i>J</i> = 5.1 Hz, 1H), 5.57 (t, <i>J</i> = 2.5 Hz, 1H), 5.24–5.20 (m, 1H), 4.98–4.94 (m, 1H), 4.84–4.92 (m, 1H), 2.57–2.72 (m, 1H), 2.37 (dd, <i>J</i> = 16.6, 5.3 Hz, 1H), 2.11–2.01 (m, 1H), 1.20 (d, <i>J</i> = 6.7 Hz, 3H), 0.94 (m, 9H), 0.15 (s, 3H), 0.12 (s, 3H). (±)-4-((3<i>R</i>,4<i>R</i>,8<i>S</i>)-4-(<i>tert</i>-Butyldimethylsilyloxy)-8-methyl-1-oxaspiro[2.5]oct-5-en-6-yl)-3-nitropyridine (<b>38</b>). To a solution of (±)-4-((3<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methyl-4-methylenecyclohex-1-enyl)-3-nitropyridine <b>37</b> (90 mg, 0.250 mmol) in DCM (832 μL) was added sodium bicarbonate (31.5 mg, 0.374 mmol). After cooling down to 0 °C, mCPBA (61.5 mg, 0.275 mmol) was added to the reaction mixture. The reaction was allowed to warm up to room temperature for 14 h. After quenched with NaHCO<sub>3</sub> solution, the reaction mixture was extracted with EtOAc. The organic layers were washed with saturated NaHCO<sub>3</sub> aquesous solution and brine, dried over anhydrous sodium sulfate, filtered off, and dried in vacuo. The crude product was purified by ISCO (gradient EtOAc in heptane) to yield (±)-4-((3<i>R</i>,4<i>R</i>,8<i>S</i>)-4-(<i>tert</i>-butyldimethylsilyloxy)-8-methyl-1-oxaspiro[2.5]oct-5-en-6-yl)-3-nitropyridine <b>38</b> (85 mg, 0.225 mmol, 90% yield). LCMS (<i>m</i>/<i>z</i>): 377.1, [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.15 (s, 1H), 8.77 (d, <i>J</i> = 4.0 Hz, 1H), 7.36 (d, <i>J</i> = 4.0 Hz, 1H), 5.65 (m, 1H), 4.53 (m, 1H), 2.95 (d, <i>J</i> = 8.0 Hz, 1H), 2.84 (d, <i>J</i> = 4.0 Hz, 1H), 2.39–2.25 (m, 3H), 0.96 (d, <i>J</i> = 8.0 Hz, 3H), 0.9 (s, 9H), 0.1 (s, 3H), 0.08 (s, 3H). 1D NOE: selective irradiation of δ 4.83 ppm (H at 3-position) revealed the strong NOEs to δ 2.95 ppm (H at epoxide) and δ 2.34 ppm (H at position 5) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><div class="NLM_p">(±)-(3<i>R</i>,4<i>R</i>,8<i>S</i>)-8-Methyl-6-(3-nitropyridin-4-yl)-1-oxaspiro[2.5]oct-5-en-4-ol <b>36-o</b> was synthesized from (±)-(1<i>R</i>,5<i>S</i>)-5-methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-enol <b>36</b> according to step f in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> (96% yield). LCMS (<i>m</i>/<i>z</i>): 263.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.16 (s, 1H), 8.77 (d, <i>J</i> = 4.0 Hz, 1H), 7.29 (d, <i>J</i> = 4.0 Hz, 1H), 5.72 (m, 1H), 4.50 (m, 1H), 3.11 (d, <i>J</i> = 8.0 Hz, 1H), 2.97 (d, <i>J</i> = 4.0 Hz, 1H), 2.53 (m, 1H), 2.27 (m, 2H), 0.91 (d, <i>J</i> = 8.0 Hz, 3H). TBDMS protecting group of <b>38</b> was deprotected to give <b>36-o</b>, <sup>1</sup>H NMR spectra of which was matched with that of <b>36-o</b> from <b>36</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). (1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-en-1-ol (<b>40</b>). To a solution of (±)-(1<i>R</i>,5<i>S</i>)-5-methyl-6-methylene-3-(3-nitropyridin-4-yl)cyclohex-2-enol <b>36</b> (9 g, 36.5 mmol) in THF (91 mL) and water (91 mL) was slowly added <i>N</i>-bromosuccinimide (7.16 g, 40.2 mmol) at 0 °C. The reaction mixture was stirred at 0 °C for 3 h. After quenched with saturated sodium thiosulfite aqueous solution (300 mL), the reaction mixture was extracted with EtOAc. The organic layers were washed with NaHCO<sub>3</sub> solution, water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo to give a mixture of diastereomers (∼2.5:1). The crude product was purified by ISCO (0–5% MeOH/DCM, 330 g column) to yield (1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diol <b>39</b> (7 g, 20.4 mmol, 56% yield). LCMS (<i>m</i>/<i>z</i>): 342.8, 344.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.13 (s, 1H), 8.77 (d, <i>J</i> = 4.0 Hz, 1H), 7.29 (d, <i>J</i> = 4.0 Hz, 1H), 5.73 (m, 1H), 4.28 (m, 1H), 4.06 (d, <i>J</i> = 8.0 Hz, 1H), 3.79 (d, <i>J</i> = 12.0 Hz, 1H), 2.75 (m, 2H), 2.42 (m, 1H), 2.27 (m, 1H), 2.12 (m, 1H), 1.19 (d, <i>J</i> = 8.0 Hz, 3H). To a solution of (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diol <b>39</b> (12 g, 35 mmol) in DMF (70 mL) was added TBDMSCl (7.91 g, 52.5 mmol), imidazole (4.76 g, 69.9 mmol) at room temperature. The reaction mixture was stirred for 24 h. After quenched with NaHCO<sub>3</sub>, the reaction mixture was extracted with EtOAc 3 times. The organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The crude product was purified by ISCO (gradient EtOAc in heptane) to afford (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol <b>40</b> (12 g, 26.2 mmol, 75%). LCMS (<i>m</i>/<i>z</i>): 457, 459.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.11 (s, 1H), 8.75 (d, <i>J</i> = 5.1 Hz, 1H), 7.31–7.25 (m, 1H), 5.61 (br s, 1H), 4.15–4.08 (m, <i>J</i> = 3.5 Hz, 1H), 3.95 (d, <i>J</i> = 10.6 Hz, 1H), 3.76 (d, <i>J</i> = 10.2 Hz, 1H), 2.81 (dd, <i>J</i> = 17.6, 5.9 Hz, 1H), 2.35 (s, 1H), 2.32–2.23 (m, 1H), 2.06 (dd, <i>J</i> = 17.6, 3.5 Hz, 1H), 1.20 (d, <i>J</i> = 7.4 Hz, 3H), 0.83–0.97 (m, 9H), 0.13 (s, 3H), 0.08 (s, 3H). (±)-4-((3<i>S</i>,4<i>R</i>,8<i>S</i>)-4-(<i>tert</i>-butyldimethylsilyloxy)-8-methyl-1-oxaspiro[2.5]oct-5-en-6-yl)-3-nitropyridine (<b>41</b>). To a solution of (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol <b>40</b> (3.0 g, 6.56 mmol) in MeOH (20 mL) and water (2 mL) was added potassium carbonate (1.36 g, 9.84 mmol). The reaction mixture was vigorously stirred for 1 h at room temperature. After the volatile material was evaporated, the reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated <i>in vacuo</i> to yield crude (±)-4-((3<i>S</i>,4<i>R</i>,8<i>S</i>)-4-(<i>tert</i>-butyldimethylsilyloxy)-8-methyl-1-oxaspiro[2.5]oct-5-en-6-yl)-3-nitropyridine <b>41</b> (2.4 g, 6.4 mmol, 97% yield). LCMS (<i>m</i>/<i>z</i>): 377.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.14 (s, 1H), 8.76 (d, <i>J</i> = 4.0 Hz, 1H), 7.31 (d, <i>J</i> = 4.0 Hz, 1H), 5.59 (s, 1H), 4.49 (br s, 1H), 2.99 (d, <i>J</i> = 4.0 Hz, 1H), 2.73 (d, <i>J</i> = 4.0 Hz, 1H), 2.5 (m, 1H), 2.41 (m, 1H), 2.25 (m, 1H), 0.94 (d, <i>J</i> = 8.0 Hz, 1H), 0.89 (s, 9H), 0.08 (m, 6H). (±)-(3<i>S</i>,4<i>R</i>,8<i>S</i>)-8-methyl-6-(3-nitropyridin-4-yl)-1-oxaspiro[2.5]oct-5-en-4-ol <b>39-o</b> was synthesized from (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diol <b>39</b> according to step i in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> (53% yield). LCMS (<i>m</i>/<i>z</i>): 263.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.17 (s, 1H), 8.78 (d, <i>J</i> = 4.0 Hz, 1H), 7.31 (d, <i>J</i> = 4.0 Hz, 1H), 5.75 (m, 1H), 4.62 (m, 1H), 3.10 (d, <i>J</i> = 4.0 Hz, 1H), 2.83 (d, <i>J</i> = 4.0 Hz, 1H), 2.51 (m, 1H), 2.28 (m, 2H), 0.96 (d, <i>J</i> = 4.0 Hz, 3H).</div><div class="NLM_p last">(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-Aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexan-1-ol (<b>32</b>). To a steel bomb reactor was added a solution of (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-2-(<i>tert</i>-butyldimethylsilyloxy)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol <b>40</b> (3.7 g, 8.09 mmol) in methanol (27 mL). After degassed by nitrogen for 10 min followed by addition of 10% Pd(OH)<sub>2</sub> on carbon (2.8 g), the reaction mixture was charged with hydrogen to 200 psi and stirred at room temperature for 4 days. The reaction mixture was filtered through Celite pad, and the filtrate was neutralized with saturated NaHCO<sub>3</sub> aqueous solution. After volatile materials were removed in vacuo, the mixture was extracted with EtOAc. The organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo. The crude product was purified by ISCO (gradient EtOAc containing 2% TEA in DCM) to yield (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexanol <b>32</b> (2.5 g, 7.13 mmol, 88% yield). LCMS (<i>m</i>/<i>z</i>): 351.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.06 (s, 1H), 8.03 (m, 1H), 6.99 (m, 1H), 3.62 (m, 1H), 2.69 (m, 1H), 1.88 (m, 1H), 1.81–1.65 (m, 4H), 1.13 (s, 3H), 1.01 (d, <i>J</i> = 8.0 Hz, 3H), 0.89 (s, 9H), 0.11 (s, 3H), 0.03 (s, 3H). (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexanol <b>32</b> (850 mg, 2.42 mmol) was resolved by chiral HPLC (AD column, heptane/IPA = 95:5, 1 mL/min). Peak 1: (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexanol <b>32a</b> (340 mg, >99% ee, R<sub>t</sub> = 2.74 min). LCMS (<i>m</i>/<i>z</i>): 351.1 [M + H]<sup>+</sup>. Peak 2: (1<i>S</i>,2<i>S</i>,4<i>S</i>,6<i>R</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexanol <b>32b</b> (360 mg, 99% ee, <i>R</i><sub><i>t</i></sub> = 4.28 min). LCMS (<i>m</i>/<i>z</i>): 351.1 [M + H]<sup>+</sup>. 6-(2,6-Difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide (<b>5</b>). To solution of (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexanol <b>32</b> (56 mg, 0.160 mmol) in DMF (200 μL) was added 6-(2,6-difluorophenyl)-5-fluoropicolinic acid (44.5 mg, 0.176 mmol), HOAt (28.3 mg, 0.208 mmol) and EDC (45.9 mg, 0.240 mmol). The reaction mixture was stirred at room temperature for 16 h. After the mixture was quenched with water and extracted with EtOAc, the combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo to yield crude <i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (93.5 mg, >99% yield). LCMS (<i>m</i>/<i>z</i>): 586.5 [M + H]<sup>+</sup>. The crude product was dissolved in THF (2 mL) and MeOH (1 mL) followed by addition of 3 N HCl aqueous solution (0.5 mL). The reaction mixture was stirred for 3 h. After neutralized with saturated NaHCO<sub>3</sub> aqueous solution, the reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo. The crude produce was purified by ISCO (gradient EtOAc in DCM followed by 10% MeOH in EtOAc) to yield (±)-6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>5-rac</b> (65 mg, 0.137 mmol, 86% yield). LCMS (<i>m</i>/<i>z</i>):472.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 9.90 (br s, 1H), 9.34 (s, 1H), 8.43 (d, <i>J</i> = 4 Hz, 1H), 8.41 (m, 1H), 7.78 (t, <i>J</i> = 8.4 Hz, 1H), 7.51 (m, 1H), 7.19 (d, <i>J</i> = 4 Hz, 1H), 7.1 (dd, <i>J</i> = 8.4, 7.6 Hz, 1H), 3.57 (m, 1H), 3.0 (m, 1H), 2.01 (m, 1H), 1.76–1.51 (m, 4H), 1.35–1.26 (m, 1H), 1.12 (s, 3H), 0.9 (d, <i>J</i> = 6.8 Hz, 3H). 65 mg of <b>5-rac</b> was resolved by chiral HPLC (AD-H column, heptane/EtOH = 75:25, 1 mL/min). Peak 1: 6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>5-ent</b> (26.8 mg, 98% ee, <i>R</i><sub><i>t</i></sub> = 3.8 min). LCMS (<i>m</i>/<i>z</i>): 472.0 [M + H]<sup>+</sup>. Peak 2: 6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-5-fluoropicolinamide <b>5</b> (27 mg, 99% ee, <i>R</i><sub><i>t</i></sub> = 5.5 min). LCMS (<i>m</i>/<i>z</i>): 472.0 [M + H]<sup>+</sup>. All analytical and biological data of compounds <b>5</b> and <b>5-ent</b> that were synthesized by procedures as described in <a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a> were matched. Compounds <b>5</b> and <b>5-ent</b> were synthesized respectively from two enantiomers <b>32a</b> and <b>32b</b> of <b>32</b> using the same procedures described above (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). All the data of compound <b>5</b> from enantiomer <b>32a</b> were matched with those of compound <b>5</b> synthesized in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-1,6-dimethylcyclohexane-1,2-diol (<b>42</b>). To a solution of (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(bromomethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diol <b>39</b> (2.3 g, 67 mmol) in ethanol (100 mL) was added Pd on carbon (content 5%, 4.28 g) and pyridine (5.42 mL, 59.4 mmol). The reaction vessel was degassed with nitrogen stream for 15 min, purged, and flushed with hydrogen gas three times. After equipped with hydrogen balloon, the reaction was stirred for 24 h. The reaction mixture was diluted with methanol and filtered. The residue was washed with 100 mL of methanol. The volatile materials were removed in vacuo. The crude product was purified by ISCO (95:5:0.5 DCM/MeOH/NH<sub>4</sub>OH to 80:19:1 DCM/MeOH/NH<sub>4</sub>OH over 15 min, 80 g silica cartridge) to give (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-1,6-dimethylcyclohexane-1,2-diol <b>42</b> (1.1 g, 4.65 mmol, 70% yield). LCMS (<i>m</i>/<i>z</i>): 237.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.92 (s, 1H), 7.77 (d, <i>J</i> = 4.8 Hz, 1H), 7.09 (d, <i>J</i> = 5.2 Hz, 1H), 4.8 (s, 4H), 3.64 (m, 1H), 2.91 (m, 1H), 1.95 (m, 1H), 1.8–1.62 (m, 4H), 1.31 (m, 1H), 1.12 (s, 3H), 0.98 (d, <i>J</i> = 6.8 Hz, 3H). 950 mg of (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-1,6-dimethylcyclohexane-1,2-diol <b>42</b> was resolved by chiral HPLC (OJ-H column, heptane/IPA = 85:15, 1 mL/min). Peak 1: (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-1,6-dimethylcyclohexane-1,2-diol <b>42a</b> (370 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 7.6 min). LCMS (<i>m</i>/<i>z</i>): 237.3 [M + H]<sup>+</sup>. Peak 2: (1<i>S</i>,2<i>S</i>,4<i>S</i>,6<i>R</i>)-4-(3-aminopyridin-4-yl)-1,6-dimethylcyclohexane-1,2-diol <b>42b</b> (340 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 10.2 min). LCMS (<i>m</i>/<i>z</i>): 237.3 [M + H]<sup>+</sup>. The amide coupling between <b>42a</b> and <b>18</b> yielded compound <b>5</b>. All analytical and biological data were matched with those for compound <b>5</b> obtained from intermediate <b>32</b>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of Compound <b>12</b></h3><div class="NLM_p last">(±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-Butyldimethylsilyloxy)-1-(hydroxymethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol (<b>43</b>). To a solution of (±)-4-((3<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methyl-4-methylenecyclohex-1-enyl)-3-nitropyridine <b>37</b> (6.3 g, 17.47 mmol) in acetone (132 mL) and water (43 mL) was added osmium tetroxide (10 mL, 2.5% in water) and NMO (13.06 g, 112 mmol). The reaction mixture was stirred at room temperature for 1 h. After quenched with Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> aqueous solution (21 g in 80 mL of water), the mixture was stirred for 1 h. After acetone was removed <i>in vacuo</i>, the reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated <i>in vacuo</i>. The crude material was purified by ISCO (gradient EtOAc in heptane) to yield (±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-(hydroxymethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol <b>43</b> (7.0 g, 17.7 mmol, 95% yield). LCMS (<i>m</i>/<i>z</i>): 395.0 [M + H]<sup>+</sup>. (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-hydroxy-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enecarbaldehyde (<b>44</b>). To a solution of (±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-(hydroxymethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol <b>43</b> (3.4 g, 8.62 mmol) in DCM (28.7 mL, 0.3 M) was added Dess–Martin periodinane (4.02 g, 9.48 mmol). The reaction mixture was stirred at room temperature for 72 h. After quenched with Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> and NaHCO<sub>3</sub> solution (1:8) and vigorously stirred for 1 h, the reaction mixture was extracted with EtOAc, the organic layer was washed with water and brine, and dried by anhydrous sodium sulfate, filtered and concentrated <i>in vacuo</i>, and the crude product was purified by ISCO (0–40% EtOAc in heptane) to afford (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-hydroxy-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enecarbaldehyde <b>44</b> (2.6 g, 6.62 mmol, 77% yield). LCMS (<i>m</i>/<i>z</i>): 393.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 9.94–9.89 (m, 1H), 9.18 (s, 1H), 8.81 (d, <i>J</i> = 4.7 Hz, 1H), 7.32 (d, <i>J</i> = 5.1 Hz, 1H), 5.67 (s, 1H), 4.46–4.55 (m, 1H), 3.86–3.80 (s, 1H), 2.54 (d, <i>J</i> = 3.1 Hz, 1H), 2.49–2.32 (m, 2H), 0.97 (d, <i>J</i> = 6.7 Hz, 3H), 0.83 (s, 9H), 0.12–0.05 (m, 6H). (±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethynyl-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol (<b>45</b>). To a solution of (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-hydroxy-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enecarbaldehyde <b>44</b> (1.58 g, 4.03 mmol) in MeOH (130 mL) was added Bestmann–Ohira’s reagent (1.55, 8.05 mmol) in MeOH (70 mL) followed by addition of potassium carbonate (2.78 g, 20.13 mmol) at room temperature. The reaction mixture was stirred for 1.5 h. After removing 90% of MeOH in vacuo, the mixture was partitioned with water and EtOAc, the organic layers were washed with saturated NH<sub>4</sub>Cl solution and brine, dried with anhydrous sodium sulfate, filtered off, and concentrated. The crude compound was purified <i>via</i> ISCO (0–30% EtOAc in heptane) to yield (±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethynyl-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol <b>45</b> (1.5 g, 3.86 mmol, 96% yield). LCMS (<i>m</i>/<i>z</i>): 389.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm, 9.12 (s, 1 H) 8.74 (d, <i>J</i> = 5.09 Hz, 1 H) 7.29 (d, <i>J</i> = 5.09 Hz, 1 H) 5.44 (s, 1 H) 4.33 (dt, <i>J</i> = 3.33, 1.86 Hz, 1 H) 2.66 (s, 1 H) 2.45 (s, 1 H) 2.38–2.30 (m, 2 H) 2.28–2.19 (m, 1 H) 1.17 (d, <i>J</i> = 6.26 Hz, 3 H) 0.93 (s, 9 H) 0.17–0.09 (m, 6 H). (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-Aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethyl-6-methylcyclohexanol (<b>46</b>). To a solution of (±)-(1<i>S</i>,2<i>R</i>,6<i>S</i>)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethynyl-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol <b>45</b> (1.1 g, 2.83 mmol) in MeOH (28 mL) was added 10% Pd on carbon (0.9 g). After degassed by nitrogen for 10 min and equipped with hydrogen balloon, the reaction mixture was stirred at room temperature for 12 h. The reaction mixture was filtered through Celite and washed by MeOH and EtOAc. After the filtrate was concentrated in vacuo, the crude product was purified by ISCO (gradient EtOAc in DCM) to yield (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethyl-6-methylcyclohexanol <b>46-rac</b> (336 mg, 0.922 mmol, 33% yield). LCMS (<i>m</i>/<i>z</i>): 365.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.05 (s, 1H), 8.03 (m, 1H), 7.0 (m, 1H), 3.65 (m, 1H), 2.72 (m, 1H), 2.11–1.62 (m, 5H), 1.35 (m, 2H), 1.05 (d, <i>J</i> = 8.0 Hz, 3H), 0.91 (s, 9H), 0.89 (m, 3H), 0.12 (s, 3H), 0.05 (s, 3H). 336 mg of (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethyl-6-methylcyclohexanol <b>46-rac</b> was resolved by chiral SFC (Chiralpak, 10 × 250, 15 mL/min, CO<sub>2</sub>/EtOH + 0.1%DEA, 85/15. 40 °C). Peak 1: (1<i>S</i>,2<i>S</i>,4<i>S</i>,6<i>R</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethyl-6-methylcyclohexanol <b>46-ent</b> (97 mg, 99% ee, <i>R</i><sub><i>t</i></sub> = 1.49 min). LCMS (<i>m</i>/<i>z</i>): 365.1 [M + H]<sup>+</sup>. Peak 2: (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethyl-6-methylcyclohexanol <b>46</b> (112 mg, 99% ee, <i>R</i><sub><i>t</i></sub> = 1.91 min). LCMS (<i>m</i>/<i>z</i>): 365.1 [M + H]<sup>+</sup>. 3-Amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-ethyl-4-hydroxy-5-methylcyclohexyl)pyridin-3-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide (<b>48</b>). To solution of (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butyldimethylsilyloxy)-1-ethyl-6-methylcyclohexanol <b>46</b> (37 mg, 0.101 mmol) in DMF (127 μL) was added 3-amino-6-bromopicolinic acid <b>47</b> (102 mg, 0.471 mmol), HOAt (17.96 mg, 0.132 mmol), and EDC (29.2 mg, 0.152 mmol). The reaction mixture was stirred at room temperature for 16 h. After quenched with water, the reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated <i>in vacuo</i> to yield crude 3-amino-6-bromo-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-ethyl-4-hydroxy-5-methylcyclohexyl)pyridin-3-yl)picolinamide (56 mg, 99%). LCMS (<i>m</i>/<i>z</i>): 563.1, 565.1 [M + H]<sup>+</sup>. To a microwave vessel was added 3-amino-6-bromo-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-ethyl-4-hydroxy-5-methylcyclohexyl)pyridin-3-yl)picolinamide (56 mg, 0.099 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (50.5 mg, 0.199 mmol), tricyclohexylphosphine (6.13 mg, 0.022 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (10.0 mg, 10.9 μmol), and dioxane (497 μL). The reaction was degassed by nitrogen stream for 5 min followed by addition of potassium acetate (29.3 mg, 0.298 mmol). The reaction mixture was microwaved at 120 °C for 10 min. After diluted with EtOAc, the mixture was filtered through Celite pad. The volatile materials were removed in vacuo to yield crude 3-amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-ethyl-4-hydroxy-5-methylcyclohexyl)pyridin-3-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide <b>48</b> (60.7 mg, 0.099 mmol, >99%). LCMS (<i>m</i>/<i>z</i>): 529.2 [M + H]<sup>+</sup> for boronic acid. 5-Amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-ethyl-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-3′-fluoro-2,2′-bipyridine-6-carboxamide (<b>12</b>). To a microwave vessel, 3-amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-ethyl-4-hydroxy-5-methylcyclohexyl)pyridin-3-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide <b>48</b> (60.7 mg, 0.099 mmol), 2-bromo-3-fluoropyridine (26.2 mg, 0.149 mmol), PdCl<sub>2</sub>(dppf) (10.91 mg, 0.015 mmol), DME (745 μL), and 2 M Na<sub>2</sub>CO<sub>3</sub> solution (248 μL) were added. The reaction mixture was degassed by N<sub>2</sub> stream for 5 min. The reaction was microwaved at 120 °C for 10 min. The reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated <i>in vacuo</i> to crude product. LCMS (<i>m</i>/<i>z</i>): 580.2 [M + H]<sup>+</sup>. The crude product was dissolved in THF and MeOH (1:1, 1 mL) followed by addition of 3 N HCl (0.5 mL). The reaction mixture was stirred for 1 h. After added with saturated Na<sub>2</sub>CO<sub>3</sub> aqueous solution until the mixture turned to pH 8, the reaction mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated <i>in vacuo</i>. The crude product was purified by prep HPLC. The combined pure fractions were lyophilized to yield 5-amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-ethyl-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-3′-fluoro-2,2′-bipyridine-6-carboxamide <b>12</b> as its TFA salt (17.4 mg, 30% yield over 3 steps). LCMS (<i>m</i>/<i>z</i>): 466.1 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub>F [M + H]<sup>+</sup>, 466.2254; found, 466.2251. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 10.52 (s, 1H), 9.35 (s, 1H), 8.51 (m, 2H), 8.11 (d, <i>J</i> = 8 Hz, 1H), 7.85 (d, <i>J</i> = 8 Hz, 1H), 7.78 (m, 1H), 7.51 (m, 1H), 7.43 (d, <i>J</i> = 8 Hz, 1H), 7.26 (br s, 2H), 3.12 (m, 1H), 1.76–1.55 (m, 5H), 1.47–1.34 (m, 2H), 0.92 (t, <i>J</i> = 8 Hz, 3H), 0.85 (d, <i>J</i> = 4 Hz, 3H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of Compound <b>13</b></h3><div class="NLM_p last">(±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(Fluoromethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diol (<b>49</b>). A solution of (±)-4-((3<i>S</i>,4<i>R</i>,8<i>S</i>)-4-(<i>tert</i>-butyldimethylsilyloxy)-8-methyl-1-oxaspiro[2.5]oct-5-en-6-yl)-3-nitropyridine <b>41</b> (520 mg, 1.381 mmol) in triethylamine trihydrofluoride (2.25 mL, 13.81 mmol) in a stainless steel reactor was heated at 100 °C for 8 h. After cooled down and quenched by saturated NaHCO<sub>3</sub> aqueous solution carefully, the reaction mixture was partitioned between EtOAc and water. The mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo to yield (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(fluoromethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diol (180 mg, 0.638 mmol, 46% yield). LCMS (<i>m</i>/<i>z</i>): 283.0 [M + H]<sup>+</sup>. A solution of (±)-(1<i>R</i>,2<i>R</i>,6<i>S</i>)-1-(fluoromethyl)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-ene-1,2-diol (180 mg, 0.638 mmol) in MeOH (5.3 mL) was degassed by nitrogen stream for 10 min followed by addition of 10% Pd on carbon (68 mg). The reaction mixture was stirred at room temperature for 12 h under hydrogen balloon. The reaction mixture was filtered through Celite pad and washed by MeOH and EtOAc, and the filtrate was concentrated in vacuo to give (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-1-(fluoromethyl)-6-methylcyclohexane-1,2-diol <b>49</b> (79 mg, 0.311 mmol, 49% yield). LCMS (<i>m</i>/<i>z</i>): 255.0 [M + H]<sup>+</sup>. 5-Amino-3′-fluoro-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-[2,2′-bipyridine]-6-carboxamide (<b>13</b>). A solution of (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-1-(fluoromethyl)-6-methylcyclohexane-1,2-diol <b>49</b> (79 mg, 0.311 mmol) and 3-amino-6-bromopicolinic acid <b>47</b> (101 mg, 0.466 mmol), HOAt (76 mg, 0.559 mmol) and EDC (107 mg, 0.559 mmol) in DMF (0.62 mL) was stirred for 12 h at room temperature. The reaction mixture was quenched with water and extracted with EtOAc. The organic layers were washed by saturated NaHCO<sub>3</sub> aqueous solution, water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo to yield crude (±)-3-amino-6-bromo-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)picolinamide (120 mg, 0.265 mmol, 85% yield). The crude product was used in the next step without further purification. LCMS (<i>m</i>/<i>z</i>): 453, 455 [M + H]<sup>+</sup>. To a microwave vessel was added (±)-3-amino-6-bromo-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)picolinamide (120 mg, 0.265 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (134 mg, 0.529 mmol), tricyclohexylphoshpine (13.36 mg, 0.048 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (19.39 mg, 0.021 mmol), and dioxane (0.88 mL). After the reaction was degassed by nitrogen stream for 5 min, potassium acetate (78 mg, 0.794 mmol) was added. The reaction mixture was microwaved at 120 °C for 10 min. LCMS (<i>m</i>/<i>z</i>): 419.0 [M + H]<sup>+</sup> for boronic acid. The reaction mixture was diluted with EtOAc, which was filtered through Celite pad. The volatile materials were removed to yield (±)-3-amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide (132 mg, 0.264 mmol, >99%), which was used in the next step without further purification. 5-Amino-3′-fluoro-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-[2,2′-bipyridine]-6-carboxamide (<b>13</b>). To solution of (±)-3-amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide (132 mg, 0.264 mmol) in DME (2 mL) and 2 M Na<sub>2</sub>CO<sub>3</sub> aqueous solution (0.66 mL) was added 2-bromo-3-fluoropyridine (55.7 mg, 0.317 mmol) and PdCl<sub>2</sub>(dppf) (19.3 mg, 0.026 mmol). The reaction mixture was heated at microwave for 10 min at 120 °C. After diluted with EtOAc and water, the mixture was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo. The crude product was purified by prep HPLC, and pure fractions were free based followed by lyophilization to yield (±)-5-amino-3′-fluoro-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-2,2′-bipyridine-6-carboxamide (12.8 mg, 10% yield) <b>13-rac</b>. LCMS (<i>m</i>/<i>z</i>): 470.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400MHz, CDCl<sub>3</sub>): δ ppm 10.32 (s, 1H), 9.31 (s, 1H), 8.52 (d, <i>J</i> = 4.3 Hz, 1H), 8.40 (d, <i>J</i> = 5.1 Hz, 1H), 8.18 (d, <i>J</i> = 8.6 Hz, 1H), 7.54 (m, 1H), 7.32 (m, 1H), 7.21 (m, 2H), 6.26 (br s, 2H), 5.30 (s, 3H), 4.89–4.61 (m, 2H), 3.85 (d, <i>J</i> = 11.3 Hz, 1H), 3.21 (br s, 1H), 2.72 (br s, 1H), 2.29 (br s, 1H), 2.14 (m, 1H), 1.97–1.68 (m, 3H), 1.59 (m, 1H), 1.06 (d, <i>J</i> = 8.0 Hz, 3H). 12.8 mg of <b>13-rac</b> was resolved by chiral SFC (OJ column, 5 mL/min, EtOH + 0.1% DEA = 20%). Peak 1: 5-amino-3′-fluoro-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-2,2′-bipyridine-6-carboxamide <b>13</b> (3.1 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 1.52). LCMS (<i>m</i>/<i>z</i>): 470.1 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub>F<sub>2</sub> [M + H]<sup>+</sup>, 470.2004; found, 470.2003. Peak 2: 5-amino-3′-fluoro-<i>N</i>-(4-((1<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)-2,2′-bipyridine-6-carboxamide <b>13-ent</b> (3.6 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 1.92). LCMS (<i>m</i>/<i>z</i>): 470.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of Compound <b>14</b></h3><div class="NLM_p last">5-Amino-2-(2,6-difluorophenyl)pyrimidine-4-carboxylic acid (<b>46</b>). A solution of 2,6-difluorobenzimidamide hydrochloride <b>50</b> (3.8 g, 19.73 mmol) in anhydrous ethanol (63 mL) was cooled to 0 °C in an ice bath. Sodium ethoxide solution (16.14 mL, 41.2 mmol, 20%) was added slowly <i>via</i> syringe, the ice bath was removed, and the reaction mixture was warmed to room temperature and stirred for 1 h. A solution of mucobromic acid, (<i>E</i>)-2,3-dibromo-4-oxobut-2-enoic acid (3.54 g, 13.73 mmol), in ethanol (69 mL) was added dropwise <i>via</i> syringe, and the reaction was heated in a 40 °C oil bath for 2 h. The volatile materials were removed in vacuo and water (100 mL) and 6 N NaOH aqueous solution (50 mL) was added to dissolve the crude product. The basic aqueous solution was extracted with EtOAc. Then, the aqueous layer was acidified to pH 4.0 by adding 3 N HCl aqueous solution slowly and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo to afford crude 5-bromo-2-(2,6-difluorophenyl)pyrimidine-4-carboxylic acid (4.3 g, 13.7 mmol, >99% yield) as a reddish brown solid, which was used in the next step without purification. LCMS (<i>m</i>/<i>z</i>): 314.9, 316.9 [M + H]<sup>+</sup>. To a steel bomb reactor was added 5-bromo-2-(2,6-difluorophenyl)pyrimidine-4-carboxylic acid (4.3 g, 13.7 mmol) dissolved in 28% NH<sub>4</sub>OH solution (10 mL) and copper (II) sulfate (0.219 g, 1.37 mmol). The reactor was placed in a preheated bath (110 °C) and stirred for 1 h. After cooling down, the reaction vessel was unsealed. The reaction mixture was transferred to Erlenmeyer flask by washing with water, which was acidified by pH 4.0 with 3 N HCl aqueous solution, and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo to yield a crude reddish solid (863 mg, 3.4 mmol, 25% yield over 2 steps). The crude product was used in the next step without further purification. LCMS (<i>m</i>/<i>z</i>): 252.0 [M + H]<sup>+</sup>. 5-Amino-2-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)pyrimidine-4-carboxamide (<b>14</b>). To a solution of (±)-(1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-1-(fluoromethyl)-6-methylcyclohexane-1,2-diol <b>49</b> (50 mg, 0.197 mmol) in DMF (0.4 mL) was added 5-amino-2-(2,6-difluorophenyl)pyrimidine-4-carboxylic acid <b>51</b> (64.2 mg, 0.256 mmol), HOAt (40.1 mg, 0.295 mmol) and EDC (56.5 mg, 0.295 mmol). The reaction mixture was stirred for 12 h at room temperature. After partitioned between EtOAc and water, the mixture was extracted with EtOAc. The combined organic layers were washed by water and brine, dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo. The crude material was purified by reverse phase HPLC. The combined pure fractions were free-based and extracted with EtOAc. The organic layers were dried over anhydrous sodium sulfate, filtered off, and concentrated in vacuo to afford (±)-5-amino-2-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)pyrimidine-4-carboxamide <b>14-rac</b> (24 mg, 0.049 mmol, 25%). LCMS (<i>m</i>/<i>z</i>): 488.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm: 10.08 (br s, 1H), 9.29 (s, 1H), 8.56 (s, 1H), 8.41 (d, <i>J</i> = 5.1 Hz, 1H), 7.35–7.45 (m, 1H), 7.20 (d, <i>J</i> = 5.1 Hz, 1H), 7.05 (t, <i>J</i> = 8.0 Hz, 2H), 6.12 (br s, 2H), 4.87–4.58 (m, 2H), 3.77 (d, <i>J</i> = 11.0 Hz, 1H), 3.07 (br s, 1H), 2.70 (br s, 1H), 2.44 (br s, 1H), 2.06 (m, 1H), 1.89–1.72 (m, 4H), 1.65–1.51 (m, 1H), 1.02 (d, <i>J</i> = 6.3 Hz, 3H). 20 mg of <b>14-rac</b> was resolved by chiral HPLC (AD-H column, EtOH/heptane = 15:85, 1 mL/min). Peak 1: 5-Amino-2-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)pyrimidine-4-carboxamide <b>14-ent</b> (5.5 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 7.83 min), LCMS (<i>m</i>/<i>z</i>): 488.1 [M + H]<sup>+</sup>. Peak 2: 5-amino-2-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-4-(fluoromethyl)-3,4-dihydroxy-5-methylcyclohexyl)pyridin-3-yl)pyrimidine-4-carboxamide <b>14</b> (6.7 mg, >99% ee, <i>R</i><sub><i>t</i></sub> = 9.28 min). LCMS (<i>m</i>/<i>z</i>): 488.1 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub> [M + H]<sup>+</sup>, 488.1909; found, 488.1913.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of Compounds <b>6</b>, <b>7</b>, <b>8</b>, <b>9</b>, and <b>10</b></h3><div class="NLM_p last">According to steps l and m in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, compounds <b>6–10</b> were synthesized using (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexanol <b>32a</b> and the corresponding acids, 2-(2,6-difluorophenyl)thiazole-4-carboxylic acid, 2-(2,6-difluorophenyl)pyrimidine-4-carboxylic acid, 5-amino-2-(2,6-difluorophenyl)thiazole-4-carboxylic acid, 5-amino-2-(2,6-difluorophenyl)pyrimidine-4-carboxylic acid <b>51</b>, and 3-amino-6-(2,6-difluorophenyl)picolinic acid, respectively. The desired products were obtained as their TFA salts through reverse phase preparative HPLC. 2-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)thiazole-4-carboxamide (<b>6</b>). LCMS (<i>m</i>/<i>z</i>): 460.0 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub>F<sub>2</sub>S [M + H]<sup>+</sup>, 460.1506; found, 460.1505. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 10.2 (s, 1H), 8.67 (m, 2H), 8.48 (m, 1H), 7.68 (m, 2H), 7.36 (m, 2H), 3.31 (m, 1H), 3.04 (m, 1H), 1.75 (m, 1H), 1.58–1.17 (m, 4H), 0.96 (s, 3H), 0.85 (d, <i>J</i> = 6.8 Hz, 3H). 2-(2,6-Difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)pyrimidine-4-carboxamide (<b>7</b>). LCMS (<i>m</i>/<i>z</i>): 455.1 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>F<sub>2</sub> [M + H]<sup>+</sup>, 455.1895; found, 455.1894. 5-Amino-2-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)thiazole-4-carboxamide (<b>8</b>). LCMS (<i>m</i>/<i>z</i>): 475.1 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>F<sub>2</sub>S [M + H]<sup>+</sup>, 475.1615; found, 475.1620. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.93 (s, 1H), 8.44 (d, <i>J</i> = 4.0 Hz, 1H), 7.63 (br s, 2H), 7.55 (m, 2H), 7.28 (m, 2H), 3.05 (m, 1H), 1.78 (m, 1H), 1.59–1.41 (m, 3H), 1.27 (m, 1H), 0.97 (s, 3H), 0.88 (d, <i>J</i> = 8.0 Hz, 3H). 5-Amino-2-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)pyrimidine-4-carboxamide (<b>9</b>). LCMS (<i>m</i>/<i>z</i>): 470.2 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>F<sub>2</sub> [M + H]<sup>+</sup>, 470.2004; found, 470.2005. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 10.4 (s, 1H), 8.95 (s, 1H), 8.38 (d, <i>J</i> = 4.0 Hz, 1H), 8.14 (m, 2H), 7.82 (m, 1H), 7.52 (m, 1H), 6.88 (d, <i>J</i> = 12.0 Hz, 1H), 3.8 (s, 1H), 2.93 (m, 1H), 1.67 (m, 1H), 1.53–1.38 (m, 3H), 1.17 (m, 1H), 0.89 (s, 3H), 0.75 (d, <i>J</i> = 8.0 Hz, 3H). 3-Amino-6-(2,6-difluorophenyl)-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)picolinamide (<b>10</b>). LCMS (<i>m</i>/<i>z</i>): 469.1 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>F<sub>2</sub> [M + H]<sup>+</sup>, 469.2051; found, 469.2056. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 10.3 (s, 1H), 9.14 (s, 1H), 8.45 (d, <i>J</i> = 4.0 Hz, 1H), 7.68 (d, <i>J</i> = 4.0 Hz, 1H), 7.58 (m, 1H), 7.45 (m, 1H), 7.20 (m, 1H), 3.0 (m, 1H), 1.72 (m, 1H), 1.54–1.35 (m, 3H), 1.24 (m, 1H), 0.94 (s, 3H), 0.77 (d, <i>J</i> = 4.0 Hz, 3H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of Compound <b>11</b></h3><div class="NLM_p last">5-Amino-<i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4-dihydroxy-4,5-dimethylcyclohexyl)pyridin-3-yl)-3′-fluoro-2,2′-bipyridine-6-carboxamide (<b>11</b>). According to steps f, g, h, and i in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, compound <b>11</b> was synthesized using (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1,6-dimethylcyclohexanol <b>32a</b>. The desired product was obtained as its TFA salt through reverse phase preparative HPLC. LCMS (<i>m</i>/<i>z</i>): 452.2 [M + H]<sup>+</sup>. HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub>F [M + H]<sup>+</sup>, 452.2098; found, 452.2096. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 10.2 (s, 1H), 9.09 (s, 1H), 8.52 (m, 1H), 8.31 (d, <i>J</i> = 4.0 Hz, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 7.72 (m, 1H), 7.48 (m, 1H), 7.41 (m, 1H), 7.26 (br s, 1H), 4.48 (s, 2H), 4.07 (s, 1H), 2.97 (m, 1H), 1.75 (m, 1H), 1.68–1.41 (m, 3H), 1.28 (m, 1H), 0.94 (s, 3H), 0.84 (d, <i>J</i> = 8.0 Hz, 3H).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Microsomal Stability Testing</h3><div class="NLM_p last">The test compounds were incubated at a concentration of 1 μM in the presence of a 0.5 mg/mL microsomal protein suspension, 1 mM UDPGA, 3 mM MgCl<sub>2</sub>, 1 mM NADPH, and 25 μg alamethicin/mg microsomal protein. Over the time course of the incubation, duplicate samples were collected at intervals of 0, 5, 15, and 30 min for determination of metabolic rate and parent compound remaining at the end of 30 min incubation. Phenolphthalein was used as a reference control. Data were obtained utilizing semi-quantitative LC–MS/MS methods. Calculation of scaled intrinsic clearance: CL<sub>int</sub> = 0.693 × [1/<i>t</i><sub>1/2</sub> (min)] × (g of liver weight/kg of body weight) × (mL incubation/mg of microsomal protein) × (45 mg of microsomal protein/g of liver weight) with rat = 45 g of liver per kg of body weight and human = 25.7 g of liver per kg of body weight. Hepatic clearance was extrapolated from microsomal data using well-stirred liver model CL<sub>h</sub> = [<i>Q</i><sub>h</sub> × (<i>f</i><sub>ub</sub>/<i>f</i><sub>ui</sub>) × CL<sub>int</sub>]/<i>Q</i><sub>h</sub> + (<i>f</i><sub>ub</sub>/<i>f</i><sub>ui</sub>) × CL<sub>int</sub>, where assumption is <i>f</i><sub>ub</sub> (fraction unbound in blood) = <i>f</i><sub>ui</sub> (fraction unbound in incubation) and <i>Q</i><sub>h</sub> values of 55 mL/min/kg and 20.7 mL/min/kg were used for rat and human. Calculation of hepatic extraction ratio: ER_H = CL<sub>h</sub>/Q<sub>h</sub>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> PIM Enzymatic Assays</h3><div class="NLM_p last"><i>Kinase-Glo Pim1, Pim2, Pim3 ATP depletion assays:</i> Pim1, Pim2 & Pim3 Kinase-Glo assays using ATP (at or below ATP Km) were used as previously described to determine the biochemical activity of compounds <b>1–7</b> and compounds <b>9–12,</b> as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><i>High ATP Pim1, Pim2, Pim3 AlphaScreen Assays:</i> Pim1, Pim2 & Pim3 AlphaScreen assays using high ATP (11–125 X ATP Km) were used as previously described to determine the biochemical activity of compounds <b>8</b>, <b>13,</b> and <b>14,</b> as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Cell Lines and Reagents</h3><div class="NLM_p last">The KMS-11.luc human multiple myeloma tumor cell line, a KMS-11 clone expressing firefly luciferase, was obtained from the University Health Network (UHN), Toronto, Ontario, Canada. KMS-11.luc was cultured in RPMI-1640 (ATCC, Manassas VA) supplemented with 10% FBS.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cellular Proliferation Assays</h3><div class="NLM_p last">Proliferation assays in KMS-11.luc were conducted as previously described with the concentration at which 50% maximal inhibition is reached reported as EC<sub>50</sub>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01279" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01279?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01279</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Kinase selectivity profiles for compounds <b>5</b> and <b>11</b> and LCMS and HPLC spectra for representative compounds <b>5</b>, <b>11</b>, and <b>14</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and statistical analysis of the associated biochemical data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_003.xlsx" class="ext-link">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_001.pdf">jm0c01279_si_001.pdf (1.19 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_002.csv">jm0c01279_si_002.csv (1.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_003.xlsx">jm0c01279_si_003.xlsx (12.27 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes of compounds <b>5</b> and <b>13</b> in PIM1 are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1oblv">1oblv</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ozrb">1ozrb</a>, respectively. The atomic coordinates will be released upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01279" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62456" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62456" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wooseok Han</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7567-1883" title="Orcid link">http://orcid.org/0000-0002-7567-1883</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#493e26263a2c262267212827092e24282025672a2624"><span class="__cf_email__" data-cfemail="31465e5e42545e5a1f59505f71565c50585d1f525e5c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Ding</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">BeiGene,
Ltd., San Mateo, California 94403, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Chen</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Boston
Analytical, Salem, New Hampshire 03079, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John L. Langowski</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Kite,
a Gilead Company, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cornelia Bellamacina</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Crystallographic
Consulting, Berkeley, California 94704, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alice Rico</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Exelixis, Alameda, California 94502, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gisele A. Nishiguchi</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">St.
Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiong Lan</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Genfleet
Therapeutics, Inc., Pudong District, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gordana Atallah</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pharmacyclics, an AbbVie Company, Sunnyvale, California 94085, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mika Lindvall</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Recursion Pharmaceuticals, Salt
Lake City, Utah 84101, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Song Lin</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Astex Pharmaceuticals Inc., Pleasanton, California 94588, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Zang</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Global Blood Therapeutics, South
San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Feucht</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span>Present Address:
                        16219 Cedar Lake View Ct, Cypress, Texas 77433, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatiana Zavorotinskaya</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ORIC Pharmaceuticals, South
San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yumin Dai</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Bristol Myers Squibb, Redwood
City, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pablo Garcia</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Circle
Pharma, Inc., South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew T. Burger</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44680" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44680" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Weiping Jia and Dahzi Tang for analytical chemistry support, Alice Wang for chiral resolution, Kent Wong for <i>in vitro</i> DMPK support, Jee-Yeon Wong for data analysis, and Fiorella Ruggiu for fruitful discussion about membrane permeability.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">BOC</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">Cbz</td><td class="NLM_def"><p class="first last">benzyloxycarbonyl</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMDO</td><td class="NLM_def"><p class="first last">dimethyldioxirane</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">ee</td><td class="NLM_def"><p class="first last">enantiomeric excess</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">ER_H</td><td class="NLM_def"><p class="first last">extraction ratio</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">Log D<sub>7.4</sub></td><td class="NLM_def"><p class="first last">log of the octanol–water distribution coefficient at pH 7.4 of ionized and unionized compound</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HT-Eq Sol.</td><td class="NLM_def"><p class="first last">high throughput equilibrium solubility</p></td></tr><tr><td class="NLM_term">ISCO</td><td class="NLM_def"><p class="first last">Teledyne ISCO chromatography system</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">mCPBA</td><td class="NLM_def"><p class="first last">meta-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">NOE</td><td class="NLM_def"><p class="first last">nuclear overhauser effect</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">TBDMS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">trimethylsilyl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuypers, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quint, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zijlstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maandag, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelens, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wezenbeek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melief, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span> <span> </span><span class="NLM_article-title">Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(84)90309-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2F0092-8674%2884%2990309-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=6327049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=141-150&author=H.+T.+Cuypersauthor=G.+Seltenauthor=W.+Quintauthor=M.+Zijlstraauthor=E.+R.+Maandagauthor=W.+Boelensauthor=P.+Van+Wezenbeekauthor=C.+Meliefauthor=A.+Berns&title=Murine+leukemia+virus-induced+T-cell+lymphomagenesis%3A+integration+of+proviruses+in+a+distinct+chromosomal+region&doi=10.1016%2F0092-8674%2884%2990309-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Murine leukemia virus-induced T-cell lymphomagenesis:  integration of proviruses in a distinct chromosomal region</span></div><div class="casAuthors">Cuypers, H. Theo; Selten, Gerard; Quint, Wim; Zijlstra, Maarten; Maandag, Els Robanus; Boelens, Wilbert; Van Wezenbeek, Peter; Melief, Cees; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Mink cell focus-forming (MCF) proviruses were molecularly cloned from mouse lymphoma DNA.  From each clone, flanking probes were prepd. to detect common integration regions in other murine leukemia virus (MuLV)-induced lymphomas.  One clone frequently revealed variations in the mol. structure of the corresponding region (Pim-1) in other lymphomas.  Changes in the Pim region are seen in 24 of 93 lymphomas tested.  Over 50% of the early T-cell lymphomas show integration in the Pim-1 region.  The alterations are seen in different mouse strains and with various MuLVs.  The obsd. variations are caused by the integration of predominantly MCF genomes.  All integrations occur in a region spanning <20 kilobases and are assocd. with the transcriptional activation of a distinct region within the Pim-1 domain.  The activated region does not show any homol. with 13 known and 3 putative oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm89Z9zs2CVrVg90H21EOLACvtfcHk0li2kWG02baybA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D&md5=8cff87b785ab0a12aacf742106aaf6a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2884%2990309-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252884%252990309-X%26sid%3Dliteratum%253Aachs%26aulast%3DCuypers%26aufirst%3DH.%2BT.%26aulast%3DSelten%26aufirst%3DG.%26aulast%3DQuint%26aufirst%3DW.%26aulast%3DZijlstra%26aufirst%3DM.%26aulast%3DMaandag%26aufirst%3DE.%2BR.%26aulast%3DBoelens%26aufirst%3DW.%26aulast%3DVan%2BWezenbeek%26aufirst%3DP.%26aulast%3DMelief%26aufirst%3DC.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DMurine%2520leukemia%2520virus-induced%2520T-cell%2520lymphomagenesis%253A%2520integration%2520of%2520proviruses%2520in%2520a%2520distinct%2520chromosomal%2520region%26jtitle%3DCell%26date%3D1984%26volume%3D37%26spage%3D141%26epage%3D150%26doi%3D10.1016%2F0092-8674%2884%2990309-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaller, J.</span></span> <span> </span><span class="NLM_article-title">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1015</span>, <span class="refDoi"> DOI: 10.3324/haematol.2009.017079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.3324%2Fhaematol.2009.017079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=20145274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1004-1015&author=L.+Braultauthor=C.+Gasserauthor=F.+Bracherauthor=K.+Huberauthor=S.+Knappauthor=J.+Schwaller&title=PIM+serine%2Fthreonine+kinases+in+the+pathogenesis+and+therapy+of+hematologic+malignancies+and+solid+cancers&doi=10.3324%2Fhaematol.2009.017079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span></div><div class="casAuthors">Brault, Laurent; Gasser, Christelle; Bracher, Franz; Huber, Kilian; Knapp, Stefan; Schwaller, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1004-1015</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A review.  The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lymphomas suggested early on that PIM serine/threonine kinases play an important role in cancer biol.  Whereas elevated levels of PIM1 and PIM2 were mostly found in hematol. malignancies and prostate cancer, increased PIM3 expression was obsd. in different solid tumors.  PIM kinases are constitutively active and their activity supports in vitro and in vivo tumor cell growth and survival through modification of an increasing no. of common as well as isoform-specific substrates including several cell cycle regulators and apoptosis mediators.  PIM1 but not PIM2 seems also to mediate homing and migration of normal and malignant hematopoietic cells by regulating chemokine receptor surface expression.  Knockdown expts. by RNA interference or dominant-neg. acting mutants suggested that PIM kinases are important for maintenance of a transformed phenotype and therefore potential therapeutic targets.  Detn. of the protein structure facilitated identification of an increasing no. of potent small mol. PIM kinase inhibitors with in vitro and in vivo anticancer activity.  Ongoing efforts aim to identify isoform-specific PIM inhibitors that would not only help to dissect the kinase function but hopefully also provide targeted therapeutics.  Here, we summarize the current knowledge about the role of PIM serine/threonine kinases for the pathogenesis and therapy of hematol. malignancies and solid cancers, and we highlight structural principles and recent progress on small mol. PIM kinase inhibitors that are on their way into first clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM0F0X8PArhLVg90H21EOLACvtfcHk0lga080p_ZIodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO&md5=241c17f65ee9203be2a6ee138a914781</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2009.017079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2009.017079%26sid%3Dliteratum%253Aachs%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DPIM%2520serine%252Fthreonine%2520kinases%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520hematologic%2520malignancies%2520and%2520solid%2520cancers%26jtitle%3DHaematologica%26date%3D2010%26volume%3D95%26spage%3D1004%26epage%3D1015%26doi%3D10.3324%2Fhaematol.2009.017079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbeek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Lohuizen, M.</span></span> <span> </span><span class="NLM_article-title">Transgenic mice as a means to study synergism between oncogenes</span>. <i>Int. J. Cancer Suppl.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910440706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2Fijc.2910440706" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1989&pages=22-25&author=A.+Bernsauthor=M.+Breuerauthor=S.+Verbeekauthor=M.+Van+Lohuizen&title=Transgenic+mice+as+a+means+to+study+synergism+between+oncogenes&doi=10.1002%2Fijc.2910440706"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910440706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910440706%26sid%3Dliteratum%253Aachs%26aulast%3DBerns%26aufirst%3DA.%26aulast%3DBreuer%26aufirst%3DM.%26aulast%3DVerbeek%26aufirst%3DS.%26aulast%3DVan%2BLohuizen%26aufirst%3DM.%26atitle%3DTransgenic%2520mice%2520as%2520a%2520means%2520to%2520study%2520synergism%2520between%2520oncogenes%26jtitle%3DInt.%2520J.%2520Cancer%2520Suppl.%26date%3D1989%26volume%3D44%26spage%3D22%26epage%3D25%26doi%3D10.1002%2Fijc.2910440706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nawijn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alendar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span> <span> </span><span class="NLM_article-title">For better or for worse: the role of Pim oncogenes in tumorigenesis</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrc2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1038%2Fnrc2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=21150935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=23-34&author=M.+C.+Nawijnauthor=A.+Alendarauthor=A.+Berns&title=For+better+or+for+worse%3A+the+role+of+Pim+oncogenes+in+tumorigenesis&doi=10.1038%2Fnrc2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">For better or for worse: the role of Pim oncogenes in tumorigenesis</span></div><div class="casAuthors">Nawijn, Martijn C.; Alendar, Andrej; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pim oncogenes are overexpressed in a wide range of tumors from a hematol. and epithelial origin.  Pim genes encode serine/threonine kinases that have been shown to counteract the increased sensitivity to apoptosis induction that is assocd. with MYC-driven tumorigenesis.  Recently, considerable progress has been made in characterizing the pathways of PIM-mediated survival signalling.  Given the unique structure of their active site and the minimal phenotype of mice mutant for all Pim family members, these oncogenes might be promising targets for highly specific and selective drugs with favorable toxicity profiles.  In this Review, we discuss the physiol. functions and oncogenic activities of Pim kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu23UDfObMZrVg90H21EOLACvtfcHk0lga080p_ZIodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE&md5=fe08e70454ca8c4d808715db87d195e1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2986%26sid%3Dliteratum%253Aachs%26aulast%3DNawijn%26aufirst%3DM.%2BC.%26aulast%3DAlendar%26aufirst%3DA.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DFor%2520better%2520or%2520for%2520worse%253A%2520the%2520role%2520of%2520Pim%2520oncogenes%2520in%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D23%26epage%3D34%26doi%3D10.1038%2Fnrc2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Lohuizen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbeek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimpenfort, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radaszkiewicz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span> <span> </span><span class="NLM_article-title">Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(89)90589-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2F0092-8674%2889%2990589-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=2537153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaL1MXhs1OhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1989&pages=673-682&author=M.+van%0ALohuizenauthor=S.+Verbeekauthor=P.+Krimpenfortauthor=J.+Domenauthor=C.+Sarisauthor=T.+Radaszkiewiczauthor=A.+Berns&title=Predisposition+to+lymphomagenesis+in+pim-1+transgenic+mice%3A+cooperation+with+c-myc+and+N-myc+in+murine+leukemia+virus-induced+tumors&doi=10.1016%2F0092-8674%2889%2990589-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Predisposition to lymphomagenesis in pim-1 transgenic mice:  cooperation with c-myc and N-myc in murine leukemia virus-induced tumors</span></div><div class="casAuthors">Van Lohuizen, Maarten; Verbeek, Sjef; Krimpenfort, Paul; Domen, Jos; Saris, Chris; Radaszkiewicz, Thaddeus; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">673-82</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Transgenic mice bearing the pim-1 gene supplemented with an upstream Ig enhancer and a downstream murine leukemia virus long terminal repeat express pim-1 mRNA at high levels in both B and T cells.  Between 5% and 10% of the pim-1 transgenic mice develop clonal T-cell lymphomas before 7 mo of age, whereas none of the age-matched control mice do, providing direct evidence for the oncogenic potential of pim-1.  Histol. examn. and FACS flow-cytometry anal. revealed no abnormalities in hematopoietic tissues of disease-free pim-1 transgenic mice.  When newborn pim-1 transgenic mice are infected with MuLV, T-cell lymphomas develop much faster (latency 7-8 wk) than in nontransgenic mice (latency 22 wk).  In all these T-cell lymphomas, either c-myc or N-myc was activated by proviral insertion, suggesting strong cooperation between pim-1 and myc in lymphomagenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh52Kc24kfvLVg90H21EOLACvtfcHk0lga080p_ZIodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhs1OhtL8%253D&md5=a99936287c0d3f56c644d9cf70e6b58d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2889%2990589-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252889%252990589-8%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLohuizen%26aufirst%3DM.%26aulast%3DVerbeek%26aufirst%3DS.%26aulast%3DKrimpenfort%26aufirst%3DP.%26aulast%3DDomen%26aufirst%3DJ.%26aulast%3DSaris%26aufirst%3DC.%26aulast%3DRadaszkiewicz%26aufirst%3DT.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DPredisposition%2520to%2520lymphomagenesis%2520in%2520pim-1%2520transgenic%2520mice%253A%2520cooperation%2520with%2520c-myc%2520and%2520N-myc%2520in%2520murine%2520leukemia%2520virus-induced%2520tumors%26jtitle%3DCell%26date%3D1989%26volume%3D56%26spage%3D673%26epage%3D682%26doi%3D10.1016%2F0092-8674%2889%2990589-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narberes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drueckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aycinena, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span> <span> </span><span class="NLM_article-title">Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1834</span>– <span class="NLM_lpage">1845</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-13-2062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1158%2F1078-0432.CCR-13-2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=24474669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1834-1845&author=P.+D.+Garciaauthor=J.+L.+Langowskiauthor=Y.+Wangauthor=M.+Chenauthor=J.+Castilloauthor=C.+Fantonauthor=M.+Isonauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Luauthor=X.-H.+Niuauthor=S.+Bashamauthor=J.+Chanauthor=J.+Yuauthor=M.+Doyleauthor=P.+Feuchtauthor=R.+Warneauthor=J.+Narberesauthor=T.+Tsangauthor=C.+Fritschauthor=A.+Kauffmannauthor=E.+Pfisterauthor=P.+Drueckesauthor=J.+Trappeauthor=C.+Wilsonauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=M.+Lindvallauthor=C.+Bellamacinaauthor=J.+A.+Aycinenaauthor=R.+Zangauthor=J.+Holashauthor=M.+T.+Burger&title=Pan-PIM+Kinase+Inhibition+Provides+a+Novel+Therapy+for+Treating+Hematologic+Cancers&doi=10.1158%2F1078-0432.ccr-13-2062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers</span></div><div class="casAuthors">Garcia, Pablo D.; Langowski, John L.; Wang, Yingyun; Chen, Min; Castillo, Joseph; Fanton, Christie; Ison, Marjorie; Zavorotinskaya, Tatiana; Dai, Yumin; Lu, Jing; Niu, Xiao-Hong; Basham, Stephen; Chan, Julie; Yu, Jianjun; Doyle, Michael; Feucht, Paul; Warne, Robert; Narberes, Jamie; Tsang, Tiffany; Fritsch, Christine; Kauffmann, Audrey; Pfister, Estelle; Drueckes, Peter; Trappe, Joerg; Wilson, Christopher; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Lindvall, Mika; Bellamacina, Cornelia; Aycinena, J. Alex; Zang, Richard; Holash, Jocelyn; Burger, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PIM kinases have been shown to act as oncogenes in mice, with each family member being able to drive progression of hematol. cancers.  Consistent with this, we found that PIMs are highly expressed in human hematol. cancers and show that each isoform has a distinct expression pattern among disease subtypes.  This suggests that inhibitors of all three PIMs would be effective in treating multiple hematol. malignancies.  Pan-PIM inhibitors have proven difficult to develop because PIM2 has a low Km for ATP and, thus, requires a very potent inhibitor to effectively block the kinase activity at the ATP levels in cells.  We developed a potent and specific pan-PIM inhibitor, LGB321, which is active on PIM2 in the cellular context.  LGB321 is active on PIM2-dependent multiple myeloma cell lines, where it inhibits proliferation, mTOR-C1 signaling and phosphorylation of BAD.  Broad cancer cell line profiling of LGB321 demonstrates limited activity in cell lines derived from solid tumors.  In contrast, significant activity in cell lines derived from diverse hematol. lineages was obsd., including acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), multiple myeloma and non-Hodgkin lymphoma (NHL).  Furthermore, we demonstrate LGB321 activity in the KG-1 AML xenograft model, in which modulation of pharmacodynamics markers is predictive of efficacy.  Finally, we demonstrate that LGB321 synergizes with cytarabine in this model.  We have developed a potent and selective pan-PIM inhibitor with single-agent antiproliferative activity and show that it synergizes with cytarabine in an AML xenograft model.  Our results strongly support the development of Pan-PIM inhibitors to treat hematol. malignancies.  Clin Cancer Res; 20(7); 1834-45. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriy2nkB_psKbVg90H21EOLACvtfcHk0lh2HJS0NITCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D&md5=c563df328e7af3ebf10c31b1a26faae4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2062%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DFanton%26aufirst%3DC.%26aulast%3DIson%26aufirst%3DM.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DX.-H.%26aulast%3DBasham%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DWarne%26aufirst%3DR.%26aulast%3DNarberes%26aufirst%3DJ.%26aulast%3DTsang%26aufirst%3DT.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DKauffmann%26aufirst%3DA.%26aulast%3DPfister%26aufirst%3DE.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DAycinena%26aufirst%3DJ.%2BA.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26atitle%3DPan-PIM%2520Kinase%2520Inhibition%2520Provides%2520a%2520Novel%2520Therapy%2520for%2520Treating%2520Hematologic%2520Cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D1834%26epage%3D1845%26doi%3D10.1158%2F1078-0432.ccr-13-2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilly, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, A. S.</span></span> <span> </span><span class="NLM_article-title">Pim family kinases enhance tumor growth of prostate cancer cells</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.mcr-05-0007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1158%2F1541-7786.MCR-05-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=16123140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovV2hs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=443-451&author=W.+W.+Chenauthor=D.+C.+Chanauthor=C.+Donaldauthor=M.+B.+Lillyauthor=A.+S.+Kraft&title=Pim+family+kinases+enhance+tumor+growth+of+prostate+cancer+cells&doi=10.1158%2F1541-7786.mcr-05-0007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pim family kinases enhance tumor growth of prostate cancer cells</span></div><div class="casAuthors">Chen, Wei Wei; Chan, Daniel C.; Donald, Carlton; Lilly, Michael B.; Kraft, Andrew S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent analyses indicate that the expression of the Pim-1 protein kinase is elevated in biopsies of prostate tumors.  To identify the mechanism by which the Pim kinases may affect the growth of prostate tumors, we expressed Pim-1, Pim-2, or a kinase-dead Pim-2 protein in human PC3 prostate cancer cells.  On implantation of the transfectants in nude mice, the growth of the cells expressing Pim-1 or Pim-2 was significantly faster than the growth of the control cells transfected with the neomycin-resistant gene or the kinase-dead Pim-2 protein.  When grown in medium, the doubling time of the Pim-1 and Pim-2 transfectants was faster (0.75 days) than that of the control cells (1.28 days).  We, therefore, examd. the ability of Pim to control the phosphorylation of proteins that regulate protein synthesis.  On growth factor starvation or rapamycin treatment, the Pim-1 and Pim-2 transfectants maintained their ability to phosphorylate 4E-BP1 and S6 kinase, although this phosphorylation did not occur in the control-transfected PC3 cells.  We have found that the cellular levels of c-Myc were elevated in the Pim-1 and Pim-2 transfectants under these conditions.  The Pim-1 and Pim-2 transfectants have lower levels of serine/threonine protein phosphatase 2A (PP2A) activity and the α- and {szligbeta}-subunit B56γ of the PP2A phosphatase do not co-immunoppt. in these cells.  Thus, the effects of Pim on PP2A activity may mediate the levels of c-Myc and the phosphorylation of proteins needed for increased protein synthesis.  Both of these changes could have a significant impact on tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobfSNRNUELt7Vg90H21EOLACvtfcHk0lh2HJS0NITCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovV2hs74%253D&md5=ef6dd2160e6acdfd03c39846e73187a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-05-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-05-0007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BW.%26aulast%3DChan%26aufirst%3DD.%2BC.%26aulast%3DDonald%26aufirst%3DC.%26aulast%3DLilly%26aufirst%3DM.%2BB.%26aulast%3DKraft%26aufirst%3DA.%2BS.%26atitle%3DPim%2520family%2520kinases%2520enhance%2520tumor%2520growth%2520of%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2005%26volume%3D3%26spage%3D443%26epage%3D451%26doi%3D10.1158%2F1541-7786.mcr-05-0007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuneyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popivanova, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span> <span> </span><span class="NLM_article-title">Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1002/ijc.20719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2Fijc.20719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=15540201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2005&pages=209-218&author=C.+Fujiiauthor=Y.+Nakamotoauthor=P.+Luauthor=K.+Tsuneyamaauthor=B.+K.+Popivanovaauthor=S.+Kanekoauthor=N.+Mukaida&title=Aberrant+expression+of+serine%2Fthreonine+kinase+Pim-3+in+hepatocellular+carcinoma+development+and+its+role+in+the+proliferation+of+human+hepatoma+cell+lines&doi=10.1002%2Fijc.20719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines</span></div><div class="casAuthors">Fujii, Chifumi; Nakamoto, Yasunari; Lu, Peirong; Tsuneyama, Koichi; Popivanova, Boryana K.; Kaneko, Shuichi; Mukaida, Naofumi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-218</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Most cases of human hepatocellular carcinoma develop after persistent chronic infection with human hepatitis B virus or hepatitis C virus, and host responses are presumed to have major roles in this process.  To recapitulate this process, we have developed the mouse model of hepatocellular carcinoma using hepatitis B virus surface antigen transgenic mice.  To identify the genes assocd. with hepatocarcinogenesis in this model, we compared the gene expression patterns between pre-malignant lesions surrounded by hepatocellular carcinoma tissues and control liver tissues by using a fluorescent differential display anal.  Among the genes that were expressed differentially in the pre-malignant lesions, we focused on Pim-3, a member of a proto-oncogene Pim family, because its contribution to hepatocarcinogenesis remains unknown.  Moreover, the unavailability of the nucleotide sequence of full-length human Pim-3 cDNA prompted us to clone it from the cDNA library constructed from a human hepatoma cell line, HepG2.  The obtained 2,392 bp human Pim-3 cDNA encodes a predicted open reading frame consisting of 326 amino acids.  Pim-3 mRNA was selectively expressed in human hepatoma cell lines, but not in normal liver tissues.  Moreover, Pim-3 protein was detected in human hepatocellular carcinoma tissues and cell lines but not in normal hepatocytes.  Furthermore, cell proliferation was attenuated and apoptosis was enhanced in human hepatoma cell lines by the ablation of Pim-3 gene with RNA interference.  These observations suggest that aberrantly expressed Pim-3 can cause autonomous cell proliferation or prevent apoptosis in hepatoma cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9fX9aasOqx7Vg90H21EOLACvtfcHk0lh2HJS0NITCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOlu7o%253D&md5=10cd20b8b712101ec80874e2c5d64991</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fijc.20719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20719%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DC.%26aulast%3DNakamoto%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DTsuneyama%26aufirst%3DK.%26aulast%3DPopivanova%26aufirst%3DB.%2BK.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DMukaida%26aufirst%3DN.%26atitle%3DAberrant%2520expression%2520of%2520serine%252Fthreonine%2520kinase%2520Pim-3%2520in%2520hepatocellular%2520carcinoma%2520development%2520and%2520its%2520role%2520in%2520the%2520proliferation%2520of%2520human%2520hepatoma%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D114%26spage%3D209%26epage%3D218%26doi%3D10.1002%2Fijc.20719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popivanova, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuneyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span> <span> </span><span class="NLM_article-title">Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2007.00390.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1111%2Fj.1349-7006.2007.00390.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=17270021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1amt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2007&pages=321-328&author=B.+K.+Popivanovaauthor=Y.-Y.+Liauthor=H.+Zhengauthor=K.+Omuraauthor=C.+Fujiiauthor=K.+Tsuneyamaauthor=N.+Mukaida&title=Proto-oncogene%2C+Pim-3+with+serine%2Fthreonine+kinase+activity%2C+is+aberrantly+expressed+in+human+colon+cancer+cells+and+can+prevent+Bad-mediated+apoptosis&doi=10.1111%2Fj.1349-7006.2007.00390.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis</span></div><div class="casAuthors">Popivanova, Boryana Konstantinova; Li, Ying-Yi; Zheng, Huachuan; Omura, Kenji; Fujii, Chifumi; Tsuneyama, Koichi; Mukaida, Naofumi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">We previously obsd. that Pim-3 with serine/threonine kinase activity, was aberrantly expressed in malignant lesions of endoderm-derived organs, liver and pancreas.  Because Pim-3 protein was not detected in normal colon mucosal tissues, we evaluated Pim-3 expression in malignant lesions of human colon, another endoderm-derived organ.  Pim-3 was detected immunohistochem. in well-differentiated (43/68 cases) and moderately differentiated (23/41 cases) but not poorly differentiated colon adenocarcinomas (0/5 cases).  Moreover, Pim-3 proteins were detected in adenoma (35/40 cases) and normal mucosa (26/111 cases), which are adjacent to adenocarcinoma.  Pim-3 was constitutively expressed in SW480 cells and the transfection with Pim-3 short hairpin RNA promoted apoptosis.  In the same cell line, a pro-apoptotic mol., Bad, was phosphorylated at Ser112 and Ser136 sites of phosphorylation that are representative of its inactive form.  Ser112 but not Ser136 phosphorylation in this cell line was abrogated by Pim-3 knockdown.  Furthermore, in human colon cancer tissues, Pim-3 co-localized with Bad in all cases (9/9) and with phospho-Ser112Bad in most cases (6/9).  These observations suggest that Pim-3 can inactivate Bad by phosphorylating its Ser112 in human colon cancer cells and thus may prevent apoptosis and promote progression of human colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzT5QEzAmPrVg90H21EOLACvtfcHk0lglnTYqOIMcvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1amt7k%253D&md5=084069e60edfbab8469eca77ac29e3bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00390.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00390.x%26sid%3Dliteratum%253Aachs%26aulast%3DPopivanova%26aufirst%3DB.%2BK.%26aulast%3DLi%26aufirst%3DY.-Y.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DFujii%26aufirst%3DC.%26aulast%3DTsuneyama%26aufirst%3DK.%26aulast%3DMukaida%26aufirst%3DN.%26atitle%3DProto-oncogene%252C%2520Pim-3%2520with%2520serine%252Fthreonine%2520kinase%2520activity%252C%2520is%2520aberrantly%2520expressed%2520in%2520human%2520colon%2520cancer%2520cells%2520and%2520can%2520prevent%2520Bad-mediated%2520apoptosis%26jtitle%3DCancer%2520Sci.%26date%3D2007%26volume%3D98%26spage%3D321%26epage%3D328%26doi%3D10.1111%2Fj.1349-7006.2007.00390.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuneyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popivanova, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span> <span> </span><span class="NLM_article-title">Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression</span>. <i>J. Canc. Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1007/s00432-007-0310-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1007%2Fs00432-007-0310-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=17876606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=481-488&author=H.-C.+Zhengauthor=K.+Tsuneyamaauthor=H.+Takahashiauthor=S.+Miwaauthor=T.+Sugiyamaauthor=B.+K.+Popivanovaauthor=C.+Fujiiauthor=K.+Nomotoauthor=N.+Mukaidaauthor=Y.+Takano&title=Aberrant+Pim-3+expression+is+involved+in+gastric+adenoma-adenocarcinoma+sequence+and+cancer+progression&doi=10.1007%2Fs00432-007-0310-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression</span></div><div class="casAuthors">Zheng, Hua-Chuan; Tsuneyama, Koichi; Takahashi, Hiroyuki; Miwa, Shigeharu; Sugiyama, Toshiro; Popivanova, Boryana Konstantinova; Fujii, Chifumi; Nomoto, Kazuhiro; Mukaida, Naofumi; Takano, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-488</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Pim-3, a member of the proto-oncogene Pim family with serine/threonine kinase activity was aberrantly expressed in cancerous lesions of endoderm-derived organs such as liver, pancreas, and colon.  The aim of this study was to clarify the role of Pim-3 expression in the tumorigenesis and the development of gastric carcinomas.  Methods: Pim-3 expression was immunohistochem. examd. on the tissue microarrays contg. primary (n = 285) and metastastic (n = 37) sites of gastric carcinomas, in comparison with adenoma (n = 48) and non-cancerous mucosa (n = 84).  It was also compared with the clinicopathol. parameters of gastric carcinomas.  Results: Pim-3 expression was enhanced in adenoma (64.6%) and metastasis sites of gastric carcinoma (73.0%), to a lesser degree in primary sites of gastric carcinoma (39.3%) when compared to non-cancerous mucosa (13.1%, p < 0.0001).  Pim-3 expression levels were higher in intestinal-type than diffuse-type gastric carcinoma (p = 0.018).  Pim-3 expression was closely correlated with sex (p = 0.047), lymphatic (p = 0.019) and venous invasion (p = 0.014).  Pim-3 expression was correlated significantly with vascular endothelial growth factor (VEGF, p = 0.009) and extracellular matrix metalloproteinase inducer (EMMPRIN, p = 0.032), both of which are presumed to be involved in neovascularization, a crucial step for metastasis.  On the contrary, phosphatase and tensin homol. deleted from human chromosome 10 (Pten) neg. gastric carcinomas exhibited higher Pim-3 expression than Pten pos. ones (p = 0.042).  There was no relationship between Pim-3 expression and MVD in gastric carcinomas (p = 0.715).  Furthermore, patients with Pim-3 pos. gastric cancer, showed a lower cumulative survival rate than those with Pim-3 neg. gastric cancer (p = 0.014) and Pim-3 pos. was also identified as an independent prognostic factor for gastric carcinoma patients (p = 0.006).  Conclusions: Aberrant Pim-3 expression was involved in gastric adenoma-adenocarcinoma sequence and subsequent invasion and metastasis process in gastric cancer.  Moreover, Pim-3 may be employed to predict the prognosis of gastric cancer patients.  Distinct Pim-3 expression underlies the mol. mechanisms for the differentiation of intestinal-type and diffuse-type carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGralDipIbQUObVg90H21EOLACvtfcHk0lglnTYqOIMcvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFCrtLc%253D&md5=187cce413ddaa8bf5e7803bff71b56a6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00432-007-0310-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-007-0310-1%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.-C.%26aulast%3DTsuneyama%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DMiwa%26aufirst%3DS.%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DPopivanova%26aufirst%3DB.%2BK.%26aulast%3DFujii%26aufirst%3DC.%26aulast%3DNomoto%26aufirst%3DK.%26aulast%3DMukaida%26aufirst%3DN.%26aulast%3DTakano%26aufirst%3DY.%26atitle%3DAberrant%2520Pim-3%2520expression%2520is%2520involved%2520in%2520gastric%2520adenoma-adenocarcinoma%2520sequence%2520and%2520cancer%2520progression%26jtitle%3DJ.%2520Canc.%2520Res.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D134%26spage%3D481%26epage%3D488%26doi%3D10.1007%2Fs00432-007-0310-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Aparicio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span> <span> </span><span class="NLM_article-title">Pim kinases in cancer: diagnostic, prognostic and treatment opportunities</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bcp.2012.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=23041228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=629-643&author=C.+Blanco-Aparicioauthor=A.+Carnero&title=Pim+kinases+in+cancer%3A+diagnostic%2C+prognostic+and+treatment+opportunities&doi=10.1016%2Fj.bcp.2012.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities</span></div><div class="casAuthors">Blanco-Aparicio, Carmen; Carnero, Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">629-643</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  PIM proteins belong to a family of ser/thr kinases composed of 3 members, PIM1, PIM2 and PIM3, with greatly overlapping functions.  PIM kinases are mainly responsible for cell cycle regulation, antiapoptotic activity and the homing and migration of receptor tyrosine kinases mediated via the JAK/STAT pathway.  PIM kinases have been found to be upregulated in many hematol. malignancies and solid tumors.  Although these kinases have been described as weak oncogenes, they are heavily targeted for anticancer drug discovery.  The present review summarizes the discoveries made to date regarding PIM kinases as driving oncogenes in the process of tumorigenesis and their validation as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbg06YAgnArVg90H21EOLACvtfcHk0lglnTYqOIMcvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK&md5=63957a55b281d4bbc8c4843249d30273</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DPim%2520kinases%2520in%2520cancer%253A%2520diagnostic%252C%2520prognostic%2520and%2520treatment%2520opportunities%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D629%26epage%3D643%26doi%3D10.1016%2Fj.bcp.2012.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span> <span> </span><span class="NLM_article-title">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1620</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-01-481457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1182%2Fblood-2013-01-481457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=23818547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1610-1620&author=J.+Luauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=X.-H.+Niuauthor=J.+Castilloauthor=J.+Simauthor=J.+Yuauthor=Y.+Wangauthor=J.+L.+Langowskiauthor=J.+Holashauthor=K.+Shannonauthor=P.+D.+Garcia&title=Pim2+is+required+for+maintaining+multiple+myeloma+cell+growth+through+modulating+TSC2+phosphorylation&doi=10.1182%2Fblood-2013-01-481457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span></div><div class="casAuthors">Lu, Jing; Zavorotinskaya, Tatiana; Dai, Yumin; Niu, Xiao-Hong; Castillo, Joseph; Sim, Janet; Yu, Jianjun; Wang, Yingyun; Langowski, John L.; Holash, Jocelyn; Shannon, Kevin; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1610-1620</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is the second most common hematol. malignancy.  Despite recent treatment advances, it remains incurable.  Here, we report that Pim2 kinase expression is highly elevated in MM cells and demonstrate that it is required for MM cell proliferation.  Functional interference of Pim2 activity either by short hairpin RNAs or by a potent and selective small-mol. inhibitor leads to significant inhibition of MM cell proliferation.  Pim inhibition results in a significant decrease of mammalian target of rapamycin C1 (mTOR-C1) activity, which is crit. for cell proliferation.  We identify TSC2, a neg. regulator of mTOR-C1, as a novel Pim2 substrate and show that Pim2 directly phosphorylates TSC2 on Ser-1798 and relieves the suppression of TSC2 on mTOR-C1.  These findings support Pim2 as a promising therapeutic target for MM and define a novel Pim2-TSC2-mTOR-C1 pathway that drives MM proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPXlAZPVNnObVg90H21EOLACvtfcHk0lhf4ePqa5XCgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ&md5=027403b9b40e4fc57836c398545e71e1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-01-481457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-01-481457%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DX.-H.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DPim2%2520is%2520required%2520for%2520maintaining%2520multiple%2520myeloma%2520cell%2520growth%2520through%2520modulating%2520TSC2%2520phosphorylation%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1610%26epage%3D1620%26doi%3D10.1182%2Fblood-2013-01-481457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcbride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beans, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span> <span> </span><span class="NLM_article-title">Structure guided optimization, in vitro activity, and in vivo activity of pan-PIM kinase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.1021/ml400307j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400307j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1193-1197&author=M.+T.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=M.+Lindvalauthor=G.+Atallahauthor=Y.+Dingauthor=M.+Mathurauthor=C.+Mcbrideauthor=E.+L.+Beansauthor=K.+Mullerauthor=V.+Tamezauthor=Y.+Zhangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Holashauthor=J.+Castilloauthor=J.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=P.+D.+Garcia&title=Structure+guided+optimization%2C+in+vitro+activity%2C+and+in+vivo+activity+of+pan-PIM+kinase+inhibitors&doi=10.1021%2Fml400307j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors</span></div><div class="casAuthors">Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Bellamacina, Cornelia; Lindval, Mika; Atallah, Gordana; Ding, Yu; Mathur, Michelle; McBride, Chris; Beans, Elizabeth L.; Muller, Kristine; Tamez, Victoriano; Zhang, Yanchen; Huh, Kay; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Holash, Jocelyn; Castillo, Joseph; Langowski, John; Wang, Yingyun; Chen, Min Y.; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1193-1197</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proviral insertion of Moloney virus (PIM) 1, 2, and 3 kinases are serine/threonine kinases that normally function in survival and proliferation of hematopoietic cells.  As high expression of PIM1, 2, and 3 is frequently obsd. in many human malignancies, including multiple myeloma, non-Hodgkins lymphoma, and myeloid leukemias, there is interest in detg. whether selective PIM inhibition can improve outcomes of these human cancers.  Herein, we describe our efforts toward this goal.  The structure guided optimization of a singleton high throughput screening hit in which the potency against all three PIM isoforms was increased >10,000-fold to yield compds. (e.g., I) with pan PIM Kis < 10 pM, nanomolar cellular potency, and in vivo activity in an acute myeloid leukemia Pim-dependent tumor model is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw9BIpeJhw1rVg90H21EOLACvtfcHk0lhf4ePqa5XCgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK&md5=f4644a2ad9bcd35c952676e492eb3b71</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fml400307j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400307j%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindval%26aufirst%3DM.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMcbride%26aufirst%3DC.%26aulast%3DBeans%26aufirst%3DE.%2BL.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520guided%2520optimization%252C%2520in%2520vitro%2520activity%252C%2520and%2520in%2520vivo%2520activity%2520of%2520pan-PIM%2520kinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fml400307j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klivansky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6366</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases&doi=10.1016%2Fj.bmcl.2011.08.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0lg2OOHBIOYuFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369%26doi%3D10.1016%2Fj.bmcl.2011.08.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent and selective PIM kinase inhibitors by targeting unique structure of ATP-binding pocket</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00518</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=504-509&author=H.+Nakanoauthor=T.+Hasegawaauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Nagano&title=Design+and+synthesis+of+potent+and+selective+PIM+kinase+inhibitors+by+targeting+unique+structure+of+ATP-binding+pocket&doi=10.1021%2Facsmedchemlett.6b00518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket</span></div><div class="casAuthors">Nakano, Hirofumi; Hasegawa, Tsukasa; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the development of kinase inhibitors, one of the major concerns is selectivity.  An effective strategy to achieve high selectivity is to utilize structural differences among kinases to inform inhibitor design.  Here, we set out to improve the PIM (proviral integration site for Moloney murine leukemia virus) kinase-inhibitory selectivity of our previously reported 7-azaindole deriv. 2, which has promising ADMET properties, by targeting a unique bulge in the ATP-binding pocket. 6-Substituted 7-azaindoles, esp. the 6-chlorinated derivs., proved to be potent and selective PIM kinase inhibitors and appear to be promising lead compds. for future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBu3SXcZr8bVg90H21EOLACvtfcHk0lg2OOHBIOYuFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D&md5=b4393c5c6f77ddfa140ebf669b552e44</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00518%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520PIM%2520kinase%2520inhibitors%2520by%2520targeting%2520unique%2520structure%2520of%2520ATP-binding%2520pocket%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D504%26epage%3D509%26doi%3D10.1021%2Facsmedchemlett.6b00518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenning, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kultgen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foulks, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merx, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCullar, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanner, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, K.-K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of pyrazolo[1,5-a]pyrimidine compounds as potent and selective Pim-1 inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1021/ml500300c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500300c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyltrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=63-67&author=Y.+Xuauthor=B.+G.+Brenningauthor=S.+G.+Kultgenauthor=J.+M.+Foulksauthor=A.+Cliffordauthor=S.+Laiauthor=A.+Chanauthor=S.+Merxauthor=M.+V.+McCullarauthor=S.+B.+Kannerauthor=K.-K.+Ho&title=Synthesis+and+biological+evaluation+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+compounds+as+potent+and+selective+Pim-1+inhibitors&doi=10.1021%2Fml500300c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 Inhibitors</span></div><div class="casAuthors">Xu, Yong; Brenning, Benjamin G.; Kultgen, Steven G.; Foulks, Jason M.; Clifford, Adrianne; Lai, Shuping; Chan, Ashley; Merx, Shannon; McCullar, Michael V.; Kanner, Steven B.; Ho, Koc-Kan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-67</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim-1 has emerged as an attractive target for developing therapeutic agents for treating disorders involving abnormal cell growth, esp. cancers.  Herein we present lead optimization, chem. synthesis and biol. evaluation of pyrazolo[1,5-a]pyrimidine compds. as potent and selective inhibitors of Pim-1 starting from a hit from virtual screening.  These pyrazolo[1,5-a]pyrimidine compds. strongly inhibited Pim-1 and Flt-3 kinases.  Selected compds. suppressed both the phosphorylation of BAD protein in a cell-based assay and 2-dimensional colony formation in a clonogenic cell survival assay at submicromolar potency, suggesting that cellular activity was mediated through inhibition of Pim-1.  Moreover, these Pim-1 inhibitors did not show significant hERG inhibition at 30 μM concn.  The lead compd. I proved to be highly selective against a panel of 119 oncogenic kinases, indicating it had an improved safety profile compared with the first generation Pim-1 inhibitor SGI-1776.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPw0i66tQM3bVg90H21EOLACvtfcHk0lg2OOHBIOYuFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyltrjE&md5=131653048268e737c4f8d7b939e726dd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml500300c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500300c%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrenning%26aufirst%3DB.%2BG.%26aulast%3DKultgen%26aufirst%3DS.%2BG.%26aulast%3DFoulks%26aufirst%3DJ.%2BM.%26aulast%3DClifford%26aufirst%3DA.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DMerx%26aufirst%3DS.%26aulast%3DMcCullar%26aufirst%3DM.%2BV.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DHo%26aufirst%3DK.-K.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520compounds%2520as%2520potent%2520and%2520selective%2520Pim-1%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D63%26epage%3D67%26doi%3D10.1021%2Fml500300c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of quinazolinone-pyrrolopyrrolones as potent and orally bioavailable pan-Pim kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6407</span>– <span class="NLM_lpage">6430</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00610</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00610" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2msbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6407-6430&author=L.+H.+Pettusauthor=K.+L.+Andrewsauthor=S.+K.+Bookerauthor=J.+Chenauthor=V.+J.+Ceeauthor=F.+Chavezauthor=Y.+Chenauthor=H.+Eastwoodauthor=N.+Guerreroauthor=B.+Herberichauthor=D.+Hickmanauthor=B.+A.+Lanmanauthor=J.+Laszloauthor=M.+R.+Leeauthor=J.+R.+Lipfordauthor=B.+Mattsonauthor=C.+Mohrauthor=Y.+Nguyenauthor=M.+H.+Normanauthor=D.+Powersauthor=A.+B.+Reedauthor=K.+Rexauthor=C.+Sastriauthor=N.+Tamayoauthor=P.+Wangauthor=J.+T.+Winstonauthor=B.+Wuauthor=T.+Wuauthor=R.+P.+Wurzauthor=Y.+Xuauthor=Y.+Zhouauthor=A.+S.+Taskerauthor=H.-L.+Wang&title=Discovery+and+optimization+of+quinazolinone-pyrrolopyrrolones+as+potent+and+orally+bioavailable+pan-Pim+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.6b00610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors</span></div><div class="casAuthors">Pettus, Liping H.; Andrews, Kristin L.; Booker, Shon K.; Chen, Jie; Cee, Victor J.; Chavez, Frank, Jr.; Chen, Yuping; Eastwood, Heather; Guerrero, Nadia; Herberich, Bradley; Hickman, Dean; Lanman, Brian A.; Laszlo, Jimmy, III; Lee, Matthew R.; Lipford, J. Russell; Mattson, Bethany; Mohr, Christopher; Nguyen, Yen; Norman, Mark H.; Powers, David; Reed, Anthony B.; Rex, Karen; Sastri, Christine; Tamayo, Nuria; Wang, Paul; Winston, Jeffrey T.; Wu, Bin; Wu, Tian; Wurz, Ryan P.; Xu, Yang; Zhou, Yihong; Tasker, Andrew S.; Wang, Hui-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6407-6430</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The high expression of proviral insertion site of Moloney murine leukemia virus kinases (Pim-1, -2, and -3) in cancers, particularly the hematopoietic malignancies, is believed to play a role in promoting cell survival and proliferation while suppressing apoptosis.  The three isoforms of Pim protein appear largely redundant in their oncogenic functions.  Thus, a pan-Pim kinase inhibitor is highly desirable.  However, cell active pan-Pim inhibitors have proven difficult to develop because Pim-2 has a low Km for ATP and therefore requires a very potent inhibitor to effectively block the kinase activity at cellular ATP concns.  Herein, the authors report a series of quinazolinone-pyrrolopyrrolones as potent and selective pan-Pim inhibitors.  In particular, compd. (R)-2-(tert-butylamino)-3-methyl-8-(6-methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)quinazolin-4(3H)-one (17) is orally efficacious in a mouse xenograft model (KMS-12 BM) of multiple myeloma, with 93% tumor growth inhibition at 50 mg/kg QD upon oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2s5EkmHtIBbVg90H21EOLACvtfcHk0liN87mwH_kWOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2msbc%253D&md5=0ac3b462493e0abee1a774aa7854c87d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00610%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEastwood%26aufirst%3DH.%26aulast%3DGuerrero%26aufirst%3DN.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DLaszlo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSastri%26aufirst%3DC.%26aulast%3DTamayo%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWinston%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DH.-L.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520quinazolinone-pyrrolopyrrolones%2520as%2520potent%2520and%2520orally%2520bioavailable%2520pan-Pim%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6407%26epage%3D6430%26doi%3D10.1021%2Facs.jmedchem.6b00610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, F.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastri, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00403</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00403" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVSjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=408-412&author=V.+J.+Ceeauthor=F.+Chavezauthor=B.+Herberichauthor=B.+A.+Lanmanauthor=L.+H.+Pettusauthor=A.+B.+Reedauthor=B.+Wuauthor=R.+P.+Wurzauthor=K.+L.+Andrewsauthor=J.+Chenauthor=D.+Hickmanauthor=J.+Laszloauthor=M.+R.+Leeauthor=N.+Guerreroauthor=B.+K.+Mattsonauthor=Y.+Nguyenauthor=C.+Mohrauthor=K.+Rexauthor=C.+E.+Sastriauthor=P.+Wangauthor=Q.+Wuauthor=T.+Wuauthor=Y.+Xuauthor=Y.+Zhouauthor=J.+T.+Winstonauthor=J.+R.+Lipfordauthor=A.+S.+Taskerauthor=H.-L.+Wang&title=Discovery+and+Optimization+of+Macrocyclic+Quinoxaline-pyrrolo-dihydropiperidinones+as+Potent+Pim-1%2F2+Kinase+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors</span></div><div class="casAuthors">Cee, Victor J.; Chavez, Frank, Jr.; Herberich, Bradley; Lanman, Brian A.; Pettus, Liping H.; Reed, Anthony B.; Wu, Bin; Wurz, Ryan P.; Andrews, Kristin L.; Chen, Jie; Hickman, Dean; Laszlo, Jimmy, III; Lee, Matthew R.; Guerrero, Nadia; Mattson, Bethany K.; Nguyen, Yen; Mohr, Christopher; Rex, Karen; Sastri, Christine E.; Wang, Paul; Wu, Qiong; Wu, Tian; Xu, Yang; Zhou, Yihong; Winston, Jeffrey T.; Lipford, J. Russell; Tasker, Andrew S.; Wang, Hui-Ling</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">408-412</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of Pim-1/2 kinase overexpression in B-cell malignancies suggests that Pim kinase inhibitors will have utility in the treatment of lymphoma, leukemia, and multiple myeloma.  Starting from a moderately potent quinoxaline-dihydropyrrolopiperidinone lead, the authors recognized the potential for macrocyclization and developed a series of 13-membered macrocycles.  The structure-activity relationships of the macrocyclic linker were systematically explored, leading to the identification of I as a potent, subnanomolar inhibitor of Pim-1 and -2.  This mol. also potently inhibited Pim kinase activity in I, a multiple myeloma cell line with relatively high endogenous levels of Pim-1/2, both in vitro (pBAD IC50 = 25 nM) and in vivo (pBAD EC50 = 30 nM, unbound), and a 100 mg/kg daily dose was found to completely arrest the growth of I xenografts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqakxW_TAberrVg90H21EOLACvtfcHk0liN87mwH_kWOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVSjsrk%253D&md5=cd64db700aa01012b74e33ba2cbaf501</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00403%26sid%3Dliteratum%253Aachs%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DLaszlo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DGuerrero%26aufirst%3DN.%26aulast%3DMattson%26aufirst%3DB.%2BK.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSastri%26aufirst%3DC.%2BE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWinston%26aufirst%3DJ.%2BT.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DH.-L.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Macrocyclic%2520Quinoxaline-pyrrolo-dihydropiperidinones%2520as%2520Potent%2520Pim-1%252F2%2520Kinase%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D408%26epage%3D412%26doi%3D10.1021%2Facsmedchemlett.5b00403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munugalavadla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-azaindazole (GNE-955) as a potent pan-Pim inhibitor with optimized bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4458</span>– <span class="NLM_lpage">4473</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00418</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00418" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslKkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4458-4473&author=X.+Wangauthor=A.+Kolesnikovauthor=S.+Tayauthor=G.+Chanauthor=Q.+Chaoauthor=S.+Doauthor=J.+Drummondauthor=A.+J.+Ebensauthor=N.+Liuauthor=J.+Lyauthor=E.+Harstadauthor=H.+Huauthor=J.+Moffatauthor=V.+Munugalavadlaauthor=J.+Murrayauthor=D.+Slagaauthor=V.+Tsuiauthor=M.+Volgrafauthor=H.+Wallweberauthor=J.+H.+Chang&title=Discovery+of+5-azaindazole+%28GNE-955%29+as+a+potent+pan-Pim+inhibitor+with+optimized+bioavailability&doi=10.1021%2Facs.jmedchem.7b00418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability</span></div><div class="casAuthors">Wang, Xiaojing; Kolesnikov, Aleksandr; Tay, Suzanne; Chan, Grace; Chao, Qi; Do, Steven; Drummond, Jason; Ebens, Allen J.; Liu, Ning; Ly, Justin; Harstad, Eric; Hu, Huiyong; Moffat, John; Munugalavadla, Veerendra; Murray, Jeremy; Slaga, Dionysos; Tsui, Vickie; Volgraf, Matthew; Wallweber, Heidi; Chang, Jae H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4458-4473</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim kinases have been identified as promising therapeutic targets for hematol.-oncol. indications, including multiple myeloma and certain leukemia.  Here, we describe our continued efforts in optimizing a lead series by improving bioavailability while maintaining high inhibitory potency against all three Pim kinase isoforms.  The discovery of extensive intestinal metab. and major metabolites helped refine our design strategy, and we obsd. that optimizing the pharmacokinetic properties first and potency second was a more successful approach than the reverse.  In the resulting work, novel analogs such as 20 (GNE-955) were discovered bearing 5-azaindazole core with noncanonical hydrogen bonding to the hinge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr14R5KRRnTebVg90H21EOLACvtfcHk0lhgHp4qfUQepQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslKkt7w%253D&md5=022c9a8b8998c4940a5cd6ad5806fc54</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00418%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DChao%26aufirst%3DQ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEbens%26aufirst%3DA.%2BJ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DSlaga%26aufirst%3DD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26atitle%3DDiscovery%2520of%25205-azaindazole%2520%2528GNE-955%2529%2520as%2520a%2520potent%2520pan-Pim%2520inhibitor%2520with%2520optimized%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4458%26epage%3D4473%26doi%3D10.1021%2Facs.jmedchem.7b00418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, F.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a potent and selective Pim-1/2 kinase inhibitor for hematological malignancies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1523</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnslSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1523-1540&author=H.-L.+Wangauthor=K.+L.+Andrewsauthor=S.+K.+Bookerauthor=J.+Canonauthor=V.+J.+Ceeauthor=F.+Chavezauthor=Y.+Chenauthor=H.+Eastwoodauthor=N.+Guerreroauthor=B.+Herberichauthor=D.+Hickmanauthor=B.+A.+Lanmanauthor=J.+Laszloauthor=M.+R.+Leeauthor=J.+R.+Lipfordauthor=B.+Mattsonauthor=C.+Mohrauthor=Y.+Nguyenauthor=M.+H.+Normanauthor=L.+H.+Pettusauthor=D.+Powersauthor=A.+B.+Reedauthor=K.+Rexauthor=C.+Sastriauthor=N.+Tamayoauthor=P.+Wangauthor=J.+T.+Winstonauthor=B.+Wuauthor=Q.+Wuauthor=T.+Wuauthor=R.+P.+Wurzauthor=Y.+Xuauthor=Y.+Zhouauthor=A.+S.+Tasker&title=Discovery+of+%28R%29-8-%286-Methyl-4-oxo-1%2C4%2C5%2C6-tetrahydropyrrolo%5B3%2C4-b%5Dpyrrol-2-yl%29-3-%281-methylcyclopropyl%29-2-%28%281-methylcyclopropyl%29amino%29quinazolin-4%283H%29-one%2C+a+potent+and+selective+Pim-1%2F2+kinase+inhibitor+for+hematological+malignancies&doi=10.1021%2Facs.jmedchem.8b01733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (R)-8-(6-methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a potent and selective Pim-1/2 kinase inhibitor for hematological malignancies</span></div><div class="casAuthors">Wang, Hui-Ling; Andrews, Kristin L.; Booker, Shon K.; Canon, Jude; Cee, Victor J.; Chavez, Frank, Jr.; Chen, Yuping; Eastwood, Heather; Guerrero, Nadia; Herberich, Brad; Hickman, Dean; Lanman, Brian A.; Laszlo, Jimmy, III; Lee, Matthew R.; Lipford, J. Russell; Mattson, Bethany; Mohr, Christopher; Nguyen, Yen; Norman, Mark H.; Pettus, Liping H.; Powers, David; Reed, Anthony B.; Rex, Karen; Sastri, Christine; Tamayo, Nuria; Wang, Paul; Winston, Jeffrey T.; Wu, Bin; Wu, Qiong; Wu, Tian; Wurz, Ryan P.; Xu, Yang; Zhou, Yihong; Tasker, Andrew S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1523-1540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim kinases are a family of constitutively active serine/threonine kinases that are partially redundant and regulate multiple pathways important for cell growth and survival.  In human disease, high expression of the three Pim isoforms has been implicated in the progression of hematopoietic and solid tumor cancers, which suggests that Pim kinase inhibitors could provide patients with therapeutic benefit.  Herein, we describe the structure-guided optimization of a series of quinazolinone-pyrrolodihydropyrrolone analogs leading to the identification of potent pan-Pim inhibitor I with improved potency, soly., and drug-like properties.  I demonstrated on-target Pim activity in an in vivo pharmacodynamic assay with significant inhibition of BAD phosphorylation in KMS-12-BM multiple myeloma tumors for 16 h postdose.  In a 2-wk mouse xenograft model, daily dosing of I resulted in 33% tumor regression at 100 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz60Rl1mRubrVg90H21EOLACvtfcHk0lhgHp4qfUQepQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnslSksw%253D%253D&md5=a7d7dbe1f106b6f5cf8c81bb5660cb3f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01733%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEastwood%26aufirst%3DH.%26aulast%3DGuerrero%26aufirst%3DN.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DLaszlo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSastri%26aufirst%3DC.%26aulast%3DTamayo%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWinston%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520of%2520%2528R%2529-8-%25286-Methyl-4-oxo-1%252C4%252C5%252C6-tetrahydropyrrolo%255B3%252C4-b%255Dpyrrol-2-yl%2529-3-%25281-methylcyclopropyl%2529-2-%2528%25281-methylcyclopropyl%2529amino%2529quinazolin-4%25283H%2529-one%252C%2520a%2520potent%2520and%2520selective%2520Pim-1%252F2%2520kinase%2520inhibitor%2520for%2520hematological%2520malignancies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1523%26epage%3D1540%26doi%3D10.1021%2Facs.jmedchem.8b01733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackaby, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diène, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munugalavadla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noland, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rosario, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebens, A. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of pan-Pim kinase activity and oral bioavailability leading to diaminopyrazole (GDC-0339) for the treatment of multiple myeloma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2153</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2140-2153&author=X.+Wangauthor=W.+Blackabyauthor=V.+Allenauthor=G.+K.+Y.+Chanauthor=J.+H.+Changauthor=P.-C.+Chiangauthor=C.+Di%C3%A8neauthor=J.+Drummondauthor=S.+Doauthor=E.+Fanauthor=E.+B.+Harstadauthor=A.+Hodgesauthor=H.+Huauthor=W.+Jiaauthor=W.+Kofieauthor=A.+Kolesnikovauthor=J.+P.+Lyssikatosauthor=J.+Lyauthor=M.+Matteucciauthor=J.+G.+Moffatauthor=V.+Munugalavadlaauthor=J.+Murrayauthor=D.+Nashauthor=C.+L.+Nolandauthor=G.+Del+Rosarioauthor=L.+Rossauthor=C.+Rouseauthor=A.+Sharpeauthor=D.+Slagaauthor=M.+Sunauthor=V.+Tsuiauthor=H.+Wallweberauthor=S.-F.+Yuauthor=A.+J.+Ebens&title=Optimization+of+pan-Pim+kinase+activity+and+oral+bioavailability+leading+to+diaminopyrazole+%28GDC-0339%29+for+the+treatment+of+multiple+myeloma&doi=10.1021%2Facs.jmedchem.8b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma</span></div><div class="casAuthors">Wang, Xiaojing; Blackaby, Wesley; Allen, Vivienne; Chan, Grace Ka Yan; Chang, Jae H.; Chiang, Po-Chang; Diene, Coura; Drummond, Jason; Do, Steven; Fan, Eric; Harstad, Eric B.; Hodges, Alastair; Hu, Huiyong; Jia, Wei; Kofie, William; Kolesnikov, Aleksandr; Lyssikatos, Joseph P.; Ly, Justin; Matteucci, Mizio; Moffat, John G.; Munugalavadla, Veerendra; Murray, Jeremy; Nash, David; Noland, Cameron L.; Del Rosario, Geoff; Ross, Leanne; Rouse, Craig; Sharpe, Andrew; Slaga, Dionysos; Sun, Minghua; Tsui, Vickie; Wallweber, Heidi; Yu, Shang-Fan; Ebens, Allen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2140-2153</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim kinases have been targets of interest for a no. of therapeutic areas.  Evidence of durable single-agent efficacy in human clin. trials validated Pim kinase inhibition as a promising therapeutic approach for multiple myeloma patients.  Here, we report the compd. optimization leading to GDC-0339 (16), a potent, orally bioavailable, and well tolerated pan-Pim kinase inhibitor that proved efficacious in RPMI8226 and MM.1S human multiple myeloma xenograft mouse models and has been evaluated as an early development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC9O3J5HZfvrVg90H21EOLACvtfcHk0lhJ5GHoQSKQyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSqt78%253D&md5=bf8f5e5ac1f4cc29d1b62dcd72e7a815</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01857%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBlackaby%26aufirst%3DW.%26aulast%3DAllen%26aufirst%3DV.%26aulast%3DChan%26aufirst%3DG.%2BK.%2BY.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DChiang%26aufirst%3DP.-C.%26aulast%3DDi%25C3%25A8ne%26aufirst%3DC.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DHarstad%26aufirst%3DE.%2BB.%26aulast%3DHodges%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DKofie%26aufirst%3DW.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DMatteucci%26aufirst%3DM.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DNoland%26aufirst%3DC.%2BL.%26aulast%3DDel%2BRosario%26aufirst%3DG.%26aulast%3DRoss%26aufirst%3DL.%26aulast%3DRouse%26aufirst%3DC.%26aulast%3DSharpe%26aufirst%3DA.%26aulast%3DSlaga%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWallweber%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DEbens%26aufirst%3DA.%2BJ.%26atitle%3DOptimization%2520of%2520pan-Pim%2520kinase%2520activity%2520and%2520oral%2520bioavailability%2520leading%2520to%2520diaminopyrazole%2520%2528GDC-0339%2529%2520for%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2140%26epage%3D2153%26doi%3D10.1021%2Facs.jmedchem.8b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2332</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2016.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=26995528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2328-2332&author=G.+A.+Nishiguchiauthor=M.+T.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Atallahauthor=V.+Tamezauthor=M.+Lindvallauthor=C.+Bellamacinaauthor=P.+Garciaauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=K.+Wong&title=Design%2C+synthesis+and+structure+activity+relationship+of+potent+pan-PIM+kinase+inhibitors+derived+from+the+pyridyl+carboxamide+scaffold&doi=10.1016%2Fj.bmcl.2016.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Atallah, Gordana; Tamez, Victoriano; Lindvall, Mika; Bellamacina, Cornelia; Garcia, Pablo; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Wong, Kent</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2328-2332</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Pim proteins (1, 2 and 3) are serine/threonine kinases that have been found to be upregulated in many hematol. malignancies and solid tumors.  As a result of overlapping functions among the three isoforms, inhibition of all three Pim kinases has become an attractive strategy for cancer therapy.  Herein the authors describe the efforts in identifying potent pan-PIM inhibitors that are derived from the previously reported pyridyl carboxamide scaffold as part of a medicinal chem. strategy to address metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDLGPtdFN-P7Vg90H21EOLACvtfcHk0lhJ5GHoQSKQyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGhs7k%253D&md5=194e13ceee212e2c37d4517a4b768f5b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DP.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure%2520activity%2520relationship%2520of%2520potent%2520pan-PIM%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520pyridyl%2520carboxamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2328%26epage%3D2332%26doi%3D10.1016%2Fj.bmcl.2016.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aycinena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span> <span> </span><span class="NLM_article-title">Identification ofN-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8373</span>– <span class="NLM_lpage">8386</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01275</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOrt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8373-8386&author=M.+T.+Burgerauthor=G.+Nishiguchiauthor=W.+Hanauthor=J.+Lanauthor=R.+Simmonsauthor=G.+Atallahauthor=Y.+Dingauthor=V.+Tamezauthor=Y.+Zhangauthor=M.+Mathurauthor=K.+Mullerauthor=C.+Bellamacinaauthor=M.+K.+Lindvallauthor=R.+Zangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=S.+Bashamauthor=J.+Chanauthor=E.+Ginnauthor=A.+Aycinenaauthor=J.+Holashauthor=J.+Castilloauthor=J.+L.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=A.+Lambertauthor=C.+Fritschauthor=A.+Kauffmannauthor=E.+Pfisterauthor=K.+G.+Vanasseauthor=P.+D.+Garcia&title=Identification+ofN-%284-%28%281R%2C3S%2C5S%29-3-Amino-5-methylcyclohexyl%29pyridin-3-yl%29-6-%282%2C6-difluorophenyl%29-5-fluoropicolinamide+%28PIM447%29%2C+a+Potent+and+Selective+Proviral+Insertion+Site+of+Moloney+Murine+Leukemia+%28PIM%29+1%2C+2%2C+and+3+Kinase+Inhibitor+in+Clinical+Trials+for+Hematological+Malignancies&doi=10.1021%2Facs.jmedchem.5b01275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies</span></div><div class="casAuthors">Burger, Matthew T.; Nishiguchi, Gisele; Han, Wooseok; Lan, Jiong; Simmons, Robert; Atallah, Gordana; Ding, Yu; Tamez, Victoriano; Zhang, Yanchen; Mathur, Michelle; Muller, Kristine; Bellamacina, Cornelia; Lindvall, Mika K.; Zang, Richard; Huh, Kay; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Basham, Steve; Chan, Julie; Ginn, Elaine; Aycinena, Alex; Holash, Jocelyn; Castillo, Joseph; Langowski, John L.; Wang, Yingyun; Chen, Min Y.; Lambert, Amy; Fritsch, Christine; Kauffmann, Audry; Pfister, Estelle; Vanasse, K. Gary; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8373-8386</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit to cancer patients.  Herein, the synthesis, in vitro activity, in vivo activity in an acute myeloid leukemia xenograft model, and preclin. profile of the potent and selective pan PIM kinase inhibitor compd. I (PIM447) are described.  Starting from the reported aminopiperidyl pan PIM kinase inhibitor compd. II, a strategy to improve the microsomal stability was pursued resulting in the identification of potent aminocyclohexyl pan PIM inhibitors with high metabolic stability.  From this aminocyclohexyl series, compd. I entered the clinic in 2012 in multiple myeloma patients and is currently in several phase 1 trials of cancer patients with hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLdBmQSYD34LVg90H21EOLACvtfcHk0lgGdeklnIwIQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOrt7%252FL&md5=c1d3cb10d1fa7efc66e7d415fa5970b4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01275%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DSimmons%26aufirst%3DR.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%2BK.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DBasham%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DGinn%26aufirst%3DE.%26aulast%3DAycinena%26aufirst%3DA.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DLambert%26aufirst%3DA.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DKauffmann%26aufirst%3DA.%26aulast%3DPfister%26aufirst%3DE.%26aulast%3DVanasse%26aufirst%3DK.%2BG.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DIdentification%2520ofN-%25284-%2528%25281R%252C3S%252C5S%2529-3-Amino-5-methylcyclohexyl%2529pyridin-3-yl%2529-6-%25282%252C6-difluorophenyl%2529-5-fluoropicolinamide%2520%2528PIM447%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Proviral%2520Insertion%2520Site%2520of%2520Moloney%2520Murine%2520Leukemia%2520%2528PIM%2529%25201%252C%25202%252C%2520and%25203%2520Kinase%2520Inhibitor%2520in%2520Clinical%2520Trials%2520for%2520Hematological%2520Malignancies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8373%26epage%3D8386%26doi%3D10.1021%2Facs.jmedchem.5b01275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raab, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocio, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S. K.</span></span> <span> </span><span class="NLM_article-title">The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2924</span>– <span class="NLM_lpage">2933</span>, <span class="refDoi"> DOI: 10.1038/s41375-019-0482-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1038%2Fs41375-019-0482-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=31092894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyqs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=2924-2933&author=M.+S.+Raabauthor=S.+K.+Thomasauthor=E.+M.+Ocioauthor=A.+Guentherauthor=Y.-T.+Gohauthor=M.+Talpazauthor=N.+Hohmannauthor=S.+Zhaoauthor=F.+Xiangauthor=C.+Simonauthor=K.+G.+Vanasseauthor=S.+K.+Kumar&title=The+first-in-human+study+of+the+pan-PIM+kinase+inhibitor+PIM447+in+patients+with+relapsed+and%2For+refractory+multiple+myeloma&doi=10.1038%2Fs41375-019-0482-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma</span></div><div class="casAuthors">Raab, Marc S.; Thomas, Sheeba K.; Ocio, Enrique M.; Guenther, Andreas; Goh, Yeow-Tee; Talpaz, Moshe; Hohmann, Nicolas; Zhao, Sylvia; Xiang, Fang; Simon, Carl; Vanasse, K. Gary; Kumar, Shaji K.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2924-2933</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">PIM447, a novel pan-PIM inhibitor, has shown preclin. activity in multiple myeloma (MM).  In the multicenter, open-label, first-in-human study, patients with relapsed and/or refractory MM were enrolled to det. the max.-tolerated dose (MTD) or recommended dose (RD), safety, pharmacokinetics, and preliminary anti-myeloma activity of PIM447.  PIM447 was administered in escalating oral doses of 70-700 mg once daily (q.d.) for 28-day continuous cycles.  Seventy-nine patients with a median of four prior therapies were enrolled.  Seventy-seven patients (97.5%) had an adverse event (AE) suspected as treatment related, with treatment-related grade 3/4 AEs being mostly hematol.  Eleven dose-limiting toxicities occurred, and an MTD of 500 mg q.d. and an RD of 300 mg q.d. were established.  The main reason for discontinuation was disease progression in 54 patients (68.4%).  In the entire study population, a disease control rate of 72.2%, a clin. benefit rate of 25.3%, and an overall response rate of 8.9% were obsd. per modified International Myeloma Working Group criteria.  Median progression-free survival at the RD was 10.9 mo.  PIM447 was well tolerated and demonstrated single-agent antitumor activity in relapsed/refractory MM patients, providing proof of principle for Pim (Proviral Insertions of Moloney Murine leukemia virus) kinase inhibition as a novel therapeutic approach in MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSi_XbgqXF4LVg90H21EOLACvtfcHk0lgGdeklnIwIQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyqs7rK&md5=f7f98f51cd91b51be551b7db8c047d6a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41375-019-0482-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-019-0482-0%26sid%3Dliteratum%253Aachs%26aulast%3DRaab%26aufirst%3DM.%2BS.%26aulast%3DThomas%26aufirst%3DS.%2BK.%26aulast%3DOcio%26aufirst%3DE.%2BM.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DGoh%26aufirst%3DY.-T.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DHohmann%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DC.%26aulast%3DVanasse%26aufirst%3DK.%2BG.%26aulast%3DKumar%26aufirst%3DS.%2BK.%26atitle%3DThe%2520first-in-human%2520study%2520of%2520the%2520pan-PIM%2520kinase%2520inhibitor%2520PIM447%2520in%2520patients%2520with%2520relapsed%2520and%252For%2520refractory%2520multiple%2520myeloma%26jtitle%3DLeukemia%26date%3D2019%26volume%3D33%26spage%3D2924%26epage%3D2933%26doi%3D10.1038%2Fs41375-019-0482-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lgGdeklnIwIQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Clearance in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2255</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01263</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVCru7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2245-2255&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Clearance+in+drug+design&doi=10.1021%2Facs.jmedchem.8b01263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Clearance in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2245-2255</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates.  Clearance can be classified into three general categories, namely, metabolic transformation, renal excretion, and hepatobiliary excretion.  Within each category, there are a host of biochem. and physiol. mechanisms that ultimately det. the clearance rate.  Physiochem. properties are often indicative of the rate-detg. mechanism, with lipophilic mols. tending toward metab. and hydrophilic, polar mols. tending toward passive or active excretion.  Optimization of clearance requires recognition of the major clearance mechanisms and use of the most relevant in vitro and in vivo tools to develop structure-clearance relationships.  The reliability of methods to detect and predict human clearance varies across mechanisms.  While methods for metabolic and passive renal clearance have proven reasonably robust, there is a clear need for better tools to support the optimization of transporter-mediated clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8nvv_L3pL-LVg90H21EOLACvtfcHk0li4qlSFmOMDRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVCru7fO&md5=e4a4d72056ed9b41842a11934fa4bffc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01263%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DClearance%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2245%26epage%3D2255%26doi%3D10.1021%2Facs.jmedchem.8b01263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Structure of compound <b>5</b> in PIM1 submitted under PDB accession code 1oblv.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">All animal experiments performed in the manuscript were conducted in compliance with institutional guidelines.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Compound <b>5</b> having no hinge amino group showed a similar selectivity profile towards these kinases: IC<sub>50</sub> for GSK3β was 0.15 μM (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Cell permeability beyond the rule of 5</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.addr.2016.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=27067608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=42-61&author=P.+Matssonauthor=B.+C.+Doakauthor=B.+Overauthor=J.+Kihlberg&title=Cell+permeability+beyond+the+rule+of+5&doi=10.1016%2Fj.addr.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeability beyond the rule of 5</span></div><div class="casAuthors">Matsson, Paer; Doak, Bradley C.; Over, Bjoern; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-61</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Drug discovery for difficult targets that have large and flat binding sites is often better suited to compds. beyond the "rule of 5" (bRo5).  However, such compds. carry higher pharmacokinetic risks, such as low soly. and permeability, and increased efflux and metab.  Interestingly, recent drug approvals and studies suggest that cell permeable and orally bioavailable drugs can be discovered far into bRo5 space.  Tactics such as redn. or shielding of polarity by N-methylation, bulky side chains and intramol. hydrogen bonds may be used to increase cell permeability in this space, but often results in decreased soly.  Conformationally flexible compds. can, however, combine high permeability and soly., properties that are keys for cell permeability and intestinal absorption.  Recent developments in computational conformational anal. will aid design of such compds. and hence prediction of cell permeability.  Transporter mediated efflux occurs for most investigated drugs in bRo5 space, however it is commonly overcome by high local intestinal concns. on oral administration.  In contrast, there is little data to support significant impact of transporter-mediated intestinal absorption in bRo5 space.  Current knowledge of compd. properties that govern transporter effects of bRo5 drugs is limited and requires further fundamental and comprehensive studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3dS_FpMvvCbVg90H21EOLACvtfcHk0li4qlSFmOMDRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D&md5=1eacb5ab6e50159f3679e3d8a1f719c4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DCell%2520permeability%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2016%26volume%3D101%26spage%3D42%26epage%3D61%26doi%3D10.1016%2Fj.addr.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span> <span> </span><span class="NLM_article-title">Intermolecular and intramolecular hydrogen bonds involving fluorine atoms: implications for recognition, selectivity, and chemical properties</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2Fcmdc.201100483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=22262517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=262-272&author=C.+Dalvitauthor=A.+Vulpetti&title=Intermolecular+and+intramolecular+hydrogen+bonds+involving+fluorine+atoms%3A+implications+for+recognition%2C+selectivity%2C+and+chemical+properties&doi=10.1002%2Fcmdc.201100483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular and Intramolecular Hydrogen Bonds Involving Fluorine Atoms: Implications for Recognition, Selectivity, and Chemical Properties</span></div><div class="casAuthors">Dalvit, Claudio; Vulpetti, Anna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-272</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A correlation between 19F NMR isotropic chem. shift and close intermol. F···H-X contacts (with X = N or O) has been identified upon anal. of the X-ray crystal structures of fluorinated mols. listed in the Cambridge Structural Database (CSD).  An optimal F···X distance involving primary and shielded secondary fluorine atoms in hydrogen-bond formation along with a correlation between F···H distance and F···H-X angle were also derived from the anal.  The hydrogen bonds involving fluorine are relevant, not only for the recognition mechanism and stabilization of a preferred conformation, but also for improvement in the permeability of the mols., as shown with examples taken from a proprietary database.  Results of an anal. of the small no. of fluorine-contg. natural products listed in the Protein Data Bank (PDB) appear to strengthen the derived correlation between 19F NMR isotropic chem. shift and interactions involving fluorine (also known as the "rule of shielding") and provides a hypothesis for the recognition mechanism and catalytic activity of specific enzymes.  Novel chem. scaffolds, based on the rule of shielding, have been designed for recognizing distinct structural motifs present in proteins.  It is envisaged that this approach could find useful applications in drug design for the efficient optimization of chem. fragments or promising compds. by increasing potency and selectivity against the desired biomol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtfxYsmG4NrVg90H21EOLACvtfcHk0li4qlSFmOMDRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D&md5=21efccc023f44ed600725e2a834222ae</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100483%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DVulpetti%26aufirst%3DA.%26atitle%3DIntermolecular%2520and%2520intramolecular%2520hydrogen%2520bonds%2520involving%2520fluorine%2520atoms%253A%2520implications%2520for%2520recognition%252C%2520selectivity%252C%2520and%2520chemical%2520properties%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D262%26epage%3D272%26doi%3D10.1002%2Fcmdc.201100483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raub, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M.-J.</span></span> <span> </span><span class="NLM_article-title">How hydrogen bonds impact P-glycoprotein transport and permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6540</span>– <span class="NLM_lpage">6548</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2012.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=23006604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6540-6548&author=P.+V.+Desaiauthor=T.+J.+Raubauthor=M.-J.+Blanco&title=How+hydrogen+bonds+impact+P-glycoprotein+transport+and+permeability&doi=10.1016%2Fj.bmcl.2012.08.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">How hydrogen bonds impact P-glycoprotein transport and permeability</span></div><div class="casAuthors">Desai, Prashant V.; Raub, Thomas J.; Blanco, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6540-6548</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The requirement to cross a biol. membrane can be a complex process esp. if multidrug transporters such as P-gp must be considered.  Drug partitioning into the lipid membrane and efflux by P-gp are tightly coupled processes wherein H-bonding interactions play a key role.  All H-bond donors and acceptors are not equal in terms of the strength of the H-bonds that they form, hence it is important to consider their relative strength.  Using various examples from literature, we illustrate the benefits of considering the relative strengths of individual H-bonds and introducing intramol. H-bonds to increase membrane permeability and/or decrease P-gp efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxB3oN1ILz7LVg90H21EOLACvtfcHk0li4qlSFmOMDRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO&md5=a27f286d4349eec6f76b745b19ccf84f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DP.%2BV.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DBlanco%26aufirst%3DM.-J.%26atitle%3DHow%2520hydrogen%2520bonds%2520impact%2520P-glycoprotein%2520transport%2520and%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6540%26epage%3D6548%26doi%3D10.1016%2Fj.bmcl.2012.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menezes, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voliva, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecchi, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,2- a ]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2016.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=26774655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=742-746&author=W.+Hanauthor=D.+L.+Menezesauthor=Y.+Xuauthor=M.+S.+Knappauthor=R.+Ellingauthor=M.+T.+Burgerauthor=Z.-J.+Niauthor=A.+Smithauthor=J.+Lanauthor=T.+E.+Williamsauthor=J.+Verhagenauthor=K.+Huhauthor=H.+Merrittauthor=J.+Chanauthor=S.+Kaufmanauthor=C.+F.+Volivaauthor=S.+Pecchi&title=Discovery+of+imidazo%5B1%2C2-+a+%5D-pyridine+inhibitors+of+pan-PI3+kinases+that+are+efficacious+in+a+mouse+xenograft+model&doi=10.1016%2Fj.bmcl.2016.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model</span></div><div class="casAuthors">Han, Wooseok; Menezes, Daniel L.; Xu, Yongjin; Knapp, Mark S.; Elling, Robert; Burger, Matthew T.; Ni, Zhi-Jie; Smith, Aaron; Lan, Jiong; Williams, Teresa E.; Verhagen, Joelle; Huh, Kay; Merritt, Hanne; Chan, John; Kaufman, Susan; Voliva, Charles F.; Pecchi, Sabina</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-746</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alterations in PI3K/AKT signaling are known to be implicated with tumorigenesis.  The PI3 kinases family of lipid kinases has been an attractive therapeutic target for cancer treatment.  Imidazopyridine compd. 1, a potent, selective, and orally available pan-PI3K inhibitor, identified by scaffold morphing of a benzothiazole hit, was further optimized in order to achieve efficacy in a PTEN-deleted A2780 ovarian cancer mouse xenograft model.  With a hypothesis that a planar conformation between the core and the 6-heteroaryl ring will allow for the accommodation of larger 5'-substituents in a hydrophobic area under P-loop, SAR efforts focused on 5'-alkoxy heteroaryl rings at the 6-position of imidazopyridine and imidazopyridazine cores that have the same dihedral angle of zero degrees. 6'-Alkoxy 5'-aminopyrazines in the imidazopyridine series were identified as the most potent compds. in the A2780 cell line.  Compd. 14 with 1,1,1-trifluoroisopropoxy group at 6'-position demonstrated excellent potency and selectivity, good oral exposure in rats and in vivo efficacy in A2780 tumor-bearing mouse.  Also, we disclose the X-ray co-crystal structure of one enantiomer of compd. 14 in PI3Kα, confirming that the trifluoromethyl group fits nicely in the hydrophobic hot spot under P-loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrX15ON5F9MLVg90H21EOLACvtfcHk0lij9Ye9gMABUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1KnsQ%253D%253D&md5=7cf6665595e375797277dcb413a86c24</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DMenezes%26aufirst%3DD.%2BL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DM.%2BS.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DT.%2BE.%26aulast%3DVerhagen%26aufirst%3DJ.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DMerritt%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DVoliva%26aufirst%3DC.%2BF.%26aulast%3DPecchi%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-%2520a%2520%255D-pyridine%2520inhibitors%2520of%2520pan-PI3%2520kinases%2520that%2520are%2520efficacious%2520in%2520a%2520mouse%2520xenograft%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D742%26epage%3D746%26doi%3D10.1016%2Fj.bmcl.2016.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">Structure of compound <b>13</b> in PIM1 submitted under PDB accession code 1ozrb.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lij9Ye9gMABUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">For compounds <b>4</b>, <b>5</b>, <b>11</b>, and <b>12</b>, IC<sub>50</sub> values for hERG potassium channel were >30 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">The synthesis of intermediates <b>16</b> and <b>18</b> was previously reported (see ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, A.</span></span> <span> </span><span class="NLM_article-title">Practical and environmentally friendly epoxidation of olefins using oxone</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1021/op025511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op025511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkt1aitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=405-406&author=N.+Hashimotoauthor=A.+Kanda&title=Practical+and+environmentally+friendly+epoxidation+of+olefins+using+oxone&doi=10.1021%2Fop025511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Practical and Environmentally Friendly Epoxidation of Olefins Using Oxone</span></div><div class="casAuthors">Hashimoto, Norio; Kanda, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-406</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical and efficient epoxidn. of arom. olefins using Oxone in a two-phase system (Et acetate-water) is described.  The reported method is suitable for large-scale synthesis and does not require a phase transfer catalyst or pH control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq078ECHtUpFrVg90H21EOLACvtfcHk0lij9Ye9gMABUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkt1aitbw%253D&md5=cbcec562a0f97b20d972f648aa07f4b0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fop025511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop025511f%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DKanda%26aufirst%3DA.%26atitle%3DPractical%2520and%2520environmentally%2520friendly%2520epoxidation%2520of%2520olefins%2520using%2520oxone%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D405%26epage%3D406%26doi%3D10.1021%2Fop025511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perali, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduri, V. R.</span></span> <span> </span><span class="NLM_article-title">An unexpected migration of O-silyl group under Mitsunobu reaction conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3045</span>– <span class="NLM_lpage">3047</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.tetlet.2011.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=3045-3047&author=R.+S.+Peraliauthor=S.+Mandavaauthor=V.+R.+Chunduri&title=An+unexpected+migration+of+O-silyl+group+under+Mitsunobu+reaction+conditions&doi=10.1016%2Fj.tetlet.2011.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An unexpected migration of O-silyl group under Mitsunobu reaction conditions</span></div><div class="casAuthors">Perali, Ramu Sridhar; Mandava, Suresh; Chunduri, Venkata Rao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3045-3047</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A 1,4 O→O silyl migration followed by nucleophilic substitution with phthalimide was obsd. under Mitsunobu reaction conditions.  This one step secondary alc. protection and primary alc. substitution with N-nucleophiles was extended to a variety of 2-hydroxyethyl trialkylsilyl-ether derivs.  A possible mechanism has been postulated based on the pKa values of the alc. and nucleophile.  The present one-pot silyl migration and substitution reaction might find application in the stereoselective synthesis of novel imino-sugar derived anti diabetic agents, e.g. I .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr0ramWWDmirVg90H21EOLACvtfcHk0ljJYTIOWH23zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWnu7w%253D&md5=711eebc1561ea2cee8b604dd2bd3ea16</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DPerali%26aufirst%3DR.%2BS.%26aulast%3DMandava%26aufirst%3DS.%26aulast%3DChunduri%26aufirst%3DV.%2BR.%26atitle%3DAn%2520unexpected%2520migration%2520of%2520O-silyl%2520group%2520under%2520Mitsunobu%2520reaction%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D3045%26epage%3D3047%26doi%3D10.1016%2Fj.tetlet.2011.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanRheenen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. Y.</span></span> <span> </span><span class="NLM_article-title">An improved catalytic OsO4 oxidation of olefins to -1,2-glycols using tertiary amine oxides as the oxidant</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(00)78093-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fs0040-4039%2800%2978093-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1976&pages=1973-1976&author=V.+VanRheenenauthor=R.+C.+Kellyauthor=D.+Y.+Cha&title=An+improved+catalytic+OsO4+oxidation+of+olefins+to+-1%2C2-glycols+using+tertiary+amine+oxides+as+the+oxidant&doi=10.1016%2Fs0040-4039%2800%2978093-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fs0040-4039%2800%2978093-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0040-4039%252800%252978093-2%26sid%3Dliteratum%253Aachs%26aulast%3DVanRheenen%26aufirst%3DV.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DCha%26aufirst%3DD.%2BY.%26atitle%3DAn%2520improved%2520catalytic%2520OsO4%2520oxidation%2520of%2520olefins%2520to%2520-1%252C2-glycols%2520using%2520tertiary%2520amine%2520oxides%2520as%2520the%2520oxidant%26jtitle%3DTetrahedron%2520Lett.%26date%3D1976%26volume%3D17%26spage%3D1973%26epage%3D1976%26doi%3D10.1016%2Fs0040-4039%2800%2978093-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span> <span> </span><span class="NLM_article-title">A direct preparation of 6-methylene-2-cyclohexenones</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1055/s-2004-829162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1055%2Fs-2004-829162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1737-1738&author=G.+Krausauthor=J.+Kim&title=A+direct+preparation+of+6-methylene-2-cyclohexenones&doi=10.1055%2Fs-2004-829162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A direct preparation of 6-methylene-2-cyclohexenones</span></div><div class="casAuthors">Kraus, George A.; Kim, Junwon</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1737-1738</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Enol silyl ethers underwent methylation with Eschenmoser's salt, followed by elimination to provide 6-methylene-2-cyclohexenones I (R1 = H, Me; R2 = H; R1 = H; R2 = Me) in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBpGmFd45iTLVg90H21EOLACvtfcHk0ljJYTIOWH23zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeis70%253D&md5=fb7e9f3489346c19250faac9b8497326</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-829162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-829162%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DA%2520direct%2520preparation%2520of%25206-methylene-2-cyclohexenones%26jtitle%3DSynthesis%26date%3D2004%26spage%3D1737%26epage%3D1738%26doi%3D10.1055%2Fs-2004-829162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berti, G.</span></span> <span> </span><span class="NLM_article-title">Stereochemical aspects of the synthesis of 1,2-epoxides</span>. In  <i>Topics in Stereochemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allinger, N. L.</span>, <span class="NLM_string-name">Eliel, E. L.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York, London, Sydney, Toronto</span>, <span class="NLM_year">1973</span>; Vol.  <span class="NLM_volume">7</span>, p  <span class="NLM_fpage">93</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2F9780470147160.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=93&author=G.+Bertiauthor=N.+L.+Allinger&author=E.+L.+Eliel&title=Topics+in+Stereochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2F9780470147160.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470147160.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DBerti%26aufirst%3DG.%26atitle%3DStereochemical%2520aspects%2520of%2520the%2520synthesis%2520of%25201%252C2-epoxides%26btitle%3DTopics%2520in%2520Stereochemistry%26aulast%3DAllinger%26aufirst%3DN.%2BL.%26pub%3DWiley%26date%3D1973%26volume%3D7%26spage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="note"><p class="first last">To further confirm the stereochemistry, we synthesized two regioisomeric epoxides through either direct mCPBA reaction or bromohydrin/ring closing reactions of 36 (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Also, see ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> for similar examples.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liepold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestmann, H. J.</span></span> <span> </span><span class="NLM_article-title">An improved one-pot procedure for the synthesis of alkynes from aldehydes</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1055/s-1996-5474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1055%2Fs-1996-5474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaK28XjvVGnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=521-522&author=S.+M%C3%BCllerauthor=B.+Liepoldauthor=G.+J.+Rothauthor=H.+J.+Bestmann&title=An+improved+one-pot+procedure+for+the+synthesis+of+alkynes+from+aldehydes&doi=10.1055%2Fs-1996-5474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">An improved one-pot procedure for the synthesis of alkynes from aldehydes</span></div><div class="casAuthors">Mueller, Stephen; Liepold, Bernd; Roth, Gerald J.; Bestmann, Hans Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">521-522</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Thieme</span>)
        </div><div class="casAbstract">The transformation of aldehydes, e.g., C6H4(CHO)2-1,3, to terminal alkynes, e.g., C6H4(C≡CH)2-1,3, can be achieved with the reagent di-Me 1-diazo-2-oxopropylphosphonate.  The one-pot procedure allows the isolation of the products under very mild conditions in good to excellent yields without requiring low temps. or inert gas techniques, and it avoids the use of strong bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQjURxPuC08LVg90H21EOLACvtfcHk0ljJYTIOWH23zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVGnsrc%253D&md5=3fa1081fc8359ab7723704758ae3e7a2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1055%2Fs-1996-5474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1996-5474%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DLiepold%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DBestmann%26aufirst%3DH.%2BJ.%26atitle%3DAn%2520improved%2520one-pot%2520procedure%2520for%2520the%2520synthesis%2520of%2520alkynes%2520from%2520aldehydes%26jtitle%3DSynlett%26date%3D1996%26spage%3D521%26epage%3D522%26doi%3D10.1055%2Fs-1996-5474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohira, S.</span></span> <span> </span><span class="NLM_article-title">Methanolysis of dimethyl (1-diazo-2-oxopropyl) phosphonate: generation of dimethyl (diazomethyl) phosphonate and reaction with carbonyl compounds</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1080/00397918908050700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1080%2F00397918908050700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1989&pages=561-564&author=S.+Ohira&title=Methanolysis+of+dimethyl+%281-diazo-2-oxopropyl%29+phosphonate%3A+generation+of+dimethyl+%28diazomethyl%29+phosphonate+and+reaction+with+carbonyl+compounds&doi=10.1080%2F00397918908050700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Methanolysis of dimethyl (1-diazo-2-oxopropyl)phosphonate:  generation of dimethyl (diazomethyl)phosphonate and reaction with carbonyl compounds</span></div><div class="casAuthors">Ohira, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Treatment of MeCOC(N2)PO3Me2 with K2CO3 in MeOH afforded N2CHPO3Me2 (I), which was used in situ for the synthesis of enol ethers or alkynes.  Thus, I and cyclohexanone or decanal afforded (methoxymethylene)cyclohexane or 1-undecyne, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmw2veCJW5vbVg90H21EOLACvtfcHk0liJUopXe5FDYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D&md5=55a1aab8bf13ca7835e3609d138fe2de</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F00397918908050700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918908050700%26sid%3Dliteratum%253Aachs%26aulast%3DOhira%26aufirst%3DS.%26atitle%3DMethanolysis%2520of%2520dimethyl%2520%25281-diazo-2-oxopropyl%2529%2520phosphonate%253A%2520generation%2520of%2520dimethyl%2520%2528diazomethyl%2529%2520phosphonate%2520and%2520reaction%2520with%2520carbonyl%2520compounds%26jtitle%3DSynth.%2520Commun.%26date%3D1989%26volume%3D19%26spage%3D561%26epage%3D564%26doi%3D10.1080%2F00397918908050700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3034-3045&author=W.+Hanauthor=Y.+Dingauthor=Y.+Xuauthor=K.+Pfisterauthor=S.+Zhuauthor=B.+Warneauthor=M.+Doyleauthor=M.+Aikawaauthor=P.+Amiriauthor=B.+Appletonauthor=D.+D.+Stuartauthor=A.+Fanidiauthor=C.+M.+Shafer&title=Discovery+of+a+Selective+and+Potent+Inhibitor+of+Mitogen-Activated+Protein+Kinase-Interacting+Kinases+1+and+2+%28MNK1%2F2%29+Utilizing+Structure-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.5b01657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design</span></div><div class="casAuthors">Han, Wooseok; Ding, Yu; Xu, Yongjin; Pfister, Keith; Zhu, Shejin; Warne, Bob; Doyle, Mike; Aikawa, Mina; Amiri, Payman; Appleton, Brent; Stuart, Darrin D.; Fanidi, Abdallah; Shafer, Cynthia M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3034-3045</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a highly potent and selective small mol. inhibitor I for in vitro target validation of MNK1/2 kinases is described.  The aminopyrazine benzimidazole series was derived from an HTS hit and optimized by utilization of a docking model, conformation anal., and binding pocket comparison against antitargets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBT5jenqIBHLVg90H21EOLACvtfcHk0liJUopXe5FDYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D&md5=b4c3eb8122635da657fa52daddb6879a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01657%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWarne%26aufirst%3DB.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DM.%26aulast%3DAmiri%26aufirst%3DP.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DD.%2BD.%26aulast%3DFanidi%26aufirst%3DA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520Selective%2520and%2520Potent%2520Inhibitor%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Interacting%2520Kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520Utilizing%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3034%26epage%3D3045%26doi%3D10.1021%2Facs.jmedchem.5b01657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wölker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of optically active vicinal fluorohydrins by lipase-catalyzed deracemization</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">3015</span>– <span class="NLM_lpage">3021</span>, <span class="refDoi"> DOI: 10.1021/jo016331r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo016331r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A280%3ADC%252BD383jvVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=3015-3021&author=D.+W%C3%B6lkerauthor=G.+Haufe&title=Synthesis+of+optically+active+vicinal+fluorohydrins+by+lipase-catalyzed+deracemization&doi=10.1021%2Fjo016331r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of optically active vicinal fluorohydrins by lipase-catalyzed deracemization</span></div><div class="casAuthors">Wolker Dorthe; Haufe Gunter</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of organic chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3015-21</span>
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Three microbial lipases have been used to deracemize trans-2-fluorocycloalkanols 2 both by hydrolysis of the corresponding acetates 3 or chloroacetates 4 and by esterification of the fluorohydrins 2 using vinyl acetate and vinyl chloroacetate, respectively.  Pseudomonas cepacia lipase was the most selective for the six- and the seven-membered-ring compounds, while the lipase from Candida rugosa was most useful for the eight-membered-ring compounds.  Both lipases transform the (R)-enantiomers preferentially.  In contrast the lipase from Candida antarctica hydrolyzed the esters of trans-2-fluorocyclohexanol 2a and esterified the fluorohydrin itself with very low enantiopreference for the (R)-isomers.  The seven- and the eight-membered ring esters and the corresponding fluorohydrins were also transformed with low, but reverse, enantioselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRABkx-oVEvhLesJRIHUP1ofW6udTcc2eZipzVVXgdIkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383jvVygtA%253D%253D&md5=2b390a0da66b890ae25e454e413e3cde</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo016331r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo016331r%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6lker%26aufirst%3DD.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520optically%2520active%2520vicinal%2520fluorohydrins%2520by%2520lipase-catalyzed%2520deracemization%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D3015%26epage%3D3021%26doi%3D10.1021%2Fjo016331r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jünnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanasova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindona, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aksnes, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, G. W.</span></span> <span> </span><span class="NLM_article-title">Reaction of Epoxyaldonolactones with HF--Amine Complexes</span>. <i>Acta Chem. Scand.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.3891/acta.chem.scand.48-0265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.3891%2Facta.chem.scand.48-0265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFKiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1994&pages=265-268&author=J.+J%C3%BCnnemannauthor=I.+Lundtauthor=J.+Thiemauthor=C.+B.+Ivanovauthor=R.+Atanasovaauthor=A.+Napoliauthor=G.+Sindonaauthor=D.+W.+Aksnesauthor=G.+W.+Francis&title=Reaction+of+Epoxyaldonolactones+with+HF%2D%2DAmine+Complexes&doi=10.3891%2Facta.chem.scand.48-0265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of epoxyaldonolactones with HF-amine complexes</span></div><div class="casAuthors">Juennemann, Josef; Lundt, Inge; Thiem, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Acta Chemica Scandinavica</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-8</span>CODEN:
                <span class="NLM_cas:coden">ACHSE7</span>;
        ISSN:<span class="NLM_cas:issn">0904-213X</span>.
    </div><div class="casAbstract">The opening of 2,3-epoxyaldonolactones, e.g. I, with trialkylamine·3HF gave 2-deoxy-2-fluoroaldonolactones, e.g. II and III regio- and stereoselectively, while collidine·3HF gave a mixt. of 2-deoxy-2-fluoro- and 3-deoxy-3-fluoro-lactones in a 2:1 ratio.  Pyridine·3HF and Olah's reagent gave complex mixts.  5,6-Epoxyhexonolactones were opened exclusively at C-6, using the tris(hydrogen fluoride) complex of either triethylamine, collidine or pyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1xtPfSjXwzLVg90H21EOLACvtfcHk0liSVUbCYcVwmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFKiurY%253D&md5=a0f36378f4038d2b41d313541e2d130d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.48-0265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.48-0265%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25BCnnemann%26aufirst%3DJ.%26aulast%3DLundt%26aufirst%3DI.%26aulast%3DThiem%26aufirst%3DJ.%26aulast%3DIvanov%26aufirst%3DC.%2BB.%26aulast%3DAtanasova%26aufirst%3DR.%26aulast%3DNapoli%26aufirst%3DA.%26aulast%3DSindona%26aufirst%3DG.%26aulast%3DAksnes%26aufirst%3DD.%2BW.%26aulast%3DFrancis%26aufirst%3DG.%2BW.%26atitle%3DReaction%2520of%2520Epoxyaldonolactones%2520with%2520HF--Amine%2520Complexes%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1994%26volume%3D48%26spage%3D265%26epage%3D268%26doi%3D10.3891%2Facta.chem.scand.48-0265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span> <span> </span><span class="NLM_article-title">Fluorination methods for drug discovery and development</span>. <i>Expet Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1080/17460441.2016.1223037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1080%2F17460441.2016.1223037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=27548817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyisL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=983-999&author=P.+Richardson&title=Fluorination+methods+for+drug+discovery+and+development&doi=10.1080%2F17460441.2016.1223037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination methods for drug discovery and development</span></div><div class="casAuthors">Richardson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">983-999</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The pivotal role that the element fluorine plays in modulating the properties of bioactive mols. is reflected by the growth of its presence in approved drugs.  In 1970, approx. 2% of drugs contained fluorine with this no. rising to 25% by 2011.  The synthetic chem. regarding incorporation of fluorine into org. mols. has also evolved over this time with a paradigm shift from harsh, toxic, hazardous reagents utilized primarily by specialist vendors to new deoxyfluorination reagents and metal-mediated techniques capable of the precise introduction of fluorine into complex org. substrates under relatively mild conditions.  This review highlights the importance of fluorinated compds. in drug discovery, and provides an overview on the synthetic strategies and methodologies developed to access them both in discovery and development.  The development of new reagents for the safe and precise regioselective fluorination of biol. relevant compds. particularly in drug discovery remains a contemporary challenge in org. chem.  However, significant strides have been made with the development of new deoxyfluorination reagents and the emergence of practical metal-mediated fluorination techniques have enabled the goal of efficient late-stage fluorination of drug-like compds. to be realized, and the extension of these methods for PET-labeling is being investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBVKZBu8dlW7Vg90H21EOLACvtfcHk0liSVUbCYcVwmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyisL7K&md5=a0f4772a1287ecef6afee01a0570b037</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F17460441.2016.1223037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2016.1223037%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%26atitle%3DFluorination%2520methods%2520for%2520drug%2520discovery%2520and%2520development%26jtitle%3DExpet%2520Opin.%2520Drug%2520Discov.%26date%3D2016%26volume%3D11%26spage%3D983%26epage%3D999%26doi%3D10.1080%2F17460441.2016.1223037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yerien, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postigo, A.</span></span> <span> </span><span class="NLM_article-title">Fluorination methods in drug discovery</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">8398</span>– <span class="NLM_lpage">8427</span>, <span class="refDoi"> DOI: 10.1039/c6ob00764c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1039%2Fc6ob00764c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=27506398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=8398-8427&author=D.+E.+Yerienauthor=S.+Bonesiauthor=A.+Postigo&title=Fluorination+methods+in+drug+discovery&doi=10.1039%2Fc6ob00764c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination methods in drug discovery</span></div><div class="casAuthors">Yerien, Damian E.; Bonesi, Sergio; Postigo, Al</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">8398-8427</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Fluorination reactions of medicinal and biol.-active compds. will be discussed.  Late stage fluorination strategies of medicinal targets have recently attracted considerable attention on account of the influence that a fluorine atom can impart to targets of medicinal importance, such as modulation of lipophilicity, electronegativity, basicity and bioavailability, the latter as a consequence of membrane permeability.  Therefore, the recourse to late-stage fluorine substitution on compds. with already known and relevant biol. activity can provide the pharmaceutical industry with new leads with improved medicinal properties.  The fluorination strategies will take into account different fluorinating reagents, either of nucleophilic or electrophilic, and of radical nature.  Diverse families of org. compds. such as (hetero)arom. rings, and aliph. substrates (Sp3, Sp2, and sp carbon atoms) will be studied in late-stage fluorination reaction strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG13ztU9olzrVg90H21EOLACvtfcHk0liSVUbCYcVwmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygt7rJ&md5=ee09c5e4464f2538460c03ecadc90123</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fc6ob00764c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc6ob00764c%26sid%3Dliteratum%253Aachs%26aulast%3DYerien%26aufirst%3DD.%2BE.%26aulast%3DBonesi%26aufirst%3DS.%26aulast%3DPostigo%26aufirst%3DA.%26atitle%3DFluorination%2520methods%2520in%2520drug%2520discovery%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D8398%26epage%3D8427%26doi%3D10.1039%2Fc6ob00764c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':[],'ref28':[],'ref29':[],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':[],'ref37':[],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':[],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">PIM Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Synfacts</span><span> <strong>2021,</strong>,, 0247. <a href="https://doi.org/10.1055/s-0040-1719370" title="DOI URL">https://doi.org/10.1055/s-0040-1719370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1719370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1719370%26sid%3Dliteratum%253Aachs%26jtitle%3DSynfacts%26atitle%3DPIM%252BKinase%252BInhibitor%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D03%26spage%3D0247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Novartis pan-PIM Inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure of compound <b>2</b> in PIM1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR">5DWR</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking model of compound <b>4</b> and the X-ray structure of compound <b>5</b> in PIM1. (a) Docking model of 4-methyl analogue of compound <b>4</b> in PIM1. (b) X-ray co-crystal structure of compound <b>5</b> in PIM1. The hydroxyl groups at the 3- and 4-positions on the cyclohexyl A-ring form H-bond interactions with the backbone residues Glu171 and Asp128, respectively. While the methyl group at the carbinol carbon made a hydrophobic interaction with Phe49, the methyl group at the 5-position occupies the hydrophobic dimple under the P-loop. The pyridine nitrogen at the B-ring interacts with the catalytic Lys67 residue (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1oblv">1oblv</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray co-crystal structure of compound <b>13</b> in PIM1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ozrb">1ozrb</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chiral separation; (b) TBDMSCl, imidazole, >99%; (c) H<sub>2</sub>, Pd on carbon, EtOAc, MeOH, 2 h, 85%; (d) EDC, HOAt, DMF; (e) HCl, THF, MeOH, 37% (over 2 steps); (f) <sup><i>t</i></sup>BuOK, THF, 90%; (g) AcOH (cat.), MeCN, water, 33%; (h) TBDMSCl, imidazole, 50%; (i) H<sub>2</sub>, Pd on carbon, EtOAc, EtOH, 50%; (j) chiral separation, 43%; (k) <b>18</b>, EDC, HOAt, DMF, >99%; (l) HCl, THF, MeOH, 57% (over 2 steps).</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiHMDS, TMSCl, THF, 0 °C, 96%; (b) Oxone, NaHCO<sub>3</sub>, acetone, water, EtOAc, 2 h, 61% (<b>24</b>/<b>24-cis</b> = 1.3:1); (c) acetic anhydride, pyridine, >99%; (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, THF, MeOH, 97%; (e) TBDMSCl, imidazole, DCM, 84%; (f) H<sub>2</sub>, Pd on carbon, EtOAc, EtOH, 88%; (g) chiral separation, 45%; (h) EDC, HOAt, DMF; (i) HCl, THF, MeOH; (j) LiOH, THF, water, 17% (over 3 steps).</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ac<sub>2</sub>O, pyridine, 83%; (b) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, THF, MeOH, 82%; (c) TBDMSCl, imidazole, DCM, 75%; (d) H<sub>2</sub>, Pd on carbon, EtOAc, EtOH, >99%; (e) Boc<sub>2</sub>O, DMAP, DCM, 65%; (f) LiOH, THF, 60 °C, 99%; (g) TBDMSCl, imidazole, DCM, 55%; (h) Dess-Martin reagent, DCM, 90%; (i) TMSCH<sub>2</sub>MgCl, THF, 35 °C, 92%; (j) HCl (cat.), acetone, 97%; (k) OsO<sub>4</sub> (cat.), NMO, 77%; (l) MsCl, pyridine, DCM; (m) LiAlH<sub>4</sub>, THF, 98% (over 2 steps); (n) TBDMSCl, imidazole, DCM, 70%; (o) TFA, DCM, >99%; (p) EDC, HOAt, DMF; (q) HCl, THF, MeOH, 45% (over 2 steps); (r) chiral separation, 39%.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Exo-methylene Intermediate <b>36</b> and Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Eschenmoser’s salt, DCM, 18 h, 99%; (b) Iodomethane, THF, 18 h; (c) NaHCO<sub>3</sub>, 5 h, 63%; (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, MeOH, 72%; (e) TBDMSCl, imidazole, DCM, 86%; (f) mCPBA, NaHCO<sub>3</sub>, DCM, 14 h, 90%; (g) NBS, THF, water, 3 h, 56%; (h) TBDMSCl, imidazole, DMF, 75%; (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, water, 1 h, 97%; (j) H<sub>2</sub> (200 psi), Pd(OH)<sub>2</sub> on carbon, MeOH, 4 d; 88%; (k) H<sub>2</sub>, Pd on carbon, pyridine, MeOH, 24 h; 70%; (l) <b>18</b>, EDC, HOAt, DMF, >99%; (m) HCl, THF, MeOH, 86% (over 2 steps); (n) chiral resolution, 31%; (o) TBAF, THF.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) OsO<sub>4</sub>, NMO, acetone, water, 1 h, 95%; (b) Dess–Martin periodinane, DCM, 72 h, 77%; (c) Bestmann–Ohira’s reagent, MeOH, K<sub>2</sub>CO<sub>3</sub>, 1.5 h, 96%; (d) H<sub>2</sub>, Pd on carbon, MeOH, 12 h, 33%; (e) chiral separation, 33%; (f) EDC, HOAt, DMF, 16 h; (g) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane), Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, KOAc, dioxane, K<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min; (h) 2-bromo-3-fluoropyridine, PdCl<sub>2</sub>(dppf), DME, Na<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min; (i) HCl, THF, MeOH, 1 h, 30% (over 3 steps).</p></p></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/medium/jm0c01279_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>13</b> and <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01279/20201203/images/large/jm0c01279_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01279&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Et<sub>3</sub>N·3HF, 100 °C, 8 h, 46%; (b) H<sub>2</sub>, Pd on carbon, MeOH, 12 h, 49%; (c) 3-amino-6-bromopicolinic acid <b>47</b>, EDC, HOAt, DMF, 16 h, 85%; (d) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane), Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, KOAc, dioxane, K<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min; (e) 2-bromo-3-fluoropyridine, PdCl<sub>2</sub>(dppf), DME, Na<sub>2</sub>CO<sub>3</sub>, μW, 120 °C, 10 min, 10% (over 3 steps); (f) chiral resolution, 24%; (g) mucobromic acid, NaOEt, EtOH, 40 °C, 2 h; (h) NH<sub>4</sub>OH, CuSO<sub>4</sub>, 110 °C, 1 h, 25% (over 2 steps); (i) <b>51</b>, EDC, HOAt, DMF, 12 h, 25%; (j) chiral resolution, 34%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuypers, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quint, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zijlstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maandag, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelens, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wezenbeek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melief, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span> <span> </span><span class="NLM_article-title">Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(84)90309-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2F0092-8674%2884%2990309-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=6327049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=141-150&author=H.+T.+Cuypersauthor=G.+Seltenauthor=W.+Quintauthor=M.+Zijlstraauthor=E.+R.+Maandagauthor=W.+Boelensauthor=P.+Van+Wezenbeekauthor=C.+Meliefauthor=A.+Berns&title=Murine+leukemia+virus-induced+T-cell+lymphomagenesis%3A+integration+of+proviruses+in+a+distinct+chromosomal+region&doi=10.1016%2F0092-8674%2884%2990309-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Murine leukemia virus-induced T-cell lymphomagenesis:  integration of proviruses in a distinct chromosomal region</span></div><div class="casAuthors">Cuypers, H. Theo; Selten, Gerard; Quint, Wim; Zijlstra, Maarten; Maandag, Els Robanus; Boelens, Wilbert; Van Wezenbeek, Peter; Melief, Cees; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Mink cell focus-forming (MCF) proviruses were molecularly cloned from mouse lymphoma DNA.  From each clone, flanking probes were prepd. to detect common integration regions in other murine leukemia virus (MuLV)-induced lymphomas.  One clone frequently revealed variations in the mol. structure of the corresponding region (Pim-1) in other lymphomas.  Changes in the Pim region are seen in 24 of 93 lymphomas tested.  Over 50% of the early T-cell lymphomas show integration in the Pim-1 region.  The alterations are seen in different mouse strains and with various MuLVs.  The obsd. variations are caused by the integration of predominantly MCF genomes.  All integrations occur in a region spanning <20 kilobases and are assocd. with the transcriptional activation of a distinct region within the Pim-1 domain.  The activated region does not show any homol. with 13 known and 3 putative oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm89Z9zs2CVrVg90H21EOLACvtfcHk0lhlqeu7tPZTpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D&md5=8cff87b785ab0a12aacf742106aaf6a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2884%2990309-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252884%252990309-X%26sid%3Dliteratum%253Aachs%26aulast%3DCuypers%26aufirst%3DH.%2BT.%26aulast%3DSelten%26aufirst%3DG.%26aulast%3DQuint%26aufirst%3DW.%26aulast%3DZijlstra%26aufirst%3DM.%26aulast%3DMaandag%26aufirst%3DE.%2BR.%26aulast%3DBoelens%26aufirst%3DW.%26aulast%3DVan%2BWezenbeek%26aufirst%3DP.%26aulast%3DMelief%26aufirst%3DC.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DMurine%2520leukemia%2520virus-induced%2520T-cell%2520lymphomagenesis%253A%2520integration%2520of%2520proviruses%2520in%2520a%2520distinct%2520chromosomal%2520region%26jtitle%3DCell%26date%3D1984%26volume%3D37%26spage%3D141%26epage%3D150%26doi%3D10.1016%2F0092-8674%2884%2990309-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaller, J.</span></span> <span> </span><span class="NLM_article-title">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1015</span>, <span class="refDoi"> DOI: 10.3324/haematol.2009.017079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.3324%2Fhaematol.2009.017079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=20145274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1004-1015&author=L.+Braultauthor=C.+Gasserauthor=F.+Bracherauthor=K.+Huberauthor=S.+Knappauthor=J.+Schwaller&title=PIM+serine%2Fthreonine+kinases+in+the+pathogenesis+and+therapy+of+hematologic+malignancies+and+solid+cancers&doi=10.3324%2Fhaematol.2009.017079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span></div><div class="casAuthors">Brault, Laurent; Gasser, Christelle; Bracher, Franz; Huber, Kilian; Knapp, Stefan; Schwaller, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1004-1015</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A review.  The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lymphomas suggested early on that PIM serine/threonine kinases play an important role in cancer biol.  Whereas elevated levels of PIM1 and PIM2 were mostly found in hematol. malignancies and prostate cancer, increased PIM3 expression was obsd. in different solid tumors.  PIM kinases are constitutively active and their activity supports in vitro and in vivo tumor cell growth and survival through modification of an increasing no. of common as well as isoform-specific substrates including several cell cycle regulators and apoptosis mediators.  PIM1 but not PIM2 seems also to mediate homing and migration of normal and malignant hematopoietic cells by regulating chemokine receptor surface expression.  Knockdown expts. by RNA interference or dominant-neg. acting mutants suggested that PIM kinases are important for maintenance of a transformed phenotype and therefore potential therapeutic targets.  Detn. of the protein structure facilitated identification of an increasing no. of potent small mol. PIM kinase inhibitors with in vitro and in vivo anticancer activity.  Ongoing efforts aim to identify isoform-specific PIM inhibitors that would not only help to dissect the kinase function but hopefully also provide targeted therapeutics.  Here, we summarize the current knowledge about the role of PIM serine/threonine kinases for the pathogenesis and therapy of hematol. malignancies and solid cancers, and we highlight structural principles and recent progress on small mol. PIM kinase inhibitors that are on their way into first clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM0F0X8PArhLVg90H21EOLACvtfcHk0lg297AR71wXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO&md5=241c17f65ee9203be2a6ee138a914781</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2009.017079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2009.017079%26sid%3Dliteratum%253Aachs%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DPIM%2520serine%252Fthreonine%2520kinases%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520hematologic%2520malignancies%2520and%2520solid%2520cancers%26jtitle%3DHaematologica%26date%3D2010%26volume%3D95%26spage%3D1004%26epage%3D1015%26doi%3D10.3324%2Fhaematol.2009.017079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbeek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Lohuizen, M.</span></span> <span> </span><span class="NLM_article-title">Transgenic mice as a means to study synergism between oncogenes</span>. <i>Int. J. Cancer Suppl.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910440706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2Fijc.2910440706" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1989&pages=22-25&author=A.+Bernsauthor=M.+Breuerauthor=S.+Verbeekauthor=M.+Van+Lohuizen&title=Transgenic+mice+as+a+means+to+study+synergism+between+oncogenes&doi=10.1002%2Fijc.2910440706"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910440706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910440706%26sid%3Dliteratum%253Aachs%26aulast%3DBerns%26aufirst%3DA.%26aulast%3DBreuer%26aufirst%3DM.%26aulast%3DVerbeek%26aufirst%3DS.%26aulast%3DVan%2BLohuizen%26aufirst%3DM.%26atitle%3DTransgenic%2520mice%2520as%2520a%2520means%2520to%2520study%2520synergism%2520between%2520oncogenes%26jtitle%3DInt.%2520J.%2520Cancer%2520Suppl.%26date%3D1989%26volume%3D44%26spage%3D22%26epage%3D25%26doi%3D10.1002%2Fijc.2910440706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nawijn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alendar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span> <span> </span><span class="NLM_article-title">For better or for worse: the role of Pim oncogenes in tumorigenesis</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrc2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1038%2Fnrc2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=21150935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=23-34&author=M.+C.+Nawijnauthor=A.+Alendarauthor=A.+Berns&title=For+better+or+for+worse%3A+the+role+of+Pim+oncogenes+in+tumorigenesis&doi=10.1038%2Fnrc2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">For better or for worse: the role of Pim oncogenes in tumorigenesis</span></div><div class="casAuthors">Nawijn, Martijn C.; Alendar, Andrej; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pim oncogenes are overexpressed in a wide range of tumors from a hematol. and epithelial origin.  Pim genes encode serine/threonine kinases that have been shown to counteract the increased sensitivity to apoptosis induction that is assocd. with MYC-driven tumorigenesis.  Recently, considerable progress has been made in characterizing the pathways of PIM-mediated survival signalling.  Given the unique structure of their active site and the minimal phenotype of mice mutant for all Pim family members, these oncogenes might be promising targets for highly specific and selective drugs with favorable toxicity profiles.  In this Review, we discuss the physiol. functions and oncogenic activities of Pim kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu23UDfObMZrVg90H21EOLACvtfcHk0lg297AR71wXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE&md5=fe08e70454ca8c4d808715db87d195e1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2986%26sid%3Dliteratum%253Aachs%26aulast%3DNawijn%26aufirst%3DM.%2BC.%26aulast%3DAlendar%26aufirst%3DA.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DFor%2520better%2520or%2520for%2520worse%253A%2520the%2520role%2520of%2520Pim%2520oncogenes%2520in%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D23%26epage%3D34%26doi%3D10.1038%2Fnrc2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Lohuizen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbeek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimpenfort, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radaszkiewicz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berns, A.</span></span> <span> </span><span class="NLM_article-title">Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(89)90589-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2F0092-8674%2889%2990589-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=2537153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaL1MXhs1OhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1989&pages=673-682&author=M.+van%0ALohuizenauthor=S.+Verbeekauthor=P.+Krimpenfortauthor=J.+Domenauthor=C.+Sarisauthor=T.+Radaszkiewiczauthor=A.+Berns&title=Predisposition+to+lymphomagenesis+in+pim-1+transgenic+mice%3A+cooperation+with+c-myc+and+N-myc+in+murine+leukemia+virus-induced+tumors&doi=10.1016%2F0092-8674%2889%2990589-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Predisposition to lymphomagenesis in pim-1 transgenic mice:  cooperation with c-myc and N-myc in murine leukemia virus-induced tumors</span></div><div class="casAuthors">Van Lohuizen, Maarten; Verbeek, Sjef; Krimpenfort, Paul; Domen, Jos; Saris, Chris; Radaszkiewicz, Thaddeus; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">673-82</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Transgenic mice bearing the pim-1 gene supplemented with an upstream Ig enhancer and a downstream murine leukemia virus long terminal repeat express pim-1 mRNA at high levels in both B and T cells.  Between 5% and 10% of the pim-1 transgenic mice develop clonal T-cell lymphomas before 7 mo of age, whereas none of the age-matched control mice do, providing direct evidence for the oncogenic potential of pim-1.  Histol. examn. and FACS flow-cytometry anal. revealed no abnormalities in hematopoietic tissues of disease-free pim-1 transgenic mice.  When newborn pim-1 transgenic mice are infected with MuLV, T-cell lymphomas develop much faster (latency 7-8 wk) than in nontransgenic mice (latency 22 wk).  In all these T-cell lymphomas, either c-myc or N-myc was activated by proviral insertion, suggesting strong cooperation between pim-1 and myc in lymphomagenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh52Kc24kfvLVg90H21EOLACvtfcHk0lg297AR71wXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhs1OhtL8%253D&md5=a99936287c0d3f56c644d9cf70e6b58d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2889%2990589-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252889%252990589-8%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLohuizen%26aufirst%3DM.%26aulast%3DVerbeek%26aufirst%3DS.%26aulast%3DKrimpenfort%26aufirst%3DP.%26aulast%3DDomen%26aufirst%3DJ.%26aulast%3DSaris%26aufirst%3DC.%26aulast%3DRadaszkiewicz%26aufirst%3DT.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DPredisposition%2520to%2520lymphomagenesis%2520in%2520pim-1%2520transgenic%2520mice%253A%2520cooperation%2520with%2520c-myc%2520and%2520N-myc%2520in%2520murine%2520leukemia%2520virus-induced%2520tumors%26jtitle%3DCell%26date%3D1989%26volume%3D56%26spage%3D673%26epage%3D682%26doi%3D10.1016%2F0092-8674%2889%2990589-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narberes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drueckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aycinena, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span> <span> </span><span class="NLM_article-title">Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1834</span>– <span class="NLM_lpage">1845</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-13-2062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1158%2F1078-0432.CCR-13-2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=24474669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1834-1845&author=P.+D.+Garciaauthor=J.+L.+Langowskiauthor=Y.+Wangauthor=M.+Chenauthor=J.+Castilloauthor=C.+Fantonauthor=M.+Isonauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Luauthor=X.-H.+Niuauthor=S.+Bashamauthor=J.+Chanauthor=J.+Yuauthor=M.+Doyleauthor=P.+Feuchtauthor=R.+Warneauthor=J.+Narberesauthor=T.+Tsangauthor=C.+Fritschauthor=A.+Kauffmannauthor=E.+Pfisterauthor=P.+Drueckesauthor=J.+Trappeauthor=C.+Wilsonauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=M.+Lindvallauthor=C.+Bellamacinaauthor=J.+A.+Aycinenaauthor=R.+Zangauthor=J.+Holashauthor=M.+T.+Burger&title=Pan-PIM+Kinase+Inhibition+Provides+a+Novel+Therapy+for+Treating+Hematologic+Cancers&doi=10.1158%2F1078-0432.ccr-13-2062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers</span></div><div class="casAuthors">Garcia, Pablo D.; Langowski, John L.; Wang, Yingyun; Chen, Min; Castillo, Joseph; Fanton, Christie; Ison, Marjorie; Zavorotinskaya, Tatiana; Dai, Yumin; Lu, Jing; Niu, Xiao-Hong; Basham, Stephen; Chan, Julie; Yu, Jianjun; Doyle, Michael; Feucht, Paul; Warne, Robert; Narberes, Jamie; Tsang, Tiffany; Fritsch, Christine; Kauffmann, Audrey; Pfister, Estelle; Drueckes, Peter; Trappe, Joerg; Wilson, Christopher; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Lindvall, Mika; Bellamacina, Cornelia; Aycinena, J. Alex; Zang, Richard; Holash, Jocelyn; Burger, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PIM kinases have been shown to act as oncogenes in mice, with each family member being able to drive progression of hematol. cancers.  Consistent with this, we found that PIMs are highly expressed in human hematol. cancers and show that each isoform has a distinct expression pattern among disease subtypes.  This suggests that inhibitors of all three PIMs would be effective in treating multiple hematol. malignancies.  Pan-PIM inhibitors have proven difficult to develop because PIM2 has a low Km for ATP and, thus, requires a very potent inhibitor to effectively block the kinase activity at the ATP levels in cells.  We developed a potent and specific pan-PIM inhibitor, LGB321, which is active on PIM2 in the cellular context.  LGB321 is active on PIM2-dependent multiple myeloma cell lines, where it inhibits proliferation, mTOR-C1 signaling and phosphorylation of BAD.  Broad cancer cell line profiling of LGB321 demonstrates limited activity in cell lines derived from solid tumors.  In contrast, significant activity in cell lines derived from diverse hematol. lineages was obsd., including acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), multiple myeloma and non-Hodgkin lymphoma (NHL).  Furthermore, we demonstrate LGB321 activity in the KG-1 AML xenograft model, in which modulation of pharmacodynamics markers is predictive of efficacy.  Finally, we demonstrate that LGB321 synergizes with cytarabine in this model.  We have developed a potent and selective pan-PIM inhibitor with single-agent antiproliferative activity and show that it synergizes with cytarabine in an AML xenograft model.  Our results strongly support the development of Pan-PIM inhibitors to treat hematol. malignancies.  Clin Cancer Res; 20(7); 1834-45. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriy2nkB_psKbVg90H21EOLACvtfcHk0ljX1g3D_z5-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D&md5=c563df328e7af3ebf10c31b1a26faae4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2062%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DFanton%26aufirst%3DC.%26aulast%3DIson%26aufirst%3DM.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DX.-H.%26aulast%3DBasham%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DWarne%26aufirst%3DR.%26aulast%3DNarberes%26aufirst%3DJ.%26aulast%3DTsang%26aufirst%3DT.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DKauffmann%26aufirst%3DA.%26aulast%3DPfister%26aufirst%3DE.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DAycinena%26aufirst%3DJ.%2BA.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26atitle%3DPan-PIM%2520Kinase%2520Inhibition%2520Provides%2520a%2520Novel%2520Therapy%2520for%2520Treating%2520Hematologic%2520Cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D1834%26epage%3D1845%26doi%3D10.1158%2F1078-0432.ccr-13-2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilly, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, A. S.</span></span> <span> </span><span class="NLM_article-title">Pim family kinases enhance tumor growth of prostate cancer cells</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.mcr-05-0007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1158%2F1541-7786.MCR-05-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=16123140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovV2hs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=443-451&author=W.+W.+Chenauthor=D.+C.+Chanauthor=C.+Donaldauthor=M.+B.+Lillyauthor=A.+S.+Kraft&title=Pim+family+kinases+enhance+tumor+growth+of+prostate+cancer+cells&doi=10.1158%2F1541-7786.mcr-05-0007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pim family kinases enhance tumor growth of prostate cancer cells</span></div><div class="casAuthors">Chen, Wei Wei; Chan, Daniel C.; Donald, Carlton; Lilly, Michael B.; Kraft, Andrew S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent analyses indicate that the expression of the Pim-1 protein kinase is elevated in biopsies of prostate tumors.  To identify the mechanism by which the Pim kinases may affect the growth of prostate tumors, we expressed Pim-1, Pim-2, or a kinase-dead Pim-2 protein in human PC3 prostate cancer cells.  On implantation of the transfectants in nude mice, the growth of the cells expressing Pim-1 or Pim-2 was significantly faster than the growth of the control cells transfected with the neomycin-resistant gene or the kinase-dead Pim-2 protein.  When grown in medium, the doubling time of the Pim-1 and Pim-2 transfectants was faster (0.75 days) than that of the control cells (1.28 days).  We, therefore, examd. the ability of Pim to control the phosphorylation of proteins that regulate protein synthesis.  On growth factor starvation or rapamycin treatment, the Pim-1 and Pim-2 transfectants maintained their ability to phosphorylate 4E-BP1 and S6 kinase, although this phosphorylation did not occur in the control-transfected PC3 cells.  We have found that the cellular levels of c-Myc were elevated in the Pim-1 and Pim-2 transfectants under these conditions.  The Pim-1 and Pim-2 transfectants have lower levels of serine/threonine protein phosphatase 2A (PP2A) activity and the α- and {szligbeta}-subunit B56γ of the PP2A phosphatase do not co-immunoppt. in these cells.  Thus, the effects of Pim on PP2A activity may mediate the levels of c-Myc and the phosphorylation of proteins needed for increased protein synthesis.  Both of these changes could have a significant impact on tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobfSNRNUELt7Vg90H21EOLACvtfcHk0ljX1g3D_z5-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovV2hs74%253D&md5=ef6dd2160e6acdfd03c39846e73187a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-05-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-05-0007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BW.%26aulast%3DChan%26aufirst%3DD.%2BC.%26aulast%3DDonald%26aufirst%3DC.%26aulast%3DLilly%26aufirst%3DM.%2BB.%26aulast%3DKraft%26aufirst%3DA.%2BS.%26atitle%3DPim%2520family%2520kinases%2520enhance%2520tumor%2520growth%2520of%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2005%26volume%3D3%26spage%3D443%26epage%3D451%26doi%3D10.1158%2F1541-7786.mcr-05-0007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuneyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popivanova, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span> <span> </span><span class="NLM_article-title">Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1002/ijc.20719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2Fijc.20719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=15540201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2005&pages=209-218&author=C.+Fujiiauthor=Y.+Nakamotoauthor=P.+Luauthor=K.+Tsuneyamaauthor=B.+K.+Popivanovaauthor=S.+Kanekoauthor=N.+Mukaida&title=Aberrant+expression+of+serine%2Fthreonine+kinase+Pim-3+in+hepatocellular+carcinoma+development+and+its+role+in+the+proliferation+of+human+hepatoma+cell+lines&doi=10.1002%2Fijc.20719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines</span></div><div class="casAuthors">Fujii, Chifumi; Nakamoto, Yasunari; Lu, Peirong; Tsuneyama, Koichi; Popivanova, Boryana K.; Kaneko, Shuichi; Mukaida, Naofumi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-218</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Most cases of human hepatocellular carcinoma develop after persistent chronic infection with human hepatitis B virus or hepatitis C virus, and host responses are presumed to have major roles in this process.  To recapitulate this process, we have developed the mouse model of hepatocellular carcinoma using hepatitis B virus surface antigen transgenic mice.  To identify the genes assocd. with hepatocarcinogenesis in this model, we compared the gene expression patterns between pre-malignant lesions surrounded by hepatocellular carcinoma tissues and control liver tissues by using a fluorescent differential display anal.  Among the genes that were expressed differentially in the pre-malignant lesions, we focused on Pim-3, a member of a proto-oncogene Pim family, because its contribution to hepatocarcinogenesis remains unknown.  Moreover, the unavailability of the nucleotide sequence of full-length human Pim-3 cDNA prompted us to clone it from the cDNA library constructed from a human hepatoma cell line, HepG2.  The obtained 2,392 bp human Pim-3 cDNA encodes a predicted open reading frame consisting of 326 amino acids.  Pim-3 mRNA was selectively expressed in human hepatoma cell lines, but not in normal liver tissues.  Moreover, Pim-3 protein was detected in human hepatocellular carcinoma tissues and cell lines but not in normal hepatocytes.  Furthermore, cell proliferation was attenuated and apoptosis was enhanced in human hepatoma cell lines by the ablation of Pim-3 gene with RNA interference.  These observations suggest that aberrantly expressed Pim-3 can cause autonomous cell proliferation or prevent apoptosis in hepatoma cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9fX9aasOqx7Vg90H21EOLACvtfcHk0ljX1g3D_z5-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOlu7o%253D&md5=10cd20b8b712101ec80874e2c5d64991</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fijc.20719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20719%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DC.%26aulast%3DNakamoto%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DTsuneyama%26aufirst%3DK.%26aulast%3DPopivanova%26aufirst%3DB.%2BK.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DMukaida%26aufirst%3DN.%26atitle%3DAberrant%2520expression%2520of%2520serine%252Fthreonine%2520kinase%2520Pim-3%2520in%2520hepatocellular%2520carcinoma%2520development%2520and%2520its%2520role%2520in%2520the%2520proliferation%2520of%2520human%2520hepatoma%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D114%26spage%3D209%26epage%3D218%26doi%3D10.1002%2Fijc.20719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popivanova, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuneyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span> <span> </span><span class="NLM_article-title">Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2007.00390.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1111%2Fj.1349-7006.2007.00390.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=17270021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1amt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2007&pages=321-328&author=B.+K.+Popivanovaauthor=Y.-Y.+Liauthor=H.+Zhengauthor=K.+Omuraauthor=C.+Fujiiauthor=K.+Tsuneyamaauthor=N.+Mukaida&title=Proto-oncogene%2C+Pim-3+with+serine%2Fthreonine+kinase+activity%2C+is+aberrantly+expressed+in+human+colon+cancer+cells+and+can+prevent+Bad-mediated+apoptosis&doi=10.1111%2Fj.1349-7006.2007.00390.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis</span></div><div class="casAuthors">Popivanova, Boryana Konstantinova; Li, Ying-Yi; Zheng, Huachuan; Omura, Kenji; Fujii, Chifumi; Tsuneyama, Koichi; Mukaida, Naofumi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">We previously obsd. that Pim-3 with serine/threonine kinase activity, was aberrantly expressed in malignant lesions of endoderm-derived organs, liver and pancreas.  Because Pim-3 protein was not detected in normal colon mucosal tissues, we evaluated Pim-3 expression in malignant lesions of human colon, another endoderm-derived organ.  Pim-3 was detected immunohistochem. in well-differentiated (43/68 cases) and moderately differentiated (23/41 cases) but not poorly differentiated colon adenocarcinomas (0/5 cases).  Moreover, Pim-3 proteins were detected in adenoma (35/40 cases) and normal mucosa (26/111 cases), which are adjacent to adenocarcinoma.  Pim-3 was constitutively expressed in SW480 cells and the transfection with Pim-3 short hairpin RNA promoted apoptosis.  In the same cell line, a pro-apoptotic mol., Bad, was phosphorylated at Ser112 and Ser136 sites of phosphorylation that are representative of its inactive form.  Ser112 but not Ser136 phosphorylation in this cell line was abrogated by Pim-3 knockdown.  Furthermore, in human colon cancer tissues, Pim-3 co-localized with Bad in all cases (9/9) and with phospho-Ser112Bad in most cases (6/9).  These observations suggest that Pim-3 can inactivate Bad by phosphorylating its Ser112 in human colon cancer cells and thus may prevent apoptosis and promote progression of human colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzT5QEzAmPrVg90H21EOLACvtfcHk0lj29lo3PSETbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1amt7k%253D&md5=084069e60edfbab8469eca77ac29e3bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00390.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00390.x%26sid%3Dliteratum%253Aachs%26aulast%3DPopivanova%26aufirst%3DB.%2BK.%26aulast%3DLi%26aufirst%3DY.-Y.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DFujii%26aufirst%3DC.%26aulast%3DTsuneyama%26aufirst%3DK.%26aulast%3DMukaida%26aufirst%3DN.%26atitle%3DProto-oncogene%252C%2520Pim-3%2520with%2520serine%252Fthreonine%2520kinase%2520activity%252C%2520is%2520aberrantly%2520expressed%2520in%2520human%2520colon%2520cancer%2520cells%2520and%2520can%2520prevent%2520Bad-mediated%2520apoptosis%26jtitle%3DCancer%2520Sci.%26date%3D2007%26volume%3D98%26spage%3D321%26epage%3D328%26doi%3D10.1111%2Fj.1349-7006.2007.00390.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuneyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popivanova, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span> <span> </span><span class="NLM_article-title">Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression</span>. <i>J. Canc. Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1007/s00432-007-0310-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1007%2Fs00432-007-0310-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=17876606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=481-488&author=H.-C.+Zhengauthor=K.+Tsuneyamaauthor=H.+Takahashiauthor=S.+Miwaauthor=T.+Sugiyamaauthor=B.+K.+Popivanovaauthor=C.+Fujiiauthor=K.+Nomotoauthor=N.+Mukaidaauthor=Y.+Takano&title=Aberrant+Pim-3+expression+is+involved+in+gastric+adenoma-adenocarcinoma+sequence+and+cancer+progression&doi=10.1007%2Fs00432-007-0310-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression</span></div><div class="casAuthors">Zheng, Hua-Chuan; Tsuneyama, Koichi; Takahashi, Hiroyuki; Miwa, Shigeharu; Sugiyama, Toshiro; Popivanova, Boryana Konstantinova; Fujii, Chifumi; Nomoto, Kazuhiro; Mukaida, Naofumi; Takano, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-488</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Pim-3, a member of the proto-oncogene Pim family with serine/threonine kinase activity was aberrantly expressed in cancerous lesions of endoderm-derived organs such as liver, pancreas, and colon.  The aim of this study was to clarify the role of Pim-3 expression in the tumorigenesis and the development of gastric carcinomas.  Methods: Pim-3 expression was immunohistochem. examd. on the tissue microarrays contg. primary (n = 285) and metastastic (n = 37) sites of gastric carcinomas, in comparison with adenoma (n = 48) and non-cancerous mucosa (n = 84).  It was also compared with the clinicopathol. parameters of gastric carcinomas.  Results: Pim-3 expression was enhanced in adenoma (64.6%) and metastasis sites of gastric carcinoma (73.0%), to a lesser degree in primary sites of gastric carcinoma (39.3%) when compared to non-cancerous mucosa (13.1%, p < 0.0001).  Pim-3 expression levels were higher in intestinal-type than diffuse-type gastric carcinoma (p = 0.018).  Pim-3 expression was closely correlated with sex (p = 0.047), lymphatic (p = 0.019) and venous invasion (p = 0.014).  Pim-3 expression was correlated significantly with vascular endothelial growth factor (VEGF, p = 0.009) and extracellular matrix metalloproteinase inducer (EMMPRIN, p = 0.032), both of which are presumed to be involved in neovascularization, a crucial step for metastasis.  On the contrary, phosphatase and tensin homol. deleted from human chromosome 10 (Pten) neg. gastric carcinomas exhibited higher Pim-3 expression than Pten pos. ones (p = 0.042).  There was no relationship between Pim-3 expression and MVD in gastric carcinomas (p = 0.715).  Furthermore, patients with Pim-3 pos. gastric cancer, showed a lower cumulative survival rate than those with Pim-3 neg. gastric cancer (p = 0.014) and Pim-3 pos. was also identified as an independent prognostic factor for gastric carcinoma patients (p = 0.006).  Conclusions: Aberrant Pim-3 expression was involved in gastric adenoma-adenocarcinoma sequence and subsequent invasion and metastasis process in gastric cancer.  Moreover, Pim-3 may be employed to predict the prognosis of gastric cancer patients.  Distinct Pim-3 expression underlies the mol. mechanisms for the differentiation of intestinal-type and diffuse-type carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGralDipIbQUObVg90H21EOLACvtfcHk0lj29lo3PSETbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFCrtLc%253D&md5=187cce413ddaa8bf5e7803bff71b56a6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00432-007-0310-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-007-0310-1%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.-C.%26aulast%3DTsuneyama%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DMiwa%26aufirst%3DS.%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DPopivanova%26aufirst%3DB.%2BK.%26aulast%3DFujii%26aufirst%3DC.%26aulast%3DNomoto%26aufirst%3DK.%26aulast%3DMukaida%26aufirst%3DN.%26aulast%3DTakano%26aufirst%3DY.%26atitle%3DAberrant%2520Pim-3%2520expression%2520is%2520involved%2520in%2520gastric%2520adenoma-adenocarcinoma%2520sequence%2520and%2520cancer%2520progression%26jtitle%3DJ.%2520Canc.%2520Res.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D134%26spage%3D481%26epage%3D488%26doi%3D10.1007%2Fs00432-007-0310-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Aparicio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span> <span> </span><span class="NLM_article-title">Pim kinases in cancer: diagnostic, prognostic and treatment opportunities</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bcp.2012.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=23041228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=629-643&author=C.+Blanco-Aparicioauthor=A.+Carnero&title=Pim+kinases+in+cancer%3A+diagnostic%2C+prognostic+and+treatment+opportunities&doi=10.1016%2Fj.bcp.2012.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities</span></div><div class="casAuthors">Blanco-Aparicio, Carmen; Carnero, Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">629-643</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  PIM proteins belong to a family of ser/thr kinases composed of 3 members, PIM1, PIM2 and PIM3, with greatly overlapping functions.  PIM kinases are mainly responsible for cell cycle regulation, antiapoptotic activity and the homing and migration of receptor tyrosine kinases mediated via the JAK/STAT pathway.  PIM kinases have been found to be upregulated in many hematol. malignancies and solid tumors.  Although these kinases have been described as weak oncogenes, they are heavily targeted for anticancer drug discovery.  The present review summarizes the discoveries made to date regarding PIM kinases as driving oncogenes in the process of tumorigenesis and their validation as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbg06YAgnArVg90H21EOLACvtfcHk0lj29lo3PSETbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK&md5=63957a55b281d4bbc8c4843249d30273</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DPim%2520kinases%2520in%2520cancer%253A%2520diagnostic%252C%2520prognostic%2520and%2520treatment%2520opportunities%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D629%26epage%3D643%26doi%3D10.1016%2Fj.bcp.2012.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span> <span> </span><span class="NLM_article-title">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1620</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-01-481457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1182%2Fblood-2013-01-481457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=23818547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1610-1620&author=J.+Luauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=X.-H.+Niuauthor=J.+Castilloauthor=J.+Simauthor=J.+Yuauthor=Y.+Wangauthor=J.+L.+Langowskiauthor=J.+Holashauthor=K.+Shannonauthor=P.+D.+Garcia&title=Pim2+is+required+for+maintaining+multiple+myeloma+cell+growth+through+modulating+TSC2+phosphorylation&doi=10.1182%2Fblood-2013-01-481457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span></div><div class="casAuthors">Lu, Jing; Zavorotinskaya, Tatiana; Dai, Yumin; Niu, Xiao-Hong; Castillo, Joseph; Sim, Janet; Yu, Jianjun; Wang, Yingyun; Langowski, John L.; Holash, Jocelyn; Shannon, Kevin; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1610-1620</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is the second most common hematol. malignancy.  Despite recent treatment advances, it remains incurable.  Here, we report that Pim2 kinase expression is highly elevated in MM cells and demonstrate that it is required for MM cell proliferation.  Functional interference of Pim2 activity either by short hairpin RNAs or by a potent and selective small-mol. inhibitor leads to significant inhibition of MM cell proliferation.  Pim inhibition results in a significant decrease of mammalian target of rapamycin C1 (mTOR-C1) activity, which is crit. for cell proliferation.  We identify TSC2, a neg. regulator of mTOR-C1, as a novel Pim2 substrate and show that Pim2 directly phosphorylates TSC2 on Ser-1798 and relieves the suppression of TSC2 on mTOR-C1.  These findings support Pim2 as a promising therapeutic target for MM and define a novel Pim2-TSC2-mTOR-C1 pathway that drives MM proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPXlAZPVNnObVg90H21EOLACvtfcHk0lgMVF6vZp2mXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ&md5=027403b9b40e4fc57836c398545e71e1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-01-481457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-01-481457%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DX.-H.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DPim2%2520is%2520required%2520for%2520maintaining%2520multiple%2520myeloma%2520cell%2520growth%2520through%2520modulating%2520TSC2%2520phosphorylation%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1610%26epage%3D1620%26doi%3D10.1182%2Fblood-2013-01-481457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcbride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beans, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span> <span> </span><span class="NLM_article-title">Structure guided optimization, in vitro activity, and in vivo activity of pan-PIM kinase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.1021/ml400307j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400307j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1193-1197&author=M.+T.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=M.+Lindvalauthor=G.+Atallahauthor=Y.+Dingauthor=M.+Mathurauthor=C.+Mcbrideauthor=E.+L.+Beansauthor=K.+Mullerauthor=V.+Tamezauthor=Y.+Zhangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Holashauthor=J.+Castilloauthor=J.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=P.+D.+Garcia&title=Structure+guided+optimization%2C+in+vitro+activity%2C+and+in+vivo+activity+of+pan-PIM+kinase+inhibitors&doi=10.1021%2Fml400307j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors</span></div><div class="casAuthors">Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Bellamacina, Cornelia; Lindval, Mika; Atallah, Gordana; Ding, Yu; Mathur, Michelle; McBride, Chris; Beans, Elizabeth L.; Muller, Kristine; Tamez, Victoriano; Zhang, Yanchen; Huh, Kay; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Holash, Jocelyn; Castillo, Joseph; Langowski, John; Wang, Yingyun; Chen, Min Y.; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1193-1197</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proviral insertion of Moloney virus (PIM) 1, 2, and 3 kinases are serine/threonine kinases that normally function in survival and proliferation of hematopoietic cells.  As high expression of PIM1, 2, and 3 is frequently obsd. in many human malignancies, including multiple myeloma, non-Hodgkins lymphoma, and myeloid leukemias, there is interest in detg. whether selective PIM inhibition can improve outcomes of these human cancers.  Herein, we describe our efforts toward this goal.  The structure guided optimization of a singleton high throughput screening hit in which the potency against all three PIM isoforms was increased >10,000-fold to yield compds. (e.g., I) with pan PIM Kis < 10 pM, nanomolar cellular potency, and in vivo activity in an acute myeloid leukemia Pim-dependent tumor model is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw9BIpeJhw1rVg90H21EOLACvtfcHk0lhagNgEF8sELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK&md5=f4644a2ad9bcd35c952676e492eb3b71</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fml400307j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400307j%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindval%26aufirst%3DM.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMcbride%26aufirst%3DC.%26aulast%3DBeans%26aufirst%3DE.%2BL.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520guided%2520optimization%252C%2520in%2520vitro%2520activity%252C%2520and%2520in%2520vivo%2520activity%2520of%2520pan-PIM%2520kinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fml400307j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klivansky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6366</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases&doi=10.1016%2Fj.bmcl.2011.08.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0lhagNgEF8sELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369%26doi%3D10.1016%2Fj.bmcl.2011.08.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent and selective PIM kinase inhibitors by targeting unique structure of ATP-binding pocket</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00518</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=504-509&author=H.+Nakanoauthor=T.+Hasegawaauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Nagano&title=Design+and+synthesis+of+potent+and+selective+PIM+kinase+inhibitors+by+targeting+unique+structure+of+ATP-binding+pocket&doi=10.1021%2Facsmedchemlett.6b00518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket</span></div><div class="casAuthors">Nakano, Hirofumi; Hasegawa, Tsukasa; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the development of kinase inhibitors, one of the major concerns is selectivity.  An effective strategy to achieve high selectivity is to utilize structural differences among kinases to inform inhibitor design.  Here, we set out to improve the PIM (proviral integration site for Moloney murine leukemia virus) kinase-inhibitory selectivity of our previously reported 7-azaindole deriv. 2, which has promising ADMET properties, by targeting a unique bulge in the ATP-binding pocket. 6-Substituted 7-azaindoles, esp. the 6-chlorinated derivs., proved to be potent and selective PIM kinase inhibitors and appear to be promising lead compds. for future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBu3SXcZr8bVg90H21EOLACvtfcHk0lhagNgEF8sELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D&md5=b4393c5c6f77ddfa140ebf669b552e44</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00518%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520PIM%2520kinase%2520inhibitors%2520by%2520targeting%2520unique%2520structure%2520of%2520ATP-binding%2520pocket%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D504%26epage%3D509%26doi%3D10.1021%2Facsmedchemlett.6b00518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenning, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kultgen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foulks, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merx, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCullar, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanner, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, K.-K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of pyrazolo[1,5-a]pyrimidine compounds as potent and selective Pim-1 inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1021/ml500300c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500300c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyltrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=63-67&author=Y.+Xuauthor=B.+G.+Brenningauthor=S.+G.+Kultgenauthor=J.+M.+Foulksauthor=A.+Cliffordauthor=S.+Laiauthor=A.+Chanauthor=S.+Merxauthor=M.+V.+McCullarauthor=S.+B.+Kannerauthor=K.-K.+Ho&title=Synthesis+and+biological+evaluation+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+compounds+as+potent+and+selective+Pim-1+inhibitors&doi=10.1021%2Fml500300c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 Inhibitors</span></div><div class="casAuthors">Xu, Yong; Brenning, Benjamin G.; Kultgen, Steven G.; Foulks, Jason M.; Clifford, Adrianne; Lai, Shuping; Chan, Ashley; Merx, Shannon; McCullar, Michael V.; Kanner, Steven B.; Ho, Koc-Kan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-67</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim-1 has emerged as an attractive target for developing therapeutic agents for treating disorders involving abnormal cell growth, esp. cancers.  Herein we present lead optimization, chem. synthesis and biol. evaluation of pyrazolo[1,5-a]pyrimidine compds. as potent and selective inhibitors of Pim-1 starting from a hit from virtual screening.  These pyrazolo[1,5-a]pyrimidine compds. strongly inhibited Pim-1 and Flt-3 kinases.  Selected compds. suppressed both the phosphorylation of BAD protein in a cell-based assay and 2-dimensional colony formation in a clonogenic cell survival assay at submicromolar potency, suggesting that cellular activity was mediated through inhibition of Pim-1.  Moreover, these Pim-1 inhibitors did not show significant hERG inhibition at 30 μM concn.  The lead compd. I proved to be highly selective against a panel of 119 oncogenic kinases, indicating it had an improved safety profile compared with the first generation Pim-1 inhibitor SGI-1776.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPw0i66tQM3bVg90H21EOLACvtfcHk0lhAhXLLk7TK0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyltrjE&md5=131653048268e737c4f8d7b939e726dd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml500300c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500300c%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrenning%26aufirst%3DB.%2BG.%26aulast%3DKultgen%26aufirst%3DS.%2BG.%26aulast%3DFoulks%26aufirst%3DJ.%2BM.%26aulast%3DClifford%26aufirst%3DA.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DMerx%26aufirst%3DS.%26aulast%3DMcCullar%26aufirst%3DM.%2BV.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DHo%26aufirst%3DK.-K.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520compounds%2520as%2520potent%2520and%2520selective%2520Pim-1%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D63%26epage%3D67%26doi%3D10.1021%2Fml500300c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of quinazolinone-pyrrolopyrrolones as potent and orally bioavailable pan-Pim kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6407</span>– <span class="NLM_lpage">6430</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00610</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00610" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2msbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6407-6430&author=L.+H.+Pettusauthor=K.+L.+Andrewsauthor=S.+K.+Bookerauthor=J.+Chenauthor=V.+J.+Ceeauthor=F.+Chavezauthor=Y.+Chenauthor=H.+Eastwoodauthor=N.+Guerreroauthor=B.+Herberichauthor=D.+Hickmanauthor=B.+A.+Lanmanauthor=J.+Laszloauthor=M.+R.+Leeauthor=J.+R.+Lipfordauthor=B.+Mattsonauthor=C.+Mohrauthor=Y.+Nguyenauthor=M.+H.+Normanauthor=D.+Powersauthor=A.+B.+Reedauthor=K.+Rexauthor=C.+Sastriauthor=N.+Tamayoauthor=P.+Wangauthor=J.+T.+Winstonauthor=B.+Wuauthor=T.+Wuauthor=R.+P.+Wurzauthor=Y.+Xuauthor=Y.+Zhouauthor=A.+S.+Taskerauthor=H.-L.+Wang&title=Discovery+and+optimization+of+quinazolinone-pyrrolopyrrolones+as+potent+and+orally+bioavailable+pan-Pim+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.6b00610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors</span></div><div class="casAuthors">Pettus, Liping H.; Andrews, Kristin L.; Booker, Shon K.; Chen, Jie; Cee, Victor J.; Chavez, Frank, Jr.; Chen, Yuping; Eastwood, Heather; Guerrero, Nadia; Herberich, Bradley; Hickman, Dean; Lanman, Brian A.; Laszlo, Jimmy, III; Lee, Matthew R.; Lipford, J. Russell; Mattson, Bethany; Mohr, Christopher; Nguyen, Yen; Norman, Mark H.; Powers, David; Reed, Anthony B.; Rex, Karen; Sastri, Christine; Tamayo, Nuria; Wang, Paul; Winston, Jeffrey T.; Wu, Bin; Wu, Tian; Wurz, Ryan P.; Xu, Yang; Zhou, Yihong; Tasker, Andrew S.; Wang, Hui-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6407-6430</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The high expression of proviral insertion site of Moloney murine leukemia virus kinases (Pim-1, -2, and -3) in cancers, particularly the hematopoietic malignancies, is believed to play a role in promoting cell survival and proliferation while suppressing apoptosis.  The three isoforms of Pim protein appear largely redundant in their oncogenic functions.  Thus, a pan-Pim kinase inhibitor is highly desirable.  However, cell active pan-Pim inhibitors have proven difficult to develop because Pim-2 has a low Km for ATP and therefore requires a very potent inhibitor to effectively block the kinase activity at cellular ATP concns.  Herein, the authors report a series of quinazolinone-pyrrolopyrrolones as potent and selective pan-Pim inhibitors.  In particular, compd. (R)-2-(tert-butylamino)-3-methyl-8-(6-methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)quinazolin-4(3H)-one (17) is orally efficacious in a mouse xenograft model (KMS-12 BM) of multiple myeloma, with 93% tumor growth inhibition at 50 mg/kg QD upon oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2s5EkmHtIBbVg90H21EOLACvtfcHk0lhAhXLLk7TK0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2msbc%253D&md5=0ac3b462493e0abee1a774aa7854c87d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00610%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEastwood%26aufirst%3DH.%26aulast%3DGuerrero%26aufirst%3DN.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DLaszlo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSastri%26aufirst%3DC.%26aulast%3DTamayo%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWinston%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DH.-L.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520quinazolinone-pyrrolopyrrolones%2520as%2520potent%2520and%2520orally%2520bioavailable%2520pan-Pim%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6407%26epage%3D6430%26doi%3D10.1021%2Facs.jmedchem.6b00610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, F.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastri, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00403</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00403" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVSjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=408-412&author=V.+J.+Ceeauthor=F.+Chavezauthor=B.+Herberichauthor=B.+A.+Lanmanauthor=L.+H.+Pettusauthor=A.+B.+Reedauthor=B.+Wuauthor=R.+P.+Wurzauthor=K.+L.+Andrewsauthor=J.+Chenauthor=D.+Hickmanauthor=J.+Laszloauthor=M.+R.+Leeauthor=N.+Guerreroauthor=B.+K.+Mattsonauthor=Y.+Nguyenauthor=C.+Mohrauthor=K.+Rexauthor=C.+E.+Sastriauthor=P.+Wangauthor=Q.+Wuauthor=T.+Wuauthor=Y.+Xuauthor=Y.+Zhouauthor=J.+T.+Winstonauthor=J.+R.+Lipfordauthor=A.+S.+Taskerauthor=H.-L.+Wang&title=Discovery+and+Optimization+of+Macrocyclic+Quinoxaline-pyrrolo-dihydropiperidinones+as+Potent+Pim-1%2F2+Kinase+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors</span></div><div class="casAuthors">Cee, Victor J.; Chavez, Frank, Jr.; Herberich, Bradley; Lanman, Brian A.; Pettus, Liping H.; Reed, Anthony B.; Wu, Bin; Wurz, Ryan P.; Andrews, Kristin L.; Chen, Jie; Hickman, Dean; Laszlo, Jimmy, III; Lee, Matthew R.; Guerrero, Nadia; Mattson, Bethany K.; Nguyen, Yen; Mohr, Christopher; Rex, Karen; Sastri, Christine E.; Wang, Paul; Wu, Qiong; Wu, Tian; Xu, Yang; Zhou, Yihong; Winston, Jeffrey T.; Lipford, J. Russell; Tasker, Andrew S.; Wang, Hui-Ling</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">408-412</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of Pim-1/2 kinase overexpression in B-cell malignancies suggests that Pim kinase inhibitors will have utility in the treatment of lymphoma, leukemia, and multiple myeloma.  Starting from a moderately potent quinoxaline-dihydropyrrolopiperidinone lead, the authors recognized the potential for macrocyclization and developed a series of 13-membered macrocycles.  The structure-activity relationships of the macrocyclic linker were systematically explored, leading to the identification of I as a potent, subnanomolar inhibitor of Pim-1 and -2.  This mol. also potently inhibited Pim kinase activity in I, a multiple myeloma cell line with relatively high endogenous levels of Pim-1/2, both in vitro (pBAD IC50 = 25 nM) and in vivo (pBAD EC50 = 30 nM, unbound), and a 100 mg/kg daily dose was found to completely arrest the growth of I xenografts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqakxW_TAberrVg90H21EOLACvtfcHk0lgltIX3nqbRFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVSjsrk%253D&md5=cd64db700aa01012b74e33ba2cbaf501</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00403%26sid%3Dliteratum%253Aachs%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DLaszlo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DGuerrero%26aufirst%3DN.%26aulast%3DMattson%26aufirst%3DB.%2BK.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSastri%26aufirst%3DC.%2BE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWinston%26aufirst%3DJ.%2BT.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DH.-L.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Macrocyclic%2520Quinoxaline-pyrrolo-dihydropiperidinones%2520as%2520Potent%2520Pim-1%252F2%2520Kinase%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D408%26epage%3D412%26doi%3D10.1021%2Facsmedchemlett.5b00403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munugalavadla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-azaindazole (GNE-955) as a potent pan-Pim inhibitor with optimized bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4458</span>– <span class="NLM_lpage">4473</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00418</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00418" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslKkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4458-4473&author=X.+Wangauthor=A.+Kolesnikovauthor=S.+Tayauthor=G.+Chanauthor=Q.+Chaoauthor=S.+Doauthor=J.+Drummondauthor=A.+J.+Ebensauthor=N.+Liuauthor=J.+Lyauthor=E.+Harstadauthor=H.+Huauthor=J.+Moffatauthor=V.+Munugalavadlaauthor=J.+Murrayauthor=D.+Slagaauthor=V.+Tsuiauthor=M.+Volgrafauthor=H.+Wallweberauthor=J.+H.+Chang&title=Discovery+of+5-azaindazole+%28GNE-955%29+as+a+potent+pan-Pim+inhibitor+with+optimized+bioavailability&doi=10.1021%2Facs.jmedchem.7b00418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability</span></div><div class="casAuthors">Wang, Xiaojing; Kolesnikov, Aleksandr; Tay, Suzanne; Chan, Grace; Chao, Qi; Do, Steven; Drummond, Jason; Ebens, Allen J.; Liu, Ning; Ly, Justin; Harstad, Eric; Hu, Huiyong; Moffat, John; Munugalavadla, Veerendra; Murray, Jeremy; Slaga, Dionysos; Tsui, Vickie; Volgraf, Matthew; Wallweber, Heidi; Chang, Jae H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4458-4473</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim kinases have been identified as promising therapeutic targets for hematol.-oncol. indications, including multiple myeloma and certain leukemia.  Here, we describe our continued efforts in optimizing a lead series by improving bioavailability while maintaining high inhibitory potency against all three Pim kinase isoforms.  The discovery of extensive intestinal metab. and major metabolites helped refine our design strategy, and we obsd. that optimizing the pharmacokinetic properties first and potency second was a more successful approach than the reverse.  In the resulting work, novel analogs such as 20 (GNE-955) were discovered bearing 5-azaindazole core with noncanonical hydrogen bonding to the hinge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr14R5KRRnTebVg90H21EOLACvtfcHk0lgltIX3nqbRFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslKkt7w%253D&md5=022c9a8b8998c4940a5cd6ad5806fc54</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00418%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DChao%26aufirst%3DQ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEbens%26aufirst%3DA.%2BJ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DSlaga%26aufirst%3DD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26atitle%3DDiscovery%2520of%25205-azaindazole%2520%2528GNE-955%2529%2520as%2520a%2520potent%2520pan-Pim%2520inhibitor%2520with%2520optimized%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4458%26epage%3D4473%26doi%3D10.1021%2Facs.jmedchem.7b00418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, F.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a potent and selective Pim-1/2 kinase inhibitor for hematological malignancies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1523</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnslSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1523-1540&author=H.-L.+Wangauthor=K.+L.+Andrewsauthor=S.+K.+Bookerauthor=J.+Canonauthor=V.+J.+Ceeauthor=F.+Chavezauthor=Y.+Chenauthor=H.+Eastwoodauthor=N.+Guerreroauthor=B.+Herberichauthor=D.+Hickmanauthor=B.+A.+Lanmanauthor=J.+Laszloauthor=M.+R.+Leeauthor=J.+R.+Lipfordauthor=B.+Mattsonauthor=C.+Mohrauthor=Y.+Nguyenauthor=M.+H.+Normanauthor=L.+H.+Pettusauthor=D.+Powersauthor=A.+B.+Reedauthor=K.+Rexauthor=C.+Sastriauthor=N.+Tamayoauthor=P.+Wangauthor=J.+T.+Winstonauthor=B.+Wuauthor=Q.+Wuauthor=T.+Wuauthor=R.+P.+Wurzauthor=Y.+Xuauthor=Y.+Zhouauthor=A.+S.+Tasker&title=Discovery+of+%28R%29-8-%286-Methyl-4-oxo-1%2C4%2C5%2C6-tetrahydropyrrolo%5B3%2C4-b%5Dpyrrol-2-yl%29-3-%281-methylcyclopropyl%29-2-%28%281-methylcyclopropyl%29amino%29quinazolin-4%283H%29-one%2C+a+potent+and+selective+Pim-1%2F2+kinase+inhibitor+for+hematological+malignancies&doi=10.1021%2Facs.jmedchem.8b01733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (R)-8-(6-methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a potent and selective Pim-1/2 kinase inhibitor for hematological malignancies</span></div><div class="casAuthors">Wang, Hui-Ling; Andrews, Kristin L.; Booker, Shon K.; Canon, Jude; Cee, Victor J.; Chavez, Frank, Jr.; Chen, Yuping; Eastwood, Heather; Guerrero, Nadia; Herberich, Brad; Hickman, Dean; Lanman, Brian A.; Laszlo, Jimmy, III; Lee, Matthew R.; Lipford, J. Russell; Mattson, Bethany; Mohr, Christopher; Nguyen, Yen; Norman, Mark H.; Pettus, Liping H.; Powers, David; Reed, Anthony B.; Rex, Karen; Sastri, Christine; Tamayo, Nuria; Wang, Paul; Winston, Jeffrey T.; Wu, Bin; Wu, Qiong; Wu, Tian; Wurz, Ryan P.; Xu, Yang; Zhou, Yihong; Tasker, Andrew S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1523-1540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim kinases are a family of constitutively active serine/threonine kinases that are partially redundant and regulate multiple pathways important for cell growth and survival.  In human disease, high expression of the three Pim isoforms has been implicated in the progression of hematopoietic and solid tumor cancers, which suggests that Pim kinase inhibitors could provide patients with therapeutic benefit.  Herein, we describe the structure-guided optimization of a series of quinazolinone-pyrrolodihydropyrrolone analogs leading to the identification of potent pan-Pim inhibitor I with improved potency, soly., and drug-like properties.  I demonstrated on-target Pim activity in an in vivo pharmacodynamic assay with significant inhibition of BAD phosphorylation in KMS-12-BM multiple myeloma tumors for 16 h postdose.  In a 2-wk mouse xenograft model, daily dosing of I resulted in 33% tumor regression at 100 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz60Rl1mRubrVg90H21EOLACvtfcHk0lgltIX3nqbRFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnslSksw%253D%253D&md5=a7d7dbe1f106b6f5cf8c81bb5660cb3f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01733%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEastwood%26aufirst%3DH.%26aulast%3DGuerrero%26aufirst%3DN.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DLaszlo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSastri%26aufirst%3DC.%26aulast%3DTamayo%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWinston%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520of%2520%2528R%2529-8-%25286-Methyl-4-oxo-1%252C4%252C5%252C6-tetrahydropyrrolo%255B3%252C4-b%255Dpyrrol-2-yl%2529-3-%25281-methylcyclopropyl%2529-2-%2528%25281-methylcyclopropyl%2529amino%2529quinazolin-4%25283H%2529-one%252C%2520a%2520potent%2520and%2520selective%2520Pim-1%252F2%2520kinase%2520inhibitor%2520for%2520hematological%2520malignancies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1523%26epage%3D1540%26doi%3D10.1021%2Facs.jmedchem.8b01733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackaby, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diène, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munugalavadla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noland, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rosario, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebens, A. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of pan-Pim kinase activity and oral bioavailability leading to diaminopyrazole (GDC-0339) for the treatment of multiple myeloma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2153</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2140-2153&author=X.+Wangauthor=W.+Blackabyauthor=V.+Allenauthor=G.+K.+Y.+Chanauthor=J.+H.+Changauthor=P.-C.+Chiangauthor=C.+Di%C3%A8neauthor=J.+Drummondauthor=S.+Doauthor=E.+Fanauthor=E.+B.+Harstadauthor=A.+Hodgesauthor=H.+Huauthor=W.+Jiaauthor=W.+Kofieauthor=A.+Kolesnikovauthor=J.+P.+Lyssikatosauthor=J.+Lyauthor=M.+Matteucciauthor=J.+G.+Moffatauthor=V.+Munugalavadlaauthor=J.+Murrayauthor=D.+Nashauthor=C.+L.+Nolandauthor=G.+Del+Rosarioauthor=L.+Rossauthor=C.+Rouseauthor=A.+Sharpeauthor=D.+Slagaauthor=M.+Sunauthor=V.+Tsuiauthor=H.+Wallweberauthor=S.-F.+Yuauthor=A.+J.+Ebens&title=Optimization+of+pan-Pim+kinase+activity+and+oral+bioavailability+leading+to+diaminopyrazole+%28GDC-0339%29+for+the+treatment+of+multiple+myeloma&doi=10.1021%2Facs.jmedchem.8b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma</span></div><div class="casAuthors">Wang, Xiaojing; Blackaby, Wesley; Allen, Vivienne; Chan, Grace Ka Yan; Chang, Jae H.; Chiang, Po-Chang; Diene, Coura; Drummond, Jason; Do, Steven; Fan, Eric; Harstad, Eric B.; Hodges, Alastair; Hu, Huiyong; Jia, Wei; Kofie, William; Kolesnikov, Aleksandr; Lyssikatos, Joseph P.; Ly, Justin; Matteucci, Mizio; Moffat, John G.; Munugalavadla, Veerendra; Murray, Jeremy; Nash, David; Noland, Cameron L.; Del Rosario, Geoff; Ross, Leanne; Rouse, Craig; Sharpe, Andrew; Slaga, Dionysos; Sun, Minghua; Tsui, Vickie; Wallweber, Heidi; Yu, Shang-Fan; Ebens, Allen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2140-2153</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pim kinases have been targets of interest for a no. of therapeutic areas.  Evidence of durable single-agent efficacy in human clin. trials validated Pim kinase inhibition as a promising therapeutic approach for multiple myeloma patients.  Here, we report the compd. optimization leading to GDC-0339 (16), a potent, orally bioavailable, and well tolerated pan-Pim kinase inhibitor that proved efficacious in RPMI8226 and MM.1S human multiple myeloma xenograft mouse models and has been evaluated as an early development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC9O3J5HZfvrVg90H21EOLACvtfcHk0ljOAGpDAC-i7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSqt78%253D&md5=bf8f5e5ac1f4cc29d1b62dcd72e7a815</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01857%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBlackaby%26aufirst%3DW.%26aulast%3DAllen%26aufirst%3DV.%26aulast%3DChan%26aufirst%3DG.%2BK.%2BY.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DChiang%26aufirst%3DP.-C.%26aulast%3DDi%25C3%25A8ne%26aufirst%3DC.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DHarstad%26aufirst%3DE.%2BB.%26aulast%3DHodges%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DKofie%26aufirst%3DW.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DMatteucci%26aufirst%3DM.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DNoland%26aufirst%3DC.%2BL.%26aulast%3DDel%2BRosario%26aufirst%3DG.%26aulast%3DRoss%26aufirst%3DL.%26aulast%3DRouse%26aufirst%3DC.%26aulast%3DSharpe%26aufirst%3DA.%26aulast%3DSlaga%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWallweber%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DEbens%26aufirst%3DA.%2BJ.%26atitle%3DOptimization%2520of%2520pan-Pim%2520kinase%2520activity%2520and%2520oral%2520bioavailability%2520leading%2520to%2520diaminopyrazole%2520%2528GDC-0339%2529%2520for%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2140%26epage%3D2153%26doi%3D10.1021%2Facs.jmedchem.8b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2332</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2016.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=26995528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2328-2332&author=G.+A.+Nishiguchiauthor=M.+T.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Atallahauthor=V.+Tamezauthor=M.+Lindvallauthor=C.+Bellamacinaauthor=P.+Garciaauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=K.+Wong&title=Design%2C+synthesis+and+structure+activity+relationship+of+potent+pan-PIM+kinase+inhibitors+derived+from+the+pyridyl+carboxamide+scaffold&doi=10.1016%2Fj.bmcl.2016.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Atallah, Gordana; Tamez, Victoriano; Lindvall, Mika; Bellamacina, Cornelia; Garcia, Pablo; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Wong, Kent</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2328-2332</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Pim proteins (1, 2 and 3) are serine/threonine kinases that have been found to be upregulated in many hematol. malignancies and solid tumors.  As a result of overlapping functions among the three isoforms, inhibition of all three Pim kinases has become an attractive strategy for cancer therapy.  Herein the authors describe the efforts in identifying potent pan-PIM inhibitors that are derived from the previously reported pyridyl carboxamide scaffold as part of a medicinal chem. strategy to address metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDLGPtdFN-P7Vg90H21EOLACvtfcHk0ljOAGpDAC-i7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGhs7k%253D&md5=194e13ceee212e2c37d4517a4b768f5b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DP.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure%2520activity%2520relationship%2520of%2520potent%2520pan-PIM%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520pyridyl%2520carboxamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2328%26epage%3D2332%26doi%3D10.1016%2Fj.bmcl.2016.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atallah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feucht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aycinena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langowski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, P. D.</span></span> <span> </span><span class="NLM_article-title">Identification ofN-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8373</span>– <span class="NLM_lpage">8386</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01275</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOrt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8373-8386&author=M.+T.+Burgerauthor=G.+Nishiguchiauthor=W.+Hanauthor=J.+Lanauthor=R.+Simmonsauthor=G.+Atallahauthor=Y.+Dingauthor=V.+Tamezauthor=Y.+Zhangauthor=M.+Mathurauthor=K.+Mullerauthor=C.+Bellamacinaauthor=M.+K.+Lindvallauthor=R.+Zangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=S.+Bashamauthor=J.+Chanauthor=E.+Ginnauthor=A.+Aycinenaauthor=J.+Holashauthor=J.+Castilloauthor=J.+L.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=A.+Lambertauthor=C.+Fritschauthor=A.+Kauffmannauthor=E.+Pfisterauthor=K.+G.+Vanasseauthor=P.+D.+Garcia&title=Identification+ofN-%284-%28%281R%2C3S%2C5S%29-3-Amino-5-methylcyclohexyl%29pyridin-3-yl%29-6-%282%2C6-difluorophenyl%29-5-fluoropicolinamide+%28PIM447%29%2C+a+Potent+and+Selective+Proviral+Insertion+Site+of+Moloney+Murine+Leukemia+%28PIM%29+1%2C+2%2C+and+3+Kinase+Inhibitor+in+Clinical+Trials+for+Hematological+Malignancies&doi=10.1021%2Facs.jmedchem.5b01275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies</span></div><div class="casAuthors">Burger, Matthew T.; Nishiguchi, Gisele; Han, Wooseok; Lan, Jiong; Simmons, Robert; Atallah, Gordana; Ding, Yu; Tamez, Victoriano; Zhang, Yanchen; Mathur, Michelle; Muller, Kristine; Bellamacina, Cornelia; Lindvall, Mika K.; Zang, Richard; Huh, Kay; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Basham, Steve; Chan, Julie; Ginn, Elaine; Aycinena, Alex; Holash, Jocelyn; Castillo, Joseph; Langowski, John L.; Wang, Yingyun; Chen, Min Y.; Lambert, Amy; Fritsch, Christine; Kauffmann, Audry; Pfister, Estelle; Vanasse, K. Gary; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8373-8386</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit to cancer patients.  Herein, the synthesis, in vitro activity, in vivo activity in an acute myeloid leukemia xenograft model, and preclin. profile of the potent and selective pan PIM kinase inhibitor compd. I (PIM447) are described.  Starting from the reported aminopiperidyl pan PIM kinase inhibitor compd. II, a strategy to improve the microsomal stability was pursued resulting in the identification of potent aminocyclohexyl pan PIM inhibitors with high metabolic stability.  From this aminocyclohexyl series, compd. I entered the clinic in 2012 in multiple myeloma patients and is currently in several phase 1 trials of cancer patients with hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLdBmQSYD34LVg90H21EOLACvtfcHk0lg1kbuGkE3JUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOrt7%252FL&md5=c1d3cb10d1fa7efc66e7d415fa5970b4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01275%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DSimmons%26aufirst%3DR.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%2BK.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DBasham%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DGinn%26aufirst%3DE.%26aulast%3DAycinena%26aufirst%3DA.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DLambert%26aufirst%3DA.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DKauffmann%26aufirst%3DA.%26aulast%3DPfister%26aufirst%3DE.%26aulast%3DVanasse%26aufirst%3DK.%2BG.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DIdentification%2520ofN-%25284-%2528%25281R%252C3S%252C5S%2529-3-Amino-5-methylcyclohexyl%2529pyridin-3-yl%2529-6-%25282%252C6-difluorophenyl%2529-5-fluoropicolinamide%2520%2528PIM447%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Proviral%2520Insertion%2520Site%2520of%2520Moloney%2520Murine%2520Leukemia%2520%2528PIM%2529%25201%252C%25202%252C%2520and%25203%2520Kinase%2520Inhibitor%2520in%2520Clinical%2520Trials%2520for%2520Hematological%2520Malignancies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8373%26epage%3D8386%26doi%3D10.1021%2Facs.jmedchem.5b01275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raab, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocio, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S. K.</span></span> <span> </span><span class="NLM_article-title">The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2924</span>– <span class="NLM_lpage">2933</span>, <span class="refDoi"> DOI: 10.1038/s41375-019-0482-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1038%2Fs41375-019-0482-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=31092894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyqs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=2924-2933&author=M.+S.+Raabauthor=S.+K.+Thomasauthor=E.+M.+Ocioauthor=A.+Guentherauthor=Y.-T.+Gohauthor=M.+Talpazauthor=N.+Hohmannauthor=S.+Zhaoauthor=F.+Xiangauthor=C.+Simonauthor=K.+G.+Vanasseauthor=S.+K.+Kumar&title=The+first-in-human+study+of+the+pan-PIM+kinase+inhibitor+PIM447+in+patients+with+relapsed+and%2For+refractory+multiple+myeloma&doi=10.1038%2Fs41375-019-0482-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma</span></div><div class="casAuthors">Raab, Marc S.; Thomas, Sheeba K.; Ocio, Enrique M.; Guenther, Andreas; Goh, Yeow-Tee; Talpaz, Moshe; Hohmann, Nicolas; Zhao, Sylvia; Xiang, Fang; Simon, Carl; Vanasse, K. Gary; Kumar, Shaji K.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2924-2933</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">PIM447, a novel pan-PIM inhibitor, has shown preclin. activity in multiple myeloma (MM).  In the multicenter, open-label, first-in-human study, patients with relapsed and/or refractory MM were enrolled to det. the max.-tolerated dose (MTD) or recommended dose (RD), safety, pharmacokinetics, and preliminary anti-myeloma activity of PIM447.  PIM447 was administered in escalating oral doses of 70-700 mg once daily (q.d.) for 28-day continuous cycles.  Seventy-nine patients with a median of four prior therapies were enrolled.  Seventy-seven patients (97.5%) had an adverse event (AE) suspected as treatment related, with treatment-related grade 3/4 AEs being mostly hematol.  Eleven dose-limiting toxicities occurred, and an MTD of 500 mg q.d. and an RD of 300 mg q.d. were established.  The main reason for discontinuation was disease progression in 54 patients (68.4%).  In the entire study population, a disease control rate of 72.2%, a clin. benefit rate of 25.3%, and an overall response rate of 8.9% were obsd. per modified International Myeloma Working Group criteria.  Median progression-free survival at the RD was 10.9 mo.  PIM447 was well tolerated and demonstrated single-agent antitumor activity in relapsed/refractory MM patients, providing proof of principle for Pim (Proviral Insertions of Moloney Murine leukemia virus) kinase inhibition as a novel therapeutic approach in MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSi_XbgqXF4LVg90H21EOLACvtfcHk0lg1kbuGkE3JUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyqs7rK&md5=f7f98f51cd91b51be551b7db8c047d6a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41375-019-0482-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-019-0482-0%26sid%3Dliteratum%253Aachs%26aulast%3DRaab%26aufirst%3DM.%2BS.%26aulast%3DThomas%26aufirst%3DS.%2BK.%26aulast%3DOcio%26aufirst%3DE.%2BM.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DGoh%26aufirst%3DY.-T.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DHohmann%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DC.%26aulast%3DVanasse%26aufirst%3DK.%2BG.%26aulast%3DKumar%26aufirst%3DS.%2BK.%26atitle%3DThe%2520first-in-human%2520study%2520of%2520the%2520pan-PIM%2520kinase%2520inhibitor%2520PIM447%2520in%2520patients%2520with%2520relapsed%2520and%252For%2520refractory%2520multiple%2520myeloma%26jtitle%3DLeukemia%26date%3D2019%26volume%3D33%26spage%3D2924%26epage%3D2933%26doi%3D10.1038%2Fs41375-019-0482-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lgEJYWm1zHKWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Clearance in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2255</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01263</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVCru7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2245-2255&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Clearance+in+drug+design&doi=10.1021%2Facs.jmedchem.8b01263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Clearance in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2245-2255</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates.  Clearance can be classified into three general categories, namely, metabolic transformation, renal excretion, and hepatobiliary excretion.  Within each category, there are a host of biochem. and physiol. mechanisms that ultimately det. the clearance rate.  Physiochem. properties are often indicative of the rate-detg. mechanism, with lipophilic mols. tending toward metab. and hydrophilic, polar mols. tending toward passive or active excretion.  Optimization of clearance requires recognition of the major clearance mechanisms and use of the most relevant in vitro and in vivo tools to develop structure-clearance relationships.  The reliability of methods to detect and predict human clearance varies across mechanisms.  While methods for metabolic and passive renal clearance have proven reasonably robust, there is a clear need for better tools to support the optimization of transporter-mediated clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8nvv_L3pL-LVg90H21EOLACvtfcHk0lgEJYWm1zHKWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVCru7fO&md5=e4a4d72056ed9b41842a11934fa4bffc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01263%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DClearance%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2245%26epage%3D2255%26doi%3D10.1021%2Facs.jmedchem.8b01263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Structure of compound <b>5</b> in PIM1 submitted under PDB accession code 1oblv.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">All animal experiments performed in the manuscript were conducted in compliance with institutional guidelines.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Compound <b>5</b> having no hinge amino group showed a similar selectivity profile towards these kinases: IC<sub>50</sub> for GSK3β was 0.15 μM (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Cell permeability beyond the rule of 5</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.addr.2016.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=27067608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=42-61&author=P.+Matssonauthor=B.+C.+Doakauthor=B.+Overauthor=J.+Kihlberg&title=Cell+permeability+beyond+the+rule+of+5&doi=10.1016%2Fj.addr.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeability beyond the rule of 5</span></div><div class="casAuthors">Matsson, Paer; Doak, Bradley C.; Over, Bjoern; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-61</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Drug discovery for difficult targets that have large and flat binding sites is often better suited to compds. beyond the "rule of 5" (bRo5).  However, such compds. carry higher pharmacokinetic risks, such as low soly. and permeability, and increased efflux and metab.  Interestingly, recent drug approvals and studies suggest that cell permeable and orally bioavailable drugs can be discovered far into bRo5 space.  Tactics such as redn. or shielding of polarity by N-methylation, bulky side chains and intramol. hydrogen bonds may be used to increase cell permeability in this space, but often results in decreased soly.  Conformationally flexible compds. can, however, combine high permeability and soly., properties that are keys for cell permeability and intestinal absorption.  Recent developments in computational conformational anal. will aid design of such compds. and hence prediction of cell permeability.  Transporter mediated efflux occurs for most investigated drugs in bRo5 space, however it is commonly overcome by high local intestinal concns. on oral administration.  In contrast, there is little data to support significant impact of transporter-mediated intestinal absorption in bRo5 space.  Current knowledge of compd. properties that govern transporter effects of bRo5 drugs is limited and requires further fundamental and comprehensive studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3dS_FpMvvCbVg90H21EOLACvtfcHk0lgEJYWm1zHKWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D&md5=1eacb5ab6e50159f3679e3d8a1f719c4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DCell%2520permeability%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2016%26volume%3D101%26spage%3D42%26epage%3D61%26doi%3D10.1016%2Fj.addr.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span> <span> </span><span class="NLM_article-title">Intermolecular and intramolecular hydrogen bonds involving fluorine atoms: implications for recognition, selectivity, and chemical properties</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2Fcmdc.201100483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=22262517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=262-272&author=C.+Dalvitauthor=A.+Vulpetti&title=Intermolecular+and+intramolecular+hydrogen+bonds+involving+fluorine+atoms%3A+implications+for+recognition%2C+selectivity%2C+and+chemical+properties&doi=10.1002%2Fcmdc.201100483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular and Intramolecular Hydrogen Bonds Involving Fluorine Atoms: Implications for Recognition, Selectivity, and Chemical Properties</span></div><div class="casAuthors">Dalvit, Claudio; Vulpetti, Anna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-272</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A correlation between 19F NMR isotropic chem. shift and close intermol. F···H-X contacts (with X = N or O) has been identified upon anal. of the X-ray crystal structures of fluorinated mols. listed in the Cambridge Structural Database (CSD).  An optimal F···X distance involving primary and shielded secondary fluorine atoms in hydrogen-bond formation along with a correlation between F···H distance and F···H-X angle were also derived from the anal.  The hydrogen bonds involving fluorine are relevant, not only for the recognition mechanism and stabilization of a preferred conformation, but also for improvement in the permeability of the mols., as shown with examples taken from a proprietary database.  Results of an anal. of the small no. of fluorine-contg. natural products listed in the Protein Data Bank (PDB) appear to strengthen the derived correlation between 19F NMR isotropic chem. shift and interactions involving fluorine (also known as the "rule of shielding") and provides a hypothesis for the recognition mechanism and catalytic activity of specific enzymes.  Novel chem. scaffolds, based on the rule of shielding, have been designed for recognizing distinct structural motifs present in proteins.  It is envisaged that this approach could find useful applications in drug design for the efficient optimization of chem. fragments or promising compds. by increasing potency and selectivity against the desired biomol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtfxYsmG4NrVg90H21EOLACvtfcHk0lgEJYWm1zHKWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1CisA%253D%253D&md5=21efccc023f44ed600725e2a834222ae</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100483%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DVulpetti%26aufirst%3DA.%26atitle%3DIntermolecular%2520and%2520intramolecular%2520hydrogen%2520bonds%2520involving%2520fluorine%2520atoms%253A%2520implications%2520for%2520recognition%252C%2520selectivity%252C%2520and%2520chemical%2520properties%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D262%26epage%3D272%26doi%3D10.1002%2Fcmdc.201100483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raub, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M.-J.</span></span> <span> </span><span class="NLM_article-title">How hydrogen bonds impact P-glycoprotein transport and permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6540</span>– <span class="NLM_lpage">6548</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2012.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=23006604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6540-6548&author=P.+V.+Desaiauthor=T.+J.+Raubauthor=M.-J.+Blanco&title=How+hydrogen+bonds+impact+P-glycoprotein+transport+and+permeability&doi=10.1016%2Fj.bmcl.2012.08.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">How hydrogen bonds impact P-glycoprotein transport and permeability</span></div><div class="casAuthors">Desai, Prashant V.; Raub, Thomas J.; Blanco, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6540-6548</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The requirement to cross a biol. membrane can be a complex process esp. if multidrug transporters such as P-gp must be considered.  Drug partitioning into the lipid membrane and efflux by P-gp are tightly coupled processes wherein H-bonding interactions play a key role.  All H-bond donors and acceptors are not equal in terms of the strength of the H-bonds that they form, hence it is important to consider their relative strength.  Using various examples from literature, we illustrate the benefits of considering the relative strengths of individual H-bonds and introducing intramol. H-bonds to increase membrane permeability and/or decrease P-gp efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxB3oN1ILz7LVg90H21EOLACvtfcHk0liWo1pmMjo67g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO&md5=a27f286d4349eec6f76b745b19ccf84f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DP.%2BV.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DBlanco%26aufirst%3DM.-J.%26atitle%3DHow%2520hydrogen%2520bonds%2520impact%2520P-glycoprotein%2520transport%2520and%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6540%26epage%3D6548%26doi%3D10.1016%2Fj.bmcl.2012.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menezes, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voliva, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecchi, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,2- a ]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.bmcl.2016.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=26774655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=742-746&author=W.+Hanauthor=D.+L.+Menezesauthor=Y.+Xuauthor=M.+S.+Knappauthor=R.+Ellingauthor=M.+T.+Burgerauthor=Z.-J.+Niauthor=A.+Smithauthor=J.+Lanauthor=T.+E.+Williamsauthor=J.+Verhagenauthor=K.+Huhauthor=H.+Merrittauthor=J.+Chanauthor=S.+Kaufmanauthor=C.+F.+Volivaauthor=S.+Pecchi&title=Discovery+of+imidazo%5B1%2C2-+a+%5D-pyridine+inhibitors+of+pan-PI3+kinases+that+are+efficacious+in+a+mouse+xenograft+model&doi=10.1016%2Fj.bmcl.2016.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model</span></div><div class="casAuthors">Han, Wooseok; Menezes, Daniel L.; Xu, Yongjin; Knapp, Mark S.; Elling, Robert; Burger, Matthew T.; Ni, Zhi-Jie; Smith, Aaron; Lan, Jiong; Williams, Teresa E.; Verhagen, Joelle; Huh, Kay; Merritt, Hanne; Chan, John; Kaufman, Susan; Voliva, Charles F.; Pecchi, Sabina</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-746</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alterations in PI3K/AKT signaling are known to be implicated with tumorigenesis.  The PI3 kinases family of lipid kinases has been an attractive therapeutic target for cancer treatment.  Imidazopyridine compd. 1, a potent, selective, and orally available pan-PI3K inhibitor, identified by scaffold morphing of a benzothiazole hit, was further optimized in order to achieve efficacy in a PTEN-deleted A2780 ovarian cancer mouse xenograft model.  With a hypothesis that a planar conformation between the core and the 6-heteroaryl ring will allow for the accommodation of larger 5'-substituents in a hydrophobic area under P-loop, SAR efforts focused on 5'-alkoxy heteroaryl rings at the 6-position of imidazopyridine and imidazopyridazine cores that have the same dihedral angle of zero degrees. 6'-Alkoxy 5'-aminopyrazines in the imidazopyridine series were identified as the most potent compds. in the A2780 cell line.  Compd. 14 with 1,1,1-trifluoroisopropoxy group at 6'-position demonstrated excellent potency and selectivity, good oral exposure in rats and in vivo efficacy in A2780 tumor-bearing mouse.  Also, we disclose the X-ray co-crystal structure of one enantiomer of compd. 14 in PI3Kα, confirming that the trifluoromethyl group fits nicely in the hydrophobic hot spot under P-loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrX15ON5F9MLVg90H21EOLACvtfcHk0liWo1pmMjo67g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1KnsQ%253D%253D&md5=7cf6665595e375797277dcb413a86c24</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DMenezes%26aufirst%3DD.%2BL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DM.%2BS.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DT.%2BE.%26aulast%3DVerhagen%26aufirst%3DJ.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DMerritt%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DVoliva%26aufirst%3DC.%2BF.%26aulast%3DPecchi%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-%2520a%2520%255D-pyridine%2520inhibitors%2520of%2520pan-PI3%2520kinases%2520that%2520are%2520efficacious%2520in%2520a%2520mouse%2520xenograft%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D742%26epage%3D746%26doi%3D10.1016%2Fj.bmcl.2016.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">Structure of compound <b>13</b> in PIM1 submitted under PDB accession code 1ozrb.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0liWo1pmMjo67g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">For compounds <b>4</b>, <b>5</b>, <b>11</b>, and <b>12</b>, IC<sub>50</sub> values for hERG potassium channel were >30 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">The synthesis of intermediates <b>16</b> and <b>18</b> was previously reported (see ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, A.</span></span> <span> </span><span class="NLM_article-title">Practical and environmentally friendly epoxidation of olefins using oxone</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1021/op025511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op025511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkt1aitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=405-406&author=N.+Hashimotoauthor=A.+Kanda&title=Practical+and+environmentally+friendly+epoxidation+of+olefins+using+oxone&doi=10.1021%2Fop025511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Practical and Environmentally Friendly Epoxidation of Olefins Using Oxone</span></div><div class="casAuthors">Hashimoto, Norio; Kanda, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-406</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical and efficient epoxidn. of arom. olefins using Oxone in a two-phase system (Et acetate-water) is described.  The reported method is suitable for large-scale synthesis and does not require a phase transfer catalyst or pH control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq078ECHtUpFrVg90H21EOLACvtfcHk0ljjMYEwJR7Jng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkt1aitbw%253D&md5=cbcec562a0f97b20d972f648aa07f4b0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fop025511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop025511f%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DKanda%26aufirst%3DA.%26atitle%3DPractical%2520and%2520environmentally%2520friendly%2520epoxidation%2520of%2520olefins%2520using%2520oxone%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D405%26epage%3D406%26doi%3D10.1021%2Fop025511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perali, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduri, V. R.</span></span> <span> </span><span class="NLM_article-title">An unexpected migration of O-silyl group under Mitsunobu reaction conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3045</span>– <span class="NLM_lpage">3047</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fj.tetlet.2011.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=3045-3047&author=R.+S.+Peraliauthor=S.+Mandavaauthor=V.+R.+Chunduri&title=An+unexpected+migration+of+O-silyl+group+under+Mitsunobu+reaction+conditions&doi=10.1016%2Fj.tetlet.2011.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An unexpected migration of O-silyl group under Mitsunobu reaction conditions</span></div><div class="casAuthors">Perali, Ramu Sridhar; Mandava, Suresh; Chunduri, Venkata Rao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3045-3047</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A 1,4 O→O silyl migration followed by nucleophilic substitution with phthalimide was obsd. under Mitsunobu reaction conditions.  This one step secondary alc. protection and primary alc. substitution with N-nucleophiles was extended to a variety of 2-hydroxyethyl trialkylsilyl-ether derivs.  A possible mechanism has been postulated based on the pKa values of the alc. and nucleophile.  The present one-pot silyl migration and substitution reaction might find application in the stereoselective synthesis of novel imino-sugar derived anti diabetic agents, e.g. I .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr0ramWWDmirVg90H21EOLACvtfcHk0ljjMYEwJR7Jng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWnu7w%253D&md5=711eebc1561ea2cee8b604dd2bd3ea16</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DPerali%26aufirst%3DR.%2BS.%26aulast%3DMandava%26aufirst%3DS.%26aulast%3DChunduri%26aufirst%3DV.%2BR.%26atitle%3DAn%2520unexpected%2520migration%2520of%2520O-silyl%2520group%2520under%2520Mitsunobu%2520reaction%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D3045%26epage%3D3047%26doi%3D10.1016%2Fj.tetlet.2011.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanRheenen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. Y.</span></span> <span> </span><span class="NLM_article-title">An improved catalytic OsO4 oxidation of olefins to -1,2-glycols using tertiary amine oxides as the oxidant</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(00)78093-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1016%2Fs0040-4039%2800%2978093-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1976&pages=1973-1976&author=V.+VanRheenenauthor=R.+C.+Kellyauthor=D.+Y.+Cha&title=An+improved+catalytic+OsO4+oxidation+of+olefins+to+-1%2C2-glycols+using+tertiary+amine+oxides+as+the+oxidant&doi=10.1016%2Fs0040-4039%2800%2978093-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fs0040-4039%2800%2978093-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0040-4039%252800%252978093-2%26sid%3Dliteratum%253Aachs%26aulast%3DVanRheenen%26aufirst%3DV.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DCha%26aufirst%3DD.%2BY.%26atitle%3DAn%2520improved%2520catalytic%2520OsO4%2520oxidation%2520of%2520olefins%2520to%2520-1%252C2-glycols%2520using%2520tertiary%2520amine%2520oxides%2520as%2520the%2520oxidant%26jtitle%3DTetrahedron%2520Lett.%26date%3D1976%26volume%3D17%26spage%3D1973%26epage%3D1976%26doi%3D10.1016%2Fs0040-4039%2800%2978093-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span> <span> </span><span class="NLM_article-title">A direct preparation of 6-methylene-2-cyclohexenones</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1055/s-2004-829162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1055%2Fs-2004-829162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1737-1738&author=G.+Krausauthor=J.+Kim&title=A+direct+preparation+of+6-methylene-2-cyclohexenones&doi=10.1055%2Fs-2004-829162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A direct preparation of 6-methylene-2-cyclohexenones</span></div><div class="casAuthors">Kraus, George A.; Kim, Junwon</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1737-1738</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Enol silyl ethers underwent methylation with Eschenmoser's salt, followed by elimination to provide 6-methylene-2-cyclohexenones I (R1 = H, Me; R2 = H; R1 = H; R2 = Me) in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBpGmFd45iTLVg90H21EOLACvtfcHk0ljjMYEwJR7Jng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeis70%253D&md5=fb7e9f3489346c19250faac9b8497326</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-829162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-829162%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DA%2520direct%2520preparation%2520of%25206-methylene-2-cyclohexenones%26jtitle%3DSynthesis%26date%3D2004%26spage%3D1737%26epage%3D1738%26doi%3D10.1055%2Fs-2004-829162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berti, G.</span></span> <span> </span><span class="NLM_article-title">Stereochemical aspects of the synthesis of 1,2-epoxides</span>. In  <i>Topics in Stereochemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allinger, N. L.</span>, <span class="NLM_string-name">Eliel, E. L.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York, London, Sydney, Toronto</span>, <span class="NLM_year">1973</span>; Vol.  <span class="NLM_volume">7</span>, p  <span class="NLM_fpage">93</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1002%2F9780470147160.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=93&author=G.+Bertiauthor=N.+L.+Allinger&author=E.+L.+Eliel&title=Topics+in+Stereochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2F9780470147160.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470147160.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DBerti%26aufirst%3DG.%26atitle%3DStereochemical%2520aspects%2520of%2520the%2520synthesis%2520of%25201%252C2-epoxides%26btitle%3DTopics%2520in%2520Stereochemistry%26aulast%3DAllinger%26aufirst%3DN.%2BL.%26pub%3DWiley%26date%3D1973%26volume%3D7%26spage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="note"><p class="first last">To further confirm the stereochemistry, we synthesized two regioisomeric epoxides through either direct mCPBA reaction or bromohydrin/ring closing reactions of 36 (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Also, see ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> for similar examples.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liepold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestmann, H. J.</span></span> <span> </span><span class="NLM_article-title">An improved one-pot procedure for the synthesis of alkynes from aldehydes</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1055/s-1996-5474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1055%2Fs-1996-5474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaK28XjvVGnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=521-522&author=S.+M%C3%BCllerauthor=B.+Liepoldauthor=G.+J.+Rothauthor=H.+J.+Bestmann&title=An+improved+one-pot+procedure+for+the+synthesis+of+alkynes+from+aldehydes&doi=10.1055%2Fs-1996-5474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">An improved one-pot procedure for the synthesis of alkynes from aldehydes</span></div><div class="casAuthors">Mueller, Stephen; Liepold, Bernd; Roth, Gerald J.; Bestmann, Hans Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">521-522</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Thieme</span>)
        </div><div class="casAbstract">The transformation of aldehydes, e.g., C6H4(CHO)2-1,3, to terminal alkynes, e.g., C6H4(C≡CH)2-1,3, can be achieved with the reagent di-Me 1-diazo-2-oxopropylphosphonate.  The one-pot procedure allows the isolation of the products under very mild conditions in good to excellent yields without requiring low temps. or inert gas techniques, and it avoids the use of strong bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQjURxPuC08LVg90H21EOLACvtfcHk0ljlSvP5SVdMjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVGnsrc%253D&md5=3fa1081fc8359ab7723704758ae3e7a2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1055%2Fs-1996-5474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1996-5474%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DLiepold%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DBestmann%26aufirst%3DH.%2BJ.%26atitle%3DAn%2520improved%2520one-pot%2520procedure%2520for%2520the%2520synthesis%2520of%2520alkynes%2520from%2520aldehydes%26jtitle%3DSynlett%26date%3D1996%26spage%3D521%26epage%3D522%26doi%3D10.1055%2Fs-1996-5474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohira, S.</span></span> <span> </span><span class="NLM_article-title">Methanolysis of dimethyl (1-diazo-2-oxopropyl) phosphonate: generation of dimethyl (diazomethyl) phosphonate and reaction with carbonyl compounds</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1080/00397918908050700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1080%2F00397918908050700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1989&pages=561-564&author=S.+Ohira&title=Methanolysis+of+dimethyl+%281-diazo-2-oxopropyl%29+phosphonate%3A+generation+of+dimethyl+%28diazomethyl%29+phosphonate+and+reaction+with+carbonyl+compounds&doi=10.1080%2F00397918908050700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Methanolysis of dimethyl (1-diazo-2-oxopropyl)phosphonate:  generation of dimethyl (diazomethyl)phosphonate and reaction with carbonyl compounds</span></div><div class="casAuthors">Ohira, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Treatment of MeCOC(N2)PO3Me2 with K2CO3 in MeOH afforded N2CHPO3Me2 (I), which was used in situ for the synthesis of enol ethers or alkynes.  Thus, I and cyclohexanone or decanal afforded (methoxymethylene)cyclohexane or 1-undecyne, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmw2veCJW5vbVg90H21EOLACvtfcHk0ljlSvP5SVdMjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltlegsLc%253D&md5=55a1aab8bf13ca7835e3609d138fe2de</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F00397918908050700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918908050700%26sid%3Dliteratum%253Aachs%26aulast%3DOhira%26aufirst%3DS.%26atitle%3DMethanolysis%2520of%2520dimethyl%2520%25281-diazo-2-oxopropyl%2529%2520phosphonate%253A%2520generation%2520of%2520dimethyl%2520%2528diazomethyl%2529%2520phosphonate%2520and%2520reaction%2520with%2520carbonyl%2520compounds%26jtitle%3DSynth.%2520Commun.%26date%3D1989%26volume%3D19%26spage%3D561%26epage%3D564%26doi%3D10.1080%2F00397918908050700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3034-3045&author=W.+Hanauthor=Y.+Dingauthor=Y.+Xuauthor=K.+Pfisterauthor=S.+Zhuauthor=B.+Warneauthor=M.+Doyleauthor=M.+Aikawaauthor=P.+Amiriauthor=B.+Appletonauthor=D.+D.+Stuartauthor=A.+Fanidiauthor=C.+M.+Shafer&title=Discovery+of+a+Selective+and+Potent+Inhibitor+of+Mitogen-Activated+Protein+Kinase-Interacting+Kinases+1+and+2+%28MNK1%2F2%29+Utilizing+Structure-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.5b01657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design</span></div><div class="casAuthors">Han, Wooseok; Ding, Yu; Xu, Yongjin; Pfister, Keith; Zhu, Shejin; Warne, Bob; Doyle, Mike; Aikawa, Mina; Amiri, Payman; Appleton, Brent; Stuart, Darrin D.; Fanidi, Abdallah; Shafer, Cynthia M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3034-3045</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a highly potent and selective small mol. inhibitor I for in vitro target validation of MNK1/2 kinases is described.  The aminopyrazine benzimidazole series was derived from an HTS hit and optimized by utilization of a docking model, conformation anal., and binding pocket comparison against antitargets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBT5jenqIBHLVg90H21EOLACvtfcHk0ljlSvP5SVdMjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D&md5=b4c3eb8122635da657fa52daddb6879a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01657%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWarne%26aufirst%3DB.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DM.%26aulast%3DAmiri%26aufirst%3DP.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DD.%2BD.%26aulast%3DFanidi%26aufirst%3DA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520Selective%2520and%2520Potent%2520Inhibitor%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Interacting%2520Kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520Utilizing%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3034%26epage%3D3045%26doi%3D10.1021%2Facs.jmedchem.5b01657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wölker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of optically active vicinal fluorohydrins by lipase-catalyzed deracemization</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">3015</span>– <span class="NLM_lpage">3021</span>, <span class="refDoi"> DOI: 10.1021/jo016331r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo016331r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A280%3ADC%252BD383jvVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=3015-3021&author=D.+W%C3%B6lkerauthor=G.+Haufe&title=Synthesis+of+optically+active+vicinal+fluorohydrins+by+lipase-catalyzed+deracemization&doi=10.1021%2Fjo016331r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of optically active vicinal fluorohydrins by lipase-catalyzed deracemization</span></div><div class="casAuthors">Wolker Dorthe; Haufe Gunter</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of organic chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3015-21</span>
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Three microbial lipases have been used to deracemize trans-2-fluorocycloalkanols 2 both by hydrolysis of the corresponding acetates 3 or chloroacetates 4 and by esterification of the fluorohydrins 2 using vinyl acetate and vinyl chloroacetate, respectively.  Pseudomonas cepacia lipase was the most selective for the six- and the seven-membered-ring compounds, while the lipase from Candida rugosa was most useful for the eight-membered-ring compounds.  Both lipases transform the (R)-enantiomers preferentially.  In contrast the lipase from Candida antarctica hydrolyzed the esters of trans-2-fluorocyclohexanol 2a and esterified the fluorohydrin itself with very low enantiopreference for the (R)-isomers.  The seven- and the eight-membered ring esters and the corresponding fluorohydrins were also transformed with low, but reverse, enantioselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRABkx-oVEvhLesJRIHUP1ofW6udTcc2ebe_qkfFYuqHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383jvVygtA%253D%253D&md5=2b390a0da66b890ae25e454e413e3cde</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo016331r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo016331r%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6lker%26aufirst%3DD.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520optically%2520active%2520vicinal%2520fluorohydrins%2520by%2520lipase-catalyzed%2520deracemization%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D3015%26epage%3D3021%26doi%3D10.1021%2Fjo016331r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jünnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanasova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindona, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aksnes, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, G. W.</span></span> <span> </span><span class="NLM_article-title">Reaction of Epoxyaldonolactones with HF--Amine Complexes</span>. <i>Acta Chem. Scand.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.3891/acta.chem.scand.48-0265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.3891%2Facta.chem.scand.48-0265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFKiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1994&pages=265-268&author=J.+J%C3%BCnnemannauthor=I.+Lundtauthor=J.+Thiemauthor=C.+B.+Ivanovauthor=R.+Atanasovaauthor=A.+Napoliauthor=G.+Sindonaauthor=D.+W.+Aksnesauthor=G.+W.+Francis&title=Reaction+of+Epoxyaldonolactones+with+HF%2D%2DAmine+Complexes&doi=10.3891%2Facta.chem.scand.48-0265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of epoxyaldonolactones with HF-amine complexes</span></div><div class="casAuthors">Juennemann, Josef; Lundt, Inge; Thiem, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Acta Chemica Scandinavica</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-8</span>CODEN:
                <span class="NLM_cas:coden">ACHSE7</span>;
        ISSN:<span class="NLM_cas:issn">0904-213X</span>.
    </div><div class="casAbstract">The opening of 2,3-epoxyaldonolactones, e.g. I, with trialkylamine·3HF gave 2-deoxy-2-fluoroaldonolactones, e.g. II and III regio- and stereoselectively, while collidine·3HF gave a mixt. of 2-deoxy-2-fluoro- and 3-deoxy-3-fluoro-lactones in a 2:1 ratio.  Pyridine·3HF and Olah's reagent gave complex mixts.  5,6-Epoxyhexonolactones were opened exclusively at C-6, using the tris(hydrogen fluoride) complex of either triethylamine, collidine or pyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1xtPfSjXwzLVg90H21EOLACvtfcHk0liqD5PZHTysLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFKiurY%253D&md5=a0f36378f4038d2b41d313541e2d130d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.48-0265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.48-0265%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25BCnnemann%26aufirst%3DJ.%26aulast%3DLundt%26aufirst%3DI.%26aulast%3DThiem%26aufirst%3DJ.%26aulast%3DIvanov%26aufirst%3DC.%2BB.%26aulast%3DAtanasova%26aufirst%3DR.%26aulast%3DNapoli%26aufirst%3DA.%26aulast%3DSindona%26aufirst%3DG.%26aulast%3DAksnes%26aufirst%3DD.%2BW.%26aulast%3DFrancis%26aufirst%3DG.%2BW.%26atitle%3DReaction%2520of%2520Epoxyaldonolactones%2520with%2520HF--Amine%2520Complexes%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1994%26volume%3D48%26spage%3D265%26epage%3D268%26doi%3D10.3891%2Facta.chem.scand.48-0265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span> <span> </span><span class="NLM_article-title">Fluorination methods for drug discovery and development</span>. <i>Expet Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1080/17460441.2016.1223037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1080%2F17460441.2016.1223037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=27548817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyisL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=983-999&author=P.+Richardson&title=Fluorination+methods+for+drug+discovery+and+development&doi=10.1080%2F17460441.2016.1223037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination methods for drug discovery and development</span></div><div class="casAuthors">Richardson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">983-999</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The pivotal role that the element fluorine plays in modulating the properties of bioactive mols. is reflected by the growth of its presence in approved drugs.  In 1970, approx. 2% of drugs contained fluorine with this no. rising to 25% by 2011.  The synthetic chem. regarding incorporation of fluorine into org. mols. has also evolved over this time with a paradigm shift from harsh, toxic, hazardous reagents utilized primarily by specialist vendors to new deoxyfluorination reagents and metal-mediated techniques capable of the precise introduction of fluorine into complex org. substrates under relatively mild conditions.  This review highlights the importance of fluorinated compds. in drug discovery, and provides an overview on the synthetic strategies and methodologies developed to access them both in discovery and development.  The development of new reagents for the safe and precise regioselective fluorination of biol. relevant compds. particularly in drug discovery remains a contemporary challenge in org. chem.  However, significant strides have been made with the development of new deoxyfluorination reagents and the emergence of practical metal-mediated fluorination techniques have enabled the goal of efficient late-stage fluorination of drug-like compds. to be realized, and the extension of these methods for PET-labeling is being investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBVKZBu8dlW7Vg90H21EOLACvtfcHk0liqD5PZHTysLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyisL7K&md5=a0f4772a1287ecef6afee01a0570b037</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F17460441.2016.1223037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2016.1223037%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%26atitle%3DFluorination%2520methods%2520for%2520drug%2520discovery%2520and%2520development%26jtitle%3DExpet%2520Opin.%2520Drug%2520Discov.%26date%3D2016%26volume%3D11%26spage%3D983%26epage%3D999%26doi%3D10.1080%2F17460441.2016.1223037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yerien, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postigo, A.</span></span> <span> </span><span class="NLM_article-title">Fluorination methods in drug discovery</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">8398</span>– <span class="NLM_lpage">8427</span>, <span class="refDoi"> DOI: 10.1039/c6ob00764c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=10.1039%2Fc6ob00764c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=27506398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=8398-8427&author=D.+E.+Yerienauthor=S.+Bonesiauthor=A.+Postigo&title=Fluorination+methods+in+drug+discovery&doi=10.1039%2Fc6ob00764c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination methods in drug discovery</span></div><div class="casAuthors">Yerien, Damian E.; Bonesi, Sergio; Postigo, Al</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">8398-8427</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Fluorination reactions of medicinal and biol.-active compds. will be discussed.  Late stage fluorination strategies of medicinal targets have recently attracted considerable attention on account of the influence that a fluorine atom can impart to targets of medicinal importance, such as modulation of lipophilicity, electronegativity, basicity and bioavailability, the latter as a consequence of membrane permeability.  Therefore, the recourse to late-stage fluorine substitution on compds. with already known and relevant biol. activity can provide the pharmaceutical industry with new leads with improved medicinal properties.  The fluorination strategies will take into account different fluorinating reagents, either of nucleophilic or electrophilic, and of radical nature.  Diverse families of org. compds. such as (hetero)arom. rings, and aliph. substrates (Sp3, Sp2, and sp carbon atoms) will be studied in late-stage fluorination reaction strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG13ztU9olzrVg90H21EOLACvtfcHk0liqD5PZHTysLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygt7rJ&md5=ee09c5e4464f2538460c03ecadc90123</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fc6ob00764c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc6ob00764c%26sid%3Dliteratum%253Aachs%26aulast%3DYerien%26aufirst%3DD.%2BE.%26aulast%3DBonesi%26aufirst%3DS.%26aulast%3DPostigo%26aufirst%3DA.%26atitle%3DFluorination%2520methods%2520in%2520drug%2520discovery%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D8398%26epage%3D8427%26doi%3D10.1039%2Fc6ob00764c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR','PDB','5DWR'); return false;">PDB: 5DWR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1oblv" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1oblv','PDB','1oblv'); return false;">PDB: 1oblv</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ozrb" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ozrb','PDB','1ozrb'); return false;">PDB: 1ozrb</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01279">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35205"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01279?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01279</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Kinase selectivity profiles for compounds <b>5</b> and <b>11</b> and LCMS and HPLC spectra for representative compounds <b>5</b>, <b>11</b>, and <b>14</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and statistical analysis of the associated biochemical data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_002.csv">CSV</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_003.xlsx">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_001.pdf">jm0c01279_si_001.pdf (1.19 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_002.csv">jm0c01279_si_002.csv (1.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01279/suppl_file/jm0c01279_si_003.xlsx">jm0c01279_si_003.xlsx (12.27 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes of compounds <b>5</b> and <b>13</b> in PIM1 are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1oblv">1oblv</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ozrb">1ozrb</a>, respectively. The atomic coordinates will be released upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01279&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01279%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01279" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996440ae6423c8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
